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Preface 
 
This thesis is submitted in partial fulfillment of the requirements for the degree of 
Philosophiae Doctor (Ph.D) at the Norwegian university of Science and Technology (NTNU) 
and consists of five papers. The work presented herein was mainly performed at the Ugelstad 
Laboratory at the Department of Chemical Engineering, at the stem cell lab at the Department 
of Circulation and Medical Imaging, and at the NTNU NanoLab. The project has been funded 
by research and development funds from NTNU, and support from MyFab/NorFab. The work 
has been supervised by Professor II Dr. Wilhelm Robert Glomm, and co-supervised by Dr. 
Ioanna Sandvig and MD, PhD Axel Sandvig.  
 I completed my Master of Science in Biotechnology with a spcialization in 
biochemistry and biopolymer chemistry at the Department of Biotechnology at NTNU in June 
2012. I was accepted as a PhD candidate at the Ugelstad Laboratory, Department of Chemical 
Engineering in August 2012.  
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No Small Matter 
 
The human body is a fortress  
wreathed in a red vortex 
of wriggling insatiable crocodile cells  
 
A hostile place for a nanoparticle. 
Getting by,  
is no small matter. 
 
The human cell is fortified   
braided in garland forests   
of branched glycosylated protein trees  
 
the viscous fluid-like membrane protecting its holy grail: 
the intracellular space. 
 
A tremendous jungle for a nanoparticle 
Getting in,  
is no small matter. 
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Abstract 
Bioimaging is a broad term that covers all processes in which biological tissues are imaged. It 
can range from single-cell visualization with fluorescence microscopy, to imaging of brain 
structures in living human beings with magnetic resonance imaging. As such, the term is not 
only interesting from a researcher’s point of view, but also to existing medical technologies.  
Imaging living organisms is mainly based on existing tissue densities between blood, 
brain, cartilage, and bone. However, in some cases these differences are not sufficient to 
separate e.g pathological tissue from healthy tissue. In these instances, a contrast agent may 
be administered to alter the contrast in the region of interest. Bioimaging of excised tissue 
usually involve staining with a dye that binds specifically to a cellular organelle or membrane, 
making it easier to separate intracellular structures from each other. Bioimaging of living and 
excised tissue both involves an external probe that enhances the available information in the 
image. Such probes must be synthesized from materials that are likely to improve the 
acquisition of the image, and must also have few toxic side-effects.  
Nanomaterials are in the size-range of molecules and proteins, and can potentially 
traverse cellular membranes as well as being systemically administered. Nanoparticles are 
described as multifunctional because they can show a range of optical responses, carry drugs 
and vibrate in response to heat. The nanomaterials in this thesis were chosen based on their 
plasmonic and magnetic properties, as well as their biocompatibility.   
The aim of this thesis is twofold. The first aim is to fully characterize and synthesize 
plasmonic nanomaterials of gold with biomineralization from proteins and from chemical 
synthesis. The second aim is synthesis and characterization of magnetic nanomaterials of iron 
and manganese. Characterization in this sense refers not only to physical description of the 
nanoparticles or nanoconstructs, but involves describing how these nanomaterials interact 
with biological tissues in vitro or in vivo, to assess their potential for bioimaging, 
hyperthermia and drug delivery.   
A plethora of methods have been used to characterize the nanomaterials synthesized in 
this thesis. The nanomaterials of gold synthesized from proteins were described with a range 
of optical techniques such as UV-visible and steady state spectroscopy, and time-correlated 
single-photon counting. Size and shape was assessed with dynamic light scattering, scanning 
transmission electron microscopy and high resolution transmission electron microscopy. The 
surface charge was determined with zeta potential measurements. The crystalinity and 
composition of nanoparticles were characterized with X-ray diffraction spectroscopy, and 
surface composition was described with X-ray photoelectron spectroscopy. Interactions 
between protein-stabilized nanomaterials and model membranes were described with 
Langmuir-trough studies and atomic force microscopy. Magnetic nanomaterials were 
characterized with magnetic resonance imaging and zero field cooling. Further, nanomaterials 
were co-incubated with human cancer and/or rodent cells to assess their in vitro uptake or 
cytotoxicity. The methods for in vitro assays involved fluorescence microscopy and a 
cytotoxicity assay. Finally, ultramicrotome sectioning and scanning transmission electron 
microscopy was used to describe cellular uptake as a function of time.     
 The main findings in the first part of this thesis are that fluorescent protein-gold 
nanoconstructs show membrane interactions radically different from the native protein. We 
also describe how protein-directed self-assembly of fluorescent gold nanoclusters and 
plasmonic nanoparticles can be tuned to yield different optical gold nanostructures. In the 
second part of this thesis, the main findings are size, - and shape-dependent uptake of novel 
V 
plasmonic and magnetic nanoparticles in vitro, as well as cell actuation in a magnetic field. 
The final part of this thesis culminates in synthesis of a nanoparticle system that can give dual 
contrast in magnetic resonance imaging while at the same time release a drug.   
VI 
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1 Motivation 
 
“There’s plenty of room at the bottom” 
- Richard Feynman, 1959 
 
Colloidal gold has been used for millennia for decoration and glass staining. When 
glassblowers mixed gold salt into the molten glass, the end-product would give off a beautiful 
red color. The reason for this color change was not known for a long time. A breakthrough 
came in the 1850’s, when Michael Faraday first synthesized colloidal gold and described that 
the color of the suspension was caused by interactions between these miniscule particles of 
gold and the incoming ray of light.
1
 However, the seed that would eventually grow into a field 
called nanotechnology was planted by Richard Feynman during a lecture held in 1959. The 
quotation above sparked the idea of creating and manipulating materials through a bottom-up 
assembly of atoms. This is the essence of creating atomically scaled materials, or 
nanomaterials, which is one of the main aims of this thesis.    
 The properties of nanomaterials arise from their size (1-100 nm), which give them 
remarkably different characteristics compared to their bulk counterparts. For instance, the 
optical properties of gold change with size and shape: bulk gold is a noble metal with a 
characteristic metallic yellow color, while nanoparticles (NPs) of gold resonate with light and 
can be red, purple, blue and orange depending on their size, shape and aggregation state. Bulk 
gold is chemically inert, in contrast to gold nanoparticles which can have catalytic activity. 
When gold nanoparticles are below a critical size, they even display molecular fluorescence.  
 The physical and chemical properties of NPs are advancing a field named 
nanobiotechnology, which can be defined as the use of fabricated nanomaterials in biological 
systems and applications. Although nanobiotechnology is largely an experimental field, the 
applications of nanomaterials can be translatable into current medical technologies, 
particularly in bioimaging. This includes diagnostic imaging techniques such as magnetic 
resonance imaging (MRI), positron emission tomography (PET), computed tomography (CT), 
ultrasound (US), and in-vivo near-infrared fluorescence (NIRF) imaging that are currently 
being used to diagnose e.g cancer, cardiac diseases, and Alzheimer’s disease. Bioimaging not 
only refers to imaging of internal organs, but also covers imaging down to single cells and 
excised tissue that has been fixated for observation.      
 The above mentioned bioimaging techniques often rely on additional contrast agents 
or probes, that typically are chemical compounds that alter the contrast through e.g  
fluorescence, X-ray scattering or magnetic susceptibility. This allows enhanced information 
retrieval which can further improve the diagnostic value of the imaging tool. However, 
current contrast agents typically serve only one function: altering the contrast. Nanoparticles 
offer the possibility of multifunctionality both by additive and emergent properties which can 
arise from surface modification with drugs, antibodies or any other biological molecule that 
serve a therapeutic or improved diagnostic function. For instance, magnetic nanoparticles, 
such as iron oxide nanoparticles, have magnetic properties that can be induced and thereby 
controlled by an external magnetic field. This effect can be utilized in modern medical 
technologies, such as in MRI or hyperthermia applications. If these NPs are combined with a 
biologically active molecule, such as a drug, they could potentially act as drug delivery 
vehicles as well. The real potential of nanoparticles is thus fulfilled when they are combined 
2 
 
with biological molecules or drugs which enables a multifunctional probe that can 
simultaneously be visualized and have a therapeutic function.   
  Although nanoparticles offer a range of functionalities not seen in today’s contrast 
agents, administering them for diagnostic purposes still involves high risk, and targeting NPs 
to a site of action still remains a tremendous challenge: NPs should be stable in a range of pH-
values, be non-toxic, escape the reticuloendothelial system, and be safely cleared from the 
body.
2-6
 This is the Pandora’s Box of nanoparticles; introducing them to the body could cause 
more harm than good. Thus, nanoparticles prepared for bioimaging and therapy must be 
steered in the direction of biocompatible bioimaging probes that have a significant signal-to-
noise ratio and that are safely removed from the body.  
 In this thesis, the focus has been on synthesizing novel nanomaterials that serve more 
than one function; several optical properties, magnetic susceptibility, and drug delivery. 
Additionally, the nanomaterials synthesized herein have been tested in biological systems, not 
only to investigate their bioimaging function but also to describe their biocompatibility.  
Specifically, this thesis aims at synthesizing and characterizing multifunctional plasmonic 
and magnetically active biocompatible nanomaterials for bioimaging applications. The work 
has been restricted to mainly three elements; gold, iron and manganese. The major reasons 
being size-tunability and optical and magnetical properties beneficial for bioimaging 
applications. Different methods were used to synthesize these nanomaterials, and they have 
been divided into two groups; the hybrid nanomaterials and magnetic nanoparticles. The 
former group involved synthesis of fluorescent and plasmonic gold nanostructures with two 
different proteins; Transferrin and bovine serum albumin, while the latter group involved 
chemical synthesis of gold nanostructures, iron oxide NPs and manganese oxide NPs.  
 The first part of this thesis aims at contributing to an increased understanding on how 
transferrin and bovine serum albumin can synthesize gold nanomaterials through 
characterization, in vitro work, and describing how growth of these constructs, and 
concomitantly the optical properties, can be tuned. The second part of this thesis aims at 
synthesizing and characterizing superparamagnetic and paramagnetic nanoparticles of 
different morphologies that are to be used as contrast agents in magnetic resonance imaging 
and potential drug delivery and hyperthermia applications.  
 Moreover, all the nanomaterials synthesized herein were assessed either in vitro or in 
vivo to increase the understanding of how nanoparticles prepared from different elements and 
with different shapes interact with cells and living animals. Nanomaterials prepared from iron 
oxide and manganese  were taken to further studies in vivo with the aim of investigating their 
properties as bioimaging probes and potential drug delivery vehicles in a living system.   
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2 Hybrid Nanomaterials 
 
Two classes of nanomaterials are synthesized, characterized and applied in this thesis and are 
divided into two groups based on their synthetic routes: either biomineralized with proteins or 
via thermal decomposition in organic solvents.  The latter group is comprised of magnetically 
active nanoparticles, which are introduced in the next chapter.  
 Proteins offer two properties particularly important for synthesis of gold nano species; 
first, their inherent reduction potential is sufficient to convert ionic gold into solid gold.
I
 
Secondly; the protein is a steric stabilizer that creates stable suspensions even in buffers. 
II
 
 Nanomaterials synthesized from protein biomineralization are here called hybrid 
nanomaterials, as the final product consists of a metallic structure (gold nanoconstruct) 
stabilized in a biological molecule (protein). These hybrid nanomaterials will be the focus of 
this chapter, starting with a basic introduction to proteins. Then, an overview of the optical 
properties of gold nanoclusters and gold nanoparticles are given. Finally, the applications of 
these unique hybrid nanomaterials are reviewed.  
2.1 Proteins  
 
Proteins are the functional expression of which the genetic code is conveyed, and proteins are 
the basis for all cellular functions. The functional properties of proteins arise from their 
structure, which governs flexibility, hydrodynamic volume, and hydrophobic pockets that can 
have catalytic activities. Irrespective of species, all proteins are built up of the same 20 amino 
acids, and the composition and sequence of these amino acids determine the final structure of 
the protein. The combined physical and chemical properties of amino acids will ultimately 
decide the structure of the protein. Some amino acids are hydrophobic, while some are 
hydrophilic and folding of the polypeptide is largely based on hydrophilic and hydrophobic 
interactions with water. For instance, water soluble proteins found in the blood stream have 
their hydrophilic amino acids mainly at the protein surface, while hydrophobic amino acids 
are forced to the interior part of the protein. In the case of membrane spanning proteins, they 
are partitioned in the membrane in such a way that hydrophobic domains reside in the interior 
of the membrane, while hydrophilic domains prefer to stay at the outer part of the membrane. 
In this way, the loss of entropy from surrounding water molecules is kept to a minimum.  
 In the cell, proteins are synthesized by cytosolic ribosomes from an mRNA strand. 
The mRNA is converted into a polypeptide chain that gradually grows and protrudes from the 
ribosome in an unfolded state. Proteins can contain several domains that can be up to 100 
amino acids long, and correct folding of a domain requires a remarkable molecular 
recognition that was initially hypothesized to be spontaneous. However, correct folding of 
non-native proteins was later shown to be mediated by an army of proteins named 
chaperones. 
7, 8
 Misfolded proteins are usually devoid of normal biological activity, and these 
are normally degraded as they pose a potential threat to the cell. 
7
 However, if degradation 
does not occur, they can aggregate or interact with cells in an unwanted manner. 
9, 10
 For 
example, in Alzheimer’s disease, neurodegeneration is caused by amyloid plaques formed by 
misfolded β-amyloid protein aggregation, 11, 12 and it is hypothesized that chaperones play a 
critical role in the development of the disease. 
13
 Interestingly, some proteins must actually be 
                                                 
I
 Standard reduction potential to reduce Au
3+
 to Au(s) is 1.40 E°(V) 
II
 AuNPs crash out in high saline solvents due to reduced thickness of the electrical double layer.   
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in an unfolded or disordered state to be functional. These proteins comprise approximately 30 
% of all proteins and are named intrinsically disordered proteins. 
14
 
 Due to the close link between the function and structure of proteins, it is useful to 
describe their structure in hierarchical levels of complexity. The primary structure of a 
protein is a description of the amino acid sequence and any disulfide bridges (S-S) binding the 
polypeptide chain together.  
 
Figure 2.1: The a) secondary, b) tertiary, and c) quaternary structure of  
bovine serum albumin. 
15, 16
 
 
The secondary structure of a protein is the three dimensional arrangements of polypeptide 
chains in α-helixes and β-sheets. These arrangements are mainly governed by hydrogen 
bonding between amino acids. The tertiary structure describes all aspects of the three 
dimensional folding of a polypeptide. If a protein has several domains or subunits, the 
quaternary structure describes how subunits are oriented in relation to each other. This means 
that the secondary, tertiary and quaternary structure of proteins describe the spatial 
arrangements of amino acids and is generally referred to as the protein conformation. 
17
 An 
example of the secondary, tertiary and quaternary structure of the protein bovine serum 
albumin (BSA) is shown in Figure 2.1. The hierarchical structure of a protein typically 
describes a protein in its native (N) state. That is, under optimal pH and temperature 
conditions. A protein may transit to the unfolded state (U) or the denatured state (D) if it is 
exposed to elevated temperatures or extreme pH values. 
 Predicting with computer modeling, and/or experimental work how a protein obtains 
its three dimensional structure is not only highly complex, but also expensive and time-
consuming. Therefore, the structure of a majority of proteins remains to be described. 
However, one protein that has been extensively studied is BSA, which undergoes several 
transitions as a function of pH. BSA has a neutral charge at pH=4.7. At neutral pH, BSA 
obtains its N state, that transit to a basic state (B) at pH 8.0, and an aged state (A) at pH 10.0. 
18
 The B isomerization is a less rigid molecule compared to the N isomerization, meaning that 
BSA at basic pH has more degrees of freedom. 
19
 At pH values above 10.5, tyrosinyl residues 
becomes deprotonated which can result in the U state. 
20
 Several proteins have an intermediate 
state, which has been named the molten globule (MG) state. The MG state is described as 
being an intermediate of the unfolded and the native state. Typically, the tertiary structure is 
lost, but secondary structural motifs such as α-helixes and β-sheets still prevail. 21 For BSA, 
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the MG state has been suggested to occur at around pH 11.0. This was investigated by 
determining the pH-dependent binding interactions between BSA and a hydrophobic 
fluorescent dye, 8-anilino-1-naphthalene-sulfonate (ANS). At around pH=11, the binding 
between ANS and BSA is higher compared to any other pH-values, which suggests that 
hydrophobic residues in BSA are more available for interactions with ANS. 
20
 Not only the 
exposure of hydrophobic pockets are an interesting property of BSA, but also that it is stable 
at very high pH-values. At high pH, BSA becomes negatively charged and can 
electrostatically attract metallic ions, and in some cases these metals can be reduced and self-
assemble into nanostructures aided and stabilized by the protein. This property is further 
discussed in the next subsection.      
 
2.2 Proteins can biomineralize gold  
 
A biomineral is a composite material that consists of a mineral and a biological molecule. The 
term biomineralization thus refers to the process in which these materials are formed. 
22
 
Proteins are particularly interesting in this context, as some have specific structures that have 
a particular affinity for ions and metals. Some proteins depend on metals for increased 
activities, and the metal is in such named a co-factor. For instance, hemoglobin has a 
porphyrin ring with a central iron ion that it needs to properly bind and transport oxygen in 
the blood. Some proteins have been shown to go beyond binding of single-metal ions and 
perform biomineralization of metals. One such enzyme is bovine serum albumin, which was 
the first protein described to synthesize nanostructures of gold. 
23
 BSA does not need co-
factors to function properly, and does not biomineralize gold at physiological pH. However, at 
basic conditions, an increasing amount of amino acids becomes negatively charged, such as 
tyrosine (pKR=10.07) histidine (pKR=6.00) and cysteine (pKR=8.18). If gold ions are incubated 
with BSA at pH values above 10.0, the protein will electrostatically attract positively charged 
gold ions particularly to areas rich in tyrosine, histidine and cysteine. 
24
 Once at the protein 
backbone, the gold ions are reduced to atomically sized gold structures, referred to as gold 
nanoclusters (AuNCs). With increased time and concentration of gold ions, these 
nanoclusters grow into gold nanoparticles (AuNPs). At the particular pH, BSA is believed to 
be in its molten globule state, which was recognized as being a flexible state with exposed 
hydrophobic residues but with retained secondary motifs.  
 As hybrid nanomaterials are comprised and stabilized by proteins, the protein structure 
may change as a result of the incorporated gold nanostructures. It is therefore important to 
describe any unfolding of the protein backbone. The aromatic amino acids tryptophan, 
phenylalanine and tyrosine are fluorophores in proteins that can be excited with wavelengths 
from 260-295 nm, and that have emission maxima from 285-350 nm (Figure 2.2). 
25
 Using 
fluorescence spectroscopy, the emission of the protein in the hybrid material can be compared 
to the native protein emission, and changes in the emission profile is explained as an 
alteration of the protein conformation due to incorporation of a metallic nanostructure (this is 
further discussed in subsection 5.2 and 5.3).   
 Here, the proteins Transferrin (Tf) and BSA were used to synthesize gold nanoclusters 
and nanoparticles. Apart from being able to reduce gold ions, they were chosen based on 
availability, water solubility, fluorescence properties and biological function. 
 
6 
 
 
Figure 2.2: The polar fluorescent amino acids in proteins (pH=7.0) 
 
 Transferrin is an iron-binding protein that carries iron from the blood and delivers it to 
cells. Once at the extracellular matrix, Tf is taken up by receptor-mediated endocytosis via the 
transferrin receptor (TfR). Iron is released intracellularly and iron-free Tf (apo- Tf) is 
recycled to the blood. 
17
 Iron is an important co-factor in many cellular events, particularly in 
proliferation and mitosis, and the expression of TfR is regulated according to the cell cycle. In 
highly proliferating cancer cells, the expression of TfR is increased, 
26, 27
 which means that 
hybrid nanomaterials created in a Tf scaffold would potentially have a higher probability of 
targeting cancer cells, assuming that the affinity of Tf towards TfR is unaltered or sufficient. 
 BSA is very similar to human serum albumin, and is as Tf also a blood protein. 
However, BSA is less specific than Tf, and can carry a plethora of molecules in the blood, 
such as drugs and lipids. 
28, 29
 As was described above, BSA has several states can undergo 
major conformational changes without denaturation.
18, 30, 31
  
 The two next subsections will describe the second component of the hybrid 
nanomaterials, which is comprised of two different structures of gold; the nanoparticles and 
the nanoclusters.  
2.3 Optical properties of gold nanoparticles 
 
 Michael Faraday (1791-1867) was a remarkable scientist most widely known for his 
contributions to the theory of electromagnetism. He is perhaps less known for his 
contributions to modern nanotechnology, as he was the first to synthesize and describe the 
optical properties of gold nanoparticles approximately 150 years ago: 
 
“Light has a relation to the matter which it meets in its course, and is affected by it, being 
reflected, deflected, transmitted, refracted, absorbed, etc. by particles very minute in their 
dimensions. Gold seemed especially fitted […] because of its development of color both in the 
reflected and transmitted ray, and because known phenomena appeared to indicate that a 
mere variation in the size of its particles gave rise to a variety of resultant colors. […] The 
waves of light are so large compared to the dimensions of the particles of gold which in 
various conditions can be subjected to a ray, that it seemed probable the particles might come 
into effective relations to the much smaller vibrations of the ether particles.” 
 -M. Faraday 
32
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 Today we know that the “effective relations” between AuNPs and light occur due to 
an optical phenomenon called localized surface plasmon resonance (LSPR).  
 A plasmon is the collective plasma oscillation of conducting electrons at the 
nanoparticle (NP) surface. The conducting electrons have a higher energy level than the 
valence electrons, and can freely move between atoms. LSPR is initiated by an external 
electromagnetic wave that displaces the electrons from the NP core (Figure 2.3). This 
displacement creates an electric field both inside and immediately outside the AuNP in a 
standing oscillation opposite to the electric field of the incident light. As the EM wave 
propagates, the electron cloud of the NP oscillates with the same frequency as the incoming 
beam, but out-of-phase, causing a shift in the dipole moment of the AuNP(indicated with 
arrows in Figure 2.3). The interactions between the incoming photons and the surface 
electrons of the AuNP lead to a high absorption coefficient, which is observed as a maximum 
absorption peak in UV-visible spectroscopy at approximately 520 nm.  
 
 
Figure 2.3: Localized surface plasmon resonance of gold nanoparticles. Arrows indicate the 
dipole moment of the AuNP.  
  
Furthermore, Faraday’s observation that the “mere variation in size […] gave rise to variety 
of resultant colors” points to the fact that the optical properties of gold are size-dependent. 33  
 Two types of gold nanostructures are described and synthesized in this thesis, and they 
are separated based on their size and interactions with light. The smallest structures are the 
gold nanoclusters which are in the size-range of molecules. AuNCs have discrete energy 
levels, no conduction bands, and can therefore not exhibit LSPR. Instead, excitation of 
AuNCs causes emission of fluorescence. Gold nanoclusters obtain their molecular properties 
as their diameter is reduced to sizes comparable to the de Broglie’s wavelength at the Fermi 
energy
III
 of the metal. 
34
 For gold, this diameter is approximately 2 nm. 
35
  
 
 
                                                 
III
 This is also called the Fermi wavelength 
8 
 
 
 
 
Figure 2.4: Size-dependent fluorescence of BSA-stabilized AuNCs excited with handheld 
UV-lamp (longwave: 365 nm). The fluorescent cuvettes contain BSA-stabilized AuNCs. The 
sizes of the AuNCs increase from the left. To the far right, BSA-stabilized AuNPs that quench 
fluorescence from AuNCs. 
 
AuNPs larger than this do not fluoresce, but absorb light in the visible region of the 
electromagnetic (EM) spectrum due to LSPR of the conducting electrons. This size-dependent 
property of gold is illustrated in Figure 2.4, which show AuNCs and AuNPs stabilized in 
BSA.  
 In this subsection, the focus is on the optical properties of AuNPs, while the optical 
properties of AuNCs are the main topic of the next subsection.  
 The oscillations of the plasmons occur at a specific frequency and wavelength, which 
depends on the size and aspect ratio of the AuNP, as well as the dielectric constant of the 
solvent. 
25, 36-39
 When an incoming beam initiates electron oscillation, the electrons are excited 
to energy levels above the Fermi level
IV
 which raise their chemical potential. The total light 
that is absorbed by a spherical particle is described by the Mie theory in equation 2.1: 
 
abs ext sca      (2.1) 
 
Where σabs, σext, and σsca are cross-sections of the absorbance, extinction, and scattering, 
respectively.
V
 For spherical NPs that have a circumference much smaller than the wavelength 
of the incoming beam (2πR<<λ), the magnitude of scattering is proportional to R6, while the 
absorption is proportional to R
3
. Thus, small AuNPs have an extinction band that is 
                                                 
IVIV
 The Fermi level is the chemical potential of electrons 
V
 A cross-section is a general term in physics describing the probability of a certain particle-particle interaction, 
for instance the probability of absorption, scattering or extinction.  
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dominated by absorption, while scattering dominates with larger AuNPs. 
40
 If we assume that 
the nanoparticle diameter (d) is very small compared to the wavelength of the incident beam 
(d<<λ), we obtain a simplified expression for the extinction and scattering cross sections:  
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Where ε1 and ε2 are part of the complex dielectric function: 
 
ε= ε1+ iε2 
 
Further, ε1 represents the real part and ε2 the imaginary part of the complex function. εm is the 
dielectric function of the solvent/medium.  The resonance condition is fulfilled when σext is 
maximized, that is when ε1(λ)=-2εm.
VI
 For instance, AuNPs in water (εm, water ~1.7) have a 
maximum absorbance wavelength when ε1=-2εm which corresponds to 520 nm. This 
wavelength is the LSPR peak, which can be estimated with Drude’s theory.   
 The Drude theory describes a frequency-dependent form of ε1 that can be used to 
determine the LSPR peak wavelength:  
 
1 2 2
1
p

 
 

  (2.2) 
 
   
Where ωp is the plasma frequency and γ is the damping parameter of the bulk material. From 
the Drude theory (equation 2.2), the maximum frequency can be expressed as a function of 
ωp: 
 
max
2 1
p
m





  (2.3) 
 
However, the maximum wavelength is a more convenient number that can be calculated from 
the maximum frequency:  
 
max
max
2 c


    (2.4) 
 
Equation 2.4 can now be rearranged to equation 2.5: 
 
                                                 
VI
 ε1 is negative because the electrons oscillate out of phase with the incoming electromagnetic wave.  
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2 1
2
m
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The plasma frequency can be rewritten to yield the plasma wavelength similar to the 
maximum wavelength (from equation 2.4) which gives:  
 
max 2 1
2 2
p
m
c c


 
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By rearranging equation 2.6 and setting the squared refractive index, n
2
, equal to the dielectric 
constant 
 
2
m n   
 
We arrive at the final expression for the peak wavelength of LSPR, λmax
36
:  
 
2
max 2 1p mn     (2.7) 
 
The LSPR peak depends on the size and aspect ratio of the AuNP, as well as the dielectric 
constant of the medium. For instance, AuNPs with a diameter of 10 nm have an LSPR 
absorption maximum at 520 nm, while AuNPs in the size-range of 80 nm have an absorption 
maximum at approximately 540 nm. This bathochromic shift of the LSPR peak is because 
AuNPs with 80 nm diameter have surface oscillating plasmons with lower frequencies. 
33
 The 
effect is best seen in gold nanoparticles shaped as rods, which have two plasmon resonances; 
one in the longitudinal and one in the transverse direction. The transverse plasmon frequency 
is the same as for spherical AuNPs, while the longitudinal plasmon frequency increases with 
the length. A change in the refractive index will cause an alteration in the surface oscillations 
of the AuNP electrons and cause a shift in the LSPR peak. However, the properties of the 
surface capping agent
VII
 is also important as they can locally alter the surface oscillations.
41
 
This is the basis of sensing applications with AuNPs which will be discussed after the optical 
properties of AuNCs.   
2.4 Optical properties of gold nanoclusters  
 In contrast to LSPR, AuNCs have discrete HOMO-LUMO transitions of a one-
electron nature. This results in molecule-like properties such as size-dependent fluorescence. 
The emission energy depends on the number of atoms, N, in each gold nanocluster and the 
Fermi energy, EF, of bulk gold via the relationship 
 
1/3
FE
N
 
 
This indicates that the electronic structure is determined by the AuNCs free electron density 
and AuNC size. AuNCs that have a diameter below 2 nm does not have LSPR, and have been 
described as semiconducting materials. 
35
 
                                                 
VII
 The capping agent in this thesis is mainly the proteins BSA and Tf.  
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 The threshold at which gold goes from exhibiting LSPR to fluorescence can be 
estimated based on the free electron theory, by approximating the average spacing of 
electronic energy levels, δ, to the Fermi energyVIII, Ef , and the number of gold atoms, N:   
 
             
fE
N
    (2.8) 
This equation states that with decreasing size, the average spacing of electronic levels gets 
larger. Setting the Fermi energy of gold (Ef=5.5 eV) into equation 2.8 and using the 
thermalenergy at room temperature (T=298 K) as a criterion for distinct energy quantization:  
 
Bk T   
 
We obtain an expression for the amount of gold atoms:  
 
5.5
298B
eV
N
k K
  
 
Using Boltzmann constant ( 5 18.6173303 10 eV K  ), the critical number of gold atoms in an 
AuNC is estimated to 200-300 atoms, which corresponds to roughly 2 nm in diameter.
39,42
 
 The amount of atoms in AuNCs follow a shell model named the Jellium model with 
the corresponding magic numbers 2, 8, 10, 20, 25, 34, 40. An analogy to the Jellium model is 
the electronic structure of atoms, in which each shell is stable with an optimal amount of 
electrons. For instance, the noble gases fulfill the octet rule, and are very stable elements not 
likely to undergo reactions with other atoms. As the stability of an atom is governed by closed 
valence shells, so is the stability of magic numbered nanoclusters.  
43-45
  
 The size-dependent fluorescence of AuNCs can be measured using steady-state 
fluorescence spectroscopy. However, the actual origin of fluorescence is not clear, as it can 
arise from the metal core, or from interactions between the metal core and surface ligands, 
named Metal to Ligand and Ligand to Metal Charge Transfer (LMCT and MLCT) transitions. 
39
 Particularly, electron-rich atoms appear to affect the fluorescence intensity in a positive 
manner, and is believed to occur either as a charge transfer or as a direct donation of 
delocalized ligand electrons. 
46
 Here, the proteins BSA and Tf were used to synthesize and 
stabilize AuNCs and AuNPs. Proteins offer a plethora of energy donating atoms, such as S, N 
and O, and can therefore collectively enhance the fluorescence intensity via surface 
interactions if they are used as capping agents. AuNCs synthesized via proteins are excited at 
370 nm and generally emit at two different wavelengths (λem=430-450 nm and λem=560-730 
nm) with different intensities, depending on the diameter and concentration of AuNCs. The 
emission peak at between 430-450 nm is attributed to populations of smaller AuNCs with 
magic numbers 8, 10 (Au8, Au10), while the peak between 600-700nm is attributed to 
populations of larger AuNCs (Au25+). 
23, 47
  
 The main work on synthesizing the AuNCs were performed with BSA as scaffold and 
reducing agent, and from this study we were able to describe the growth of AuNCs in the 
protein backbone. The results were reproducible, and we were able to synthesize different 
populations of AuNCs and AuNPs by varying the reaction parameters. As the populations of 
                                                 
VIII
 The Fermi energy is defined at absolute zero temperature, and is the energy difference between the highest 
and lowest occupied single- particle states.  
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AuNCs and AuNPs dictate protein unfolding and optical properties, tuning the sizes of 
AuNCs/AuNPs is one important factor for their applications, some of which are discussed in 
the next subsection.   
  
2.5 Applications of protein-stabilized AuNPs and AuNCs 
 
AuNPs can be synthesized via a range of methods, and an extensive review of synthesis 
methods is given in reviews by Saha
37
 and Szunerits. 
48
 AuNPs can be water stabilized by 
binding of thiol groups to the surface, due to the affinity of thiol groups to gold. 
49-51
 The low 
toxicity and surface active electronic structure of AuNPs makes them useful in a range of 
applications; from cancer therapeutics
52
 to catalysis applications. 
53
 The principle of sensing 
with AuNCs and AuNPs stems from alteration of the optical properties that occur due to 
interactions with biological molecules or ions. This can for example be from quenching or 
enhancement of AuNC fluorescence, or from alterations in the LSPR absorbance of AuNPs.   
 Techniques for sensing with AuNPs can involve tuned aggregation or changes to the 
refractive index surrounding the AuNP. Aggregation of AuNPs would be observed as a red-
shift in the LSPR peak. The principle of sensing with AuNPs can for instance be done by 
designing the surface chemistry of AuNPs in such a way that when specific molecules bind, 
AuNPs aggregate. The aggregation can for instance be driven by folding of a polypeptide 
chain on the surface. 
54, 55
 The sensitivity can be tuned towards enzymes such as 
metalloproteinases,
56
 or neurotoxins, 
57
 by changing the properties of the surface polypeptide 
or receptor. A complete coverage of applications is beyond the scope of this subsection, and 
the reader is referred to Daniel et al 
58
 for a review of general applications of AuNPs. 
 Adsorption of proteins onto AuNPs has been extensively studied, 
9, 59-62
 but it was not 
until 2009 that Xie et al suggested a bottom-up approach for synthesis of AuNCs, with BSA 
acting as both a template and reducing agent of gold ions. 
23
 In this thesis, the bottom-up 
biomineralization approach was used to synthesize AuNPs and AuNCs and the work mainly 
centered on the synthesis mechanism, characterization and biocompatibility of protein-
stabilized gold nanoconstructs. Therefore, the focus of this subsection will be on applications 
of these nanomaterials rather than applications involving adsorption of peptides/proteins onto 
separately synthesized AuNPs.    
  During AuNC and AuNP synthesis the protein backbone unfolds, and depending on 
the degree of unfolding this may in some cases disrupt biological membranes. 
63
  
 Elevated concentrations of heavy metal ions (e.g Pb
2+
, Hg
2+
, Cd
2+
) in biological tissue 
is toxic and potentially deadly for the host. For instance, high doses of Hg
2+
 are related to 
neurotoxicology, and heavy metals have been linked to development of Parkinson’s and 
Alzheimer’s disease. 64 Sensing of heavy metal ions in blood and in water is important to 
protect the host and the environment. 
65
 With BSA-stabilized AuNCs, colorimetric detection 
assays of heavy metal ions such as Hg
2+
 and Cu
2+
 is possible, due to quenching of the 
fluorescence. 
66,67,68
 The basis of sensing Hg
2+
 is that Hg
2+ 
can complex with BSA-AuNCs via 
cysteine bonding (Hg-S), and this affects the optical properties of AuNCs. Specifically, 
excited BSA stabilized AuNCs transfer the excited electron to Hg
2+
 leading to oxidation of 
Hg
2+
 to Hg
+
. This causes fluorescence quenching which can be observed as a decrease in the 
intensity of the signal. 
69
 AuNCs stabilized in proteins can not only detect heavy metals, but 
also biological molecules such as dopamine, which is relevant in applications towards 
Parkinson’s disease. 70 One major advantage of protein-stabilized AuNCs is that they are 
more biocompatible compared to the quantum dots (QDs), which are prepared from 
13 
 
semiconductor materials. 
66, 71
 BSA-stabilized AuNCs can also compete with QDs as they 
show comparable detection limits, for instance detecting the amino acid cysteine down to 10 
nM. 
72
  
 The optical properties of protein-stabilized AuNPs and AuNCs are without a doubt 
very intriguing, and they appear to have a promising future in biosensing. However, we found 
that when incubated with typical fluorescent dyes for cell experiments, we observed what 
appeared to be spectral interactions between the dyes and the AuNCs (See paper I, Figure 6). 
When the cells were incubated only with protein-AuNCs and no dyes, the emission intensity 
of AuNCs were too weak to be observed through the fluorescence microscope. This probably 
was an effect of low concentrations of AuNCs and the high intensity of the inverted beam 
from the microscope optics that could have photobleached the AuNCs. Because of this, we 
were unable to determine whether the cells internalized the AuNPs/AuNCs or not, and we 
decided to not further investigate the internalization with transmission electron microscopy. 
However, it is worth mentioning that we did test AuNPs as contrast agents in X-ray 
computerized tomography (CT)
IX
. AuNPs below 100 nm have attracted a lot of attention as 
potential CT CAs 
73-75
 and AuNPs stabilized in BSA could be used as contrast agents in CT. 
76
 
BSA-stabilized gold have a remarkable suspension stability, which gives them shelf lives up 
to one year. This is a very important feature of nanobiomaterials as it increases their 
applicability. We managed to see a size-dependent attenuation with CT (see paper II, 
supporting information), but the results were not convincing enough to elaborate on further 
studies. We therefore shifted our attention to another method for imaging deep tissue, namely 
magnetic resonance imaging (MRI). In contrast to CT, MRI is based on relaxation of 
hydrogen nuclei after a radiofrequency pulse. The acquired images separate blood from fat, 
muscles from bones, and potentially malignant tissue from normal tissue. Contrast agents 
(CAs) are used in MRI to ease the diagnostics, and must be of materials capable of altering 
the relaxation of protons. The most commonly used clinical CAs are chelates of Gd
3+
 (e.g 
Gadovist, Magnevist). 
77, 78
 However, magnetic nanoparticles are emerging as potential CAs 
in MRI, for several reasons. NPs have longer blood circulation times as compared to chelates, 
1 
and the large surface-to-volume ratio of NPs results in a greater contact area between 
magnetically active centers and the tissue. Moreover, the large surface-to-volume ratio allow 
not only for an altered contrast, but for surface-functionalization with drugs. This creates the 
possibility of designing multifunctional nanoparticles that can carry drugs as well as signaling 
its location. The remaining theoretic parts of this thesis will focus on the properties of 
magnetic nanoparticles, and their possibility for entering eukaryotic cells.  
 
 
 
 
 
 
 
 
                                                 
IX
 CT is a diagnostic imaging technique based on different tissue absorptions. 
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3 Magnetic nanomaterials 
 
The previous chapter covered the hybrid nanomaterials that could be synthesized with 
proteins due to the combined reduction potential of amino acids. However, synthesis of 
magnetic nanomaterials requires a different approach and here involves thermal 
decomposition of a metal-oleate complex in organic solvents under high pressure and argon 
atmosphere. With thermal degradation, the geometry, size, and size distribution of the 
resultant particles can be fine-tuned by adjusting the rate of nucleation events.  
 Magnetic nanomaterials were here used for bioimaging with magnetic resonance 
imaging, and the focus will therefore be on the magnetic properties of nanoparticles that 
enable contrast in MRI. This chapter starts with an introduction to magnetism and MRI, 
before the physical properties and applications of contrast agents are described.   
3.1   Magnetism and Magnetic Resonance Imaging 
 
According to the law of electromagnetism, a moving charge will induce a local magnetic 
field. As such, magnetism is a fundamental property of the atom that arises from spinning 
electrons. In the nucleus, the neutrons and protons also spin, but in opposite directions. The 
sum of the nuclear spins is called the quantum spin number, I, where a proton has I= ½, and a 
neutron has I= - ½. If there is an equal amount of neutrons and protons in a nucleus, the total 
spin is zero (I=0). However, when there is an uneven amount of protons and neutrons in the 
nucleus, for instance in isotopes, the nucleus has a net spin (I≠0) which is called an angular 
momentum. 
79
 The 
1
H (protium) is an isotope of hydrogen, with only one proton and no 
neutrons. As there are no opposite spins from any neutrons, protium has a net nuclear spin (I= 
½), and therefore an angular momentum. The magnetic moment of the protium is the basis for 
MRI, which is a diagnostic tool for imaging soft tissues.  
 When a protium is placed in an external magnetic field, B0, it becomes polarized, 
meaning that the rotation of electrical charges spin in the direction of the applied force, and a 
magnetic dipole moment, μ, is produced in a direction perpendicular to the applied force. X 
The magnetic moment describes the direction and magnitude of the produced field. As 
1
H is 
abundant in biological tissue, it provides a relatively large magnetic moment that is sufficient 
to acquire an MR signal. 
78
   
 MR images are collected by an MR scanner which provides an external magnetic field, 
B0.  This causes the protium in a tissue to align with the field (Figure 3.1). Depending on the 
thermal energy of the different protiums, they will be oriented either as spin-up or spin-down. 
Spin-up nuclei are low energy nuclei that align parallel to B0, while spin-down nuclei are high 
energy nuclei that align antiparallel to B0. The net magnetization vector (NMV) is the vector 
sum of the spin-up and spin-down nuclei (Figure 3.1). Once aligned, all the magnetic 
moments of 
1
H spin around the field lines of B0 in a precessional path. The speed of 
precession is the precessional frequency, or Larmor frequency, ω0, which is related to B0 as 
described by the Larmor equation: 
 
0 0B   
Where  is the gyromagnetic ratio. 80 
 
                                                 
X
 According to the right-hand rule 
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Figure 3.1: Precession of hydrogen nuclei (
1
H) and parallel and antiparallel spin. 
78
 
 
The MR signal is acquired by applying a radiofrequency (RF) pulse to the sample. The RF 
pulse has the same frequency as the Larmor frequency of the protium. The low energy spin-up 
nuclei absorbs the energy of the RF pulse and becomes high energy spin-down nuclei. This 
causes the NMV to move out of alignment with B0. Depending on the length of the RF pulse, 
the NMV takes up an angle to B0 in the longitudinal plane, called a flip angle (FA). A FA of 
90° brings the NMV all the way down to the transverse plane. After the RF pulse is switched 
off, the NMV will relax back to its original position. This leads to magnetic field fluctuations 
that induce an electrical voltage in a receiver coil. The magnetically induced electrical current 
is the MR signal that is converted to an MR image via Fast Fourier Transformation. The 
NMV relaxes in a three dimensional rotating coordinate system. The NMV can therefore be 
decomposed into a transverse and a longitudinal component, and the MR signal is collected in 
either of these planes. Relaxation in the longitudinal plane is named the T1 relaxation time, 
while relaxation in the transverse plane is named the T2 relaxation time. The T1 relaxation 
time is defined as the time it takes for 63% of the longitudinal magnetization to recover, while 
the T2 relaxation time reflects the time it takes to recover 37% of the transverse 
magnetization.  
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Figure 3.2: Longitudinal and transverse relaxation of fat and water after an RF pulse. 
MR images can be weighted to depict tissue differences in the T2 or the T1 time, and these 
images are called T1 weighted (T1w) or T2 weighted (T2w) images, respectively. 
78
 Both
relaxation times are affected by three factors, but to a different degree
78
:
1. Spin-lattice interactions. Relaxation of the protium involves thermal interaction
with surrounding molecules, named the lattice. If the lattice contains
macromolecules that can absorb energy from the spinning protium, then the energy
transfer and relaxation is more efficient. Thus, protiums in fat are in close
proximity to a large lattice of macromolecules, and therefore have an efficient
relaxation, while protiums in water have a less structured lattice, making spin-
lattice relaxation less efficient.
2. Density of molecules. Densely packed protiums have faster dephasing of the
magnetic moments, as they have a higher probability of interactions with
neighboring magnetic fields (spin-spin interactions).
3. Matching of tumbling rate and Larmor frequency. If the molecular tumbling rate is
close to the Larmor frequency, there is efficient exchange between the lattice and
the protium.
The T1 time is the spin lattice relaxation, where the energy of protiums is dissipated to the 
surrounding molecular lattice. The T1 time is therefore affected by the first factor in the list 
above. In a T1w image, the different relaxations in the longitudinal plane are compared, and 
the tissue with the largest component in the longitudinal plane will appear bright. In fatty 
tissue, there is efficient absorption of energy after an RF pulse, and fatty tissue quickly 
realigns its longitudinal magnetization. Fat therefore has a short T1 time, and a large 
longitudinal component (Figure 3.2, relaxation in fat). In blood (water), the energy dissipation 
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between hydrogen nuclei is less efficient, meaning that blood needs longer time to relax, 
making the longitudinal component smaller than that of fat (Figure 3.2, relaxation in blood). 
In a T1w image, fat will therefore appear bright while blood will appear dark, as the 
longitudinal component of fat is larger than that of blood.  
 The T2 relaxation time reflects the spin-spin interactions between magnetic fields of 
neighboring hydrogen nuclei, and is therefore particularly affected by the density of the 
protiums (factor 2 in the list above). A T2w image is based on differences in contributions to 
the transverse relaxation. Fat is closely packed, which leads to an efficient spin-spin 
relaxation, a short T2 time, and a small contribution to the transverse component. However, 
the spin-spin relaxation in water is less efficient as water molecules are spaced apart and thus 
less likely to interact. This results in a longer T2 time and a greater contribution to the 
transverse component. Thus, the magnetic relaxation contribution from hydrogen nuclei in 
water leads to a longer induced voltage in the receiver coil, which in turn leads to a 
hyperintense signal making blood appear bright in a T2w image, while fatty tissue remain 
dark. Finally, a third relaxation time, T2*, takes field inhomogeneities into account. The T2* 
relaxation time is therefore faster than the T2 relaxation, as field inhomogeneities speed up the 
spin-spin relaxation.  
 With MRI it is possible to set diagnosis in a non-invasive manner, and the technique 
can be used to image deep brain tissue, muscles and fluid accumulations. An MR image can 
be very detailed by itself, and be sufficient to set a diagnosis. But in some cases, an external 
contrast agent may be administered to distinguish differences in vascularization or diffusion, 
which could indicate pathological distinct tissue from normal tissue. The topic of the next 
subsection is how these contrast agents can affect the relaxation of protons and to give an 
altered contrast in an MR image.  
3.2 Contrast agents in MRI 
  
Altering the relaxation of the NMV is the basis for enhanced or reduced contrast in MRI. 
Contrast agents are materials that are capable of altering the T1 or T2/T2* relaxation times. 
Although CAs affect both the T1 and T2 times, they are named according to the relaxation 
process they affect the most. 
81
 CAs that shorten the T1 relaxation time are named T1 CAs, 
while CAs that shorten the T2 relaxation time are T2 CAs. The efficacy of a CA is the 
relaxivity, ri, which is a ratio of the relaxation rate, Ri and the concentration of the contrast 
agent, CCA,  
 
i
i
CA
R
r
C
  
Where i is either 1 or 2 and refer to the T1 or T2 time respectively. The relaxivity of a contrast 
agent is a relative value to the relaxivity of water, Ti, water, and can be calculated 
experimentally from the observed relaxation time, Ti, observed , from:  
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Figure 3.3: Magnetic flux density in dia, -para, and superparamagnetic materials 
The relaxivity is defined as “the increase in the relaxation rate of the solvent (water) induced 
by 1 mmol·L
−1
 of the active ion of the contrast agent”. 81
In this thesis, paramagnetic and superparamagnetic CAs were prepared from 
manganese, gadolinium and iron. Although the paper on gadolinium NPs are listed as an 
additional paper, the origin of magnetic susceptibility is included here as it is often compared 
to the magnetic properties of manganese. This subsection describes the different magnetic 
properties of these materials and how it affects the contrast in MRI.  
A magnetic field has direction and density, illustrated as magnetic flux lines in Figure 
3.3. The number of flux lines per unit area is the magnetic flux density or magnetic induction. 
82
A CA alters the magnetic flux density compared to the external magnetic flux. The extent to 
which a material is capable of altering the flux line density is called the susceptibility, which 
is the ratio of magnetic moments per volume material.
78, 80
 Magnetic substances are then
further categorized as diamagnetic, paramagnetic, superparamagnetic or ferromagnetic 
depending on their magnetic susceptibilities (Figure 3.3).  
Diamagnetic atoms have paired electrons that interact negatively with the magnetic 
field, resulting in a lower magnetic flux density inside the material compared to the outside. 
Paramagnetic substances have a positive susceptibility, meaning that they orient and create 
magnetization in the same direction as the applied field, and thus slightly increase the 
magnetic density.  
The rotation of electrical charges within a material is random and the energy of 
electrons is either spin-up or spin-down. If there are equal amounts of spin-up and spin-down 
electrons, they cancel each other out resulting in no net spin of charges. The configurations of 
electrons therefore determine the magnetic behavior of an atom. Most free atoms have a 
permanent magnetic dipole, however when in molecules or materials, the electronic 
configurations change. Typically, these configurations are closed shells that have a zero net 
spin, and the substance is diamagnetic. Exceptions to closed shells are the transition elements 
which have half-filled shells. Unclosed shells lead to a permanent magnetic dipole moment 
and paramagnetic susceptibility. Atoms with partly filled shells are the 3d (iron group), 4d 
(palladium group), 4f, (lanthanide group), 5d (platinum group) and 5f (actinide group). T1 
CAs are typically prepared from paramagnetic elements, such as gadolinium and manganese, 
as they effectively shorten the local T1 time in the tissue. The emphasis will therefore be on 
the 4f and 3d group as they contain gadolinium, manganese and iron.  
Paramagnetism is a property of the ion and not the material, meaning that it is Gd
3+
and Mn
2+
 that are paramagnetic, and not their solid counterparts. Gadolinium is a lanthanide
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element broadly used as a contrast agent due to its seven unpaired 4f electrons. These 
electrons have large magnetic dipole moments (7μ) that lead to local fluctuations of the 
magnetic field that cause a reduction in the relaxation time of protiums. This increases the 
longitudinal component of the NMV which results in a distinct bright local signal. Chelates of 
gadolinium are used clinically as T1 CAs (e.g Gadovist®, Magnevist®), as they provide a 
hyperintense region in a T1w image.
77,78
  
 Manganese ions have five unpaired 3d electrons (5μ) that contribute to the relaxation 
of protiums. Albeit smaller magnetic moment than Gd
3+
, the valence charge of Mn
2+ 
gives it 
interesting biological applications. For instance, Mn
2+ 
is a Ca
2+
 analogue that can bind to 
enzymes (e.g calmodulin)
83
 and enter through voltage-gated Ca
2+
 ion channels in firing 
neurons. 
84
 This allows for in vivo neuronal tract tracing in a technique called Manganese 
Enhanced MRI (MEMRI). 
85, 86
  
 T2/T2* contrast can also be obtained from high concentrations of Mn
2+
 ions 
87,88
 but 
high doses of Mn
2+
 must be used with caution as it can accumulate in the brain and cause a 
toxic condition named manganism. 
89 
 However, recent synthesis of manganese oxide-based 
NPs could lead to a resurgence of manganese as an MRI contrast agent. 
90-93
 For instance, 
manganese oxide NPs (MONPs) are T2 active CAs, but they degrade in water within a 
reasonable time-frame (hours to days) and release T1 active Mn
2+
 ions. 
91, 94-96
  
 Ferromagnetic materials have a strong positive susceptibility which gives a high 
magnetic density compared to the external magnetic field. The ferromagnetic materials are 
permanent magnets, which mean that they do not need an external magnetic field to be 
magnetic. 
78
 However, when a ferromagnetic substance, such as iron, is reduced in size below 
the dimensions of the magnetic domains, it becomes superparamagnetic. This property is 
confined to the iron oxide nanoparticles, which have positive magnetic susceptibility 
intermediate of ferromagnetism and paramagnetism. 
97
  Superparamagnetic materials can for 
instance be superparamagnetic iron oxide nanoparticles (SPIONs). As SPIONs are not 
permanent magnets, they do not aggregate in suspension due to magnetic interactions, which 
is very important for biological applications. The magnetic susceptibilities of SPIONs can 
therefore be switched on or off by an external magnetic field. This allows control over the 
magnetic properties of the material. The high magnetic susceptibilities of SPIONs affects the 
spin-spin relaxation time (T2 and T2*) and cause a more efficient relaxation in the transverse 
plane, resulting in a dark contrast in a T2w image. 
98-100
 SPIONs have paved the way for 
magnetic nanoparticles into the clinic (Lumirem/Gastromark
®
)
101
 and are generally 
considered safe. 
102, 103
 However, the biocompatibility is a topic of debate, 
18
 and 
commercially available SPIONs have recently been retracted due to reports on toxicity.
104
 
Additionally, the hypointense signal from SPIONs can be confused with e.g magnetic 
susceptibilities, bleeding or calcification which can lead to inaccurate diagnosis.
78, 104, 105 
However, recent reports on ultra-small iron oxide nanoparticles also demonstrates that they 
can be used as T1 CAs, which produce a hyperintense signal mostly associated with 
paramagnetic materials.  
106, 107
 
 The MR contrast imparted by NPs can be combined with other functionalities, for 
instance as either passive or active drug delivery vehicles. MRI CAs have also been shown to 
respond to several biomarkers (see Hingorani
108
 and references therein). Some applications of 
multifunctional MR active NPs are discussed in the next subsection.   
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3.3 Nanoparticles as multifunctional contrast agents 
 
Magnetic nanoparticles of iron oxide are already multifunctional; they are CAs in MRI and 
they can produce heat when exposed to an alternating magnetic field. This induced heating is 
called hyperthermia. If iron oxide NPs can be directed to tumors, hyperthermia can be used to 
kill malignant tissues. 
109, 110
 Nanoparticles for hyperthermia can either be injected directly 
into the tumor, or can be surface functionalized with targeting moieties that guide the NPs to 
the tumor.  
 In contrast to gold nanoparticles that were synthesized and stabilized in water with 
proteins, both iron and manganese oxide nanoparticles were decomposed in an organic 
solvent, giving NPs with a hydrophobic surface. As such, the metallic nanoparticles are not 
soluble in aqueous buffers and must be surface functionalized before they can be used in 
biological applications. Surface functionalization or stabilization depends on the properties of 
the stabilizing ligand. For instance, in paper V, we functionalized MONPs with L-DOPA 
which acts both as a stabilizing ligand and as a drug.  
 A common molecule for surface functionalization is dopamine. To increase the 
stability and biocompatibility of the NPs, a second molecule is attached on the N-terminus of 
dopamine, and this is most commonly polyethylene glycol (PEG). Dopamine-PEG molecules 
are first synthesized with carbodiimide chemistry before they are attached to the NP. 
Carbodiimide chemistry is a general procedure for creating a peptide bond between a primary 
amine (dopamine) and a carboxylic acid (PEG) via several intermediates (not shown):  
 
 
 
The negatively charged carboxylic group will undergo a nucleophilic attack to the partial 
positive carbodiimide (R1-N=C=N-R2). This in turn leads to a series of events finally resulting 
in peptide bond formation.  N-hydroxysuccinimide (NHS) is added to stabilize one of the 
intermediates, and to increase the yield. 
111, 112
  
 After synthesis of the dopamine-PEG molecules, the NPs are added to the reagent 
beaker, and the dopamine-PEG molecules attach to the NP. The hydroxyl groups of dopamine 
bridge with the surface oxide layer of the NP, while the second acid group of PEG will point 
towards the bulk and give steric and electrostatic stability to the suspension, as illustrated in 
Figure 3.4.
113, 114, 115
 It is therefore ultimately the surface coverage of PEG-molecules that will 
decide the charge and hydrodynamic volume of the nanoparticle. Secondary moieties may be 
attached to the carboxylic group of PEG by performing a second round of carbodiimide 
chemistry. For an extensive review of surface functionalization of nanoparticles, see Sapsford 
et al. 
97
   
 One of the main goals of nanomedicine is to deliver drugs to a specific site of action, 
for instance a malignant tumor. First and foremost, the biocompatibility of the NP system 
must be assessed as the NP can be toxic to the host. If an NP is being used for drug delivery 
purposes, one strategy is to deliver the drug intracellularly, which means that the nanoparticle 
must be able to traverse the cellular membrane. Therefore, interactions between cells and 
21 
 
nanoparticles are important to describe as they can give information on cellular uptake, 
clearance, and toxicity of nanoparticles. This is the topic of the next chapter. 
 
 
 
Figure 3.4: Surface functionalization of IONPs 
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4 Mechanisms of cellular uptake and cytotoxicity 
 
Nanoparticles that are engineered to function in biological systems must be compatible with 
the microenvironment inside the host. The first step towards establishing the biocompatibility 
is to assess how cultured cells interact with nanoparticles. Are the nanoparticles taken up? Do 
they adhere to the cells or alter their viability in some way? Answers to these questions can be 
found with cellular viability assays.  
 In the context of this thesis, the biocompatibility of synthesized nanoparticles was 
tested against human and rodent cell lines with the aim of investigating their uptake and 
potential cytotoxicity. This chapter aims to give a general overview of the main entry routes 
to a mammalian cell, before the cellular effect on internalized NPs will be addressed.   
   
4.1 Endocytosis 
 
The first barrier between a nanoparticle and a cell is the extracellular matrix (ECM). This is a 
thick mesh of intertwined proteins and sugars that protrude from the cell. The cellular 
membrane is hidden below the ECM, and is a complex bilayer of phospholipids containing 
cholesterol and a plethora of proteins. The cellular membrane separates the extracellular fluid 
from the inner cytosolic environment. A vital osmotic pressure is obtained by permitting 
water molecules to move through aquaporins, 
116
 while salts like potassium and sodium are 
exchanged through ion channels. Molecules that do not have a specific channel or transporter 
over the cell membrane may be taken up through endocytosis. Generally, endocytosis occurs 
with a physical change in the cell membrane, resulting in entrapment of an extracellular 
molecule/component in an intracellular vesicle. Endocytosis is a highly dynamic process 
which involves the cytoskeleton and many intracellular proteins, some of which are believed 
yet to be discovered. A full description of the biochemistry of endocytosis is beyond the scope 
of this text, and the reader is referred to Doherty et al for an extensive review on the topic. 
117
 
This subsection aims at describing the general concepts of endocytosis and point to 
characteristics of a nanoparticle that seem to be important for cellular entry. As nanoparticles 
have sizes comparable to biological molecules they can in principle traverse biological 
membranes through several of the routes described below. 
118
  
 Endocytosis is a general term for cellular uptake and is further divided into 
Phagocytosis, Pinocytosis, and Receptor-mediated endocytosis (Figure 4.1). Phagocytosis, or 
cell eating, is the uptake of bacteria or protozoal pathogens and only occurs in a few 
specialized cells. Pinocytosis, or cell drinking, is the uptake of extracellular fluid, further 
divided into micro, -and macropinocytosis. The latter is recognized by filopodia that fold back 
onto and fuse with the membrane which result in large intracellular vacuoles containing 
extracellular fluid. Macropinocytosis is non-specific and receptor-independent, and is used to 
take up larger extracellular components, up to 5μm. 119  Micropinocytosis is uptake of smaller 
aliquots and is a general term for a range of internalization events. 
120
 Both phagocytosis and 
macropinocytosis involves the actin cytoskeleton. 
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Figure 4.1: Major routes of endocytosis. The black lines in phagocytosis and pinocytosis 
represents actin filaments.  
119
 The orange line surrounding the cell represents the extracellular
membrane. 
 Receptor-mediated endocytosis (RME) involves receptors situated on the extracellular 
membrane, 
121
 and is either caveolin- or clathrin-mediated, depending on the mechanism and
vesicle size. Smaller species, as for instance viruses, are taken up via clathrin-mediated 
endocytosis, in which a small vesicle (100-120 nm) is formed and pinched off from the 
membrane with the aid of the protein clathrin. For even smaller species, caveolin-dependent 
endocytosis involves formation of a caveolae
XI
 that is in the size range 60-80 nm. 
119
Recently, a new class of cytoplasmic proteins are being recognized for their role in caveolin-
mediated endocytosis, and these are the cavins. 
122
 Assuming that an NP adheres to the cellular membrane, the second event that must 
take place is formation of a vesicle by wrapping of the membrane. Wrapping is a deformation 
of the local membrane structure that is restricted by the elastic properties of the membrane, 
the contact area between the NP and the concentration of receptors on the surface. For 
instance, if several large NPs adhere to the membrane, wrapping affects the global elasticity 
of the membrane, which may cause cellular rupture. Also, the time it takes for an NP to be 
endocytosed is related to its size; it takes longer time to wrap a large NP than a small. 
123,124
 In
the scenario of receptor-mediated endocytosis, mobile surface receptors must move towards 
the adhered NP, lower the free energy of interaction and induce a wrapping event. 
125, 126
 It
has been argued that the optimal size of NPs for uptake through receptor-mediated 
endocytosis is 25-30 nm. 
127
 Mu et al argues that when NPs are smaller than 20 nm, the
adhesion energy to the membrane is too small to induce membrane wrapping.  If receptor-
mediated endocytosis is the route of entry, a large NP (<60 nm) would need a higher amount 
of available receptors than a small NP, and will thus deplete the membrane of receptors. In 
comparison, smaller NPs may not be able to recruit enough receptors, and may as such not be 
endocytosed. 
128
 However, if several small NPs adhere in clusters, the contact area may be
large enough to induce receptor-mediated endocytosis. This may be one explanation for the 
fact that multiple NPs are imaged in a single vesicle
129
, which we also observed in paper III
(Figure 6.6h). With increased size, the time it takes to recruit receptors increases. As smaller 
XI
 Caveola means “little cave” in latin 
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NPs do not need to recruit as many surface receptors as larger NPs, a more rapid uptake of 
smaller NPs may depend on the recruitment time of membrane receptors. With this in mind, it 
might seem apparent that small NPs (<10 nm) may be the optimal size. However, a literature 
review by Beddoes et al states that although smaller NPs appear to be more rapidly taken up 
by cells, they also appear to have higher cytotoxicity. 
121
  
 Studies have shown that nanoparticles in the size range 20-50 nm have a good uptake 
in cells. 
130, 131
 This might correlate with the size-range of viruses (20-100 nm) that have 
evolved as to rapidly being taken up by cells. 
132
  A study by Roiter et al on adsorption of 
silica NPs on lipid bilayers showed that NPs larger than 22 nm reached full surface coverage 
of the lipid, while smaller NPs (1.2 -22 nm) created pores in the membrane. 
133
 Size does not 
only appear to govern the endocytosis of nanoparticles, but it seems as though exocytosis is 
size-dependent as well. For instance, the removal half-life of 14 nm AuNPs was much faster 
than removal half-life of 74 nm AuNPs.
134
  
 The aspect ratio, or shape, of the NP may also govern the cellular uptake mechanism. 
For instance, rod-like NPs with high aspect ratio were shown to be taken up more rapidly than 
cylindrical NPs in HeLa cells. 
135
 However, compared to spherical AuNPs, rod-shaped AuNPs 
were demonstrated to have a lower uptake. 
134
 In light of the discussion above, this might be 
explained as a result of the aspect ratio of rods. If a rod adheres to the cellular membrane with 
its transverse plane (side), this would result in a long membrane wrapping time compared to if 
the nanoparticle adhered to the cell membrane with its longitudinal plane (head). If RME was 
involved, a less efficient uptake could be described as a function of receptor recruitment time.   
 Interestingly, the size of the NPs may also decide their surface properties. NPs smaller 
than 2 nm may actually be hydrophobic, which gives them dramatically different interactions 
with the cellular membrane. The hydrophobic nature of these ultra-small NPs was explained 
based on the different orientation of water molecules surrounding the NP. Molecular dynamic 
simulations showed that NPs smaller than 2 nm interrupted hydrogen bonding between water 
molecules. 
136
 This might be an explanation for why small NPs tend to aggregate. A cluster of 
NPs would have a larger radius than single NPs and thus be less able to disrupt hydrogen 
bonds, be more hydrophilic which would cause an entropic gain to the water molecules. 
137
 
 The properties of the surface molecules are very important for the biological properties 
of the NP. For instance, the charge of the surface molecule will effectively become the charge 
of the NP which in turn could add several nanometers to the hydrodynamic volume of the NP 
(Figure 3.4). 
138
 Additionally, the surface properties of the nanoparticle will determine the 
outcome of the first encounter between a nanoparticle and a biological medium. For instance, 
if the NP is negatively charged, adsorption of proteins will be less than for a positively 
charged NP. The surface charge of the NP may determine the adsorption of biological 
molecules. Ensheathing of NPs in a biological media is believed to occur in two steps, giving 
rise to two different sheathes; an inner hard layer, and an outer soft layer. The inner hard layer 
is rapidly formed and is comprised of sugars and amino acids. A second soft layer of vicinal 
proteins is slowly formed on top of the inner layer, and is ultimately the contact point between 
the NP and the cell. 
121
 Therefore, the hydrodynamic volume of a positively charged NP in a 
biological medium may be very different from that of a negatively charged NP. Many 
nanoparticles are surface functionalized/stabilized, and choosing a surface molecule that has 
the desired chemical properties is the first step towards preparing biocompatible NPs. 
Generally, the surface charge should be neutral or negatively charged as to avoid protein 
adsorption, and the magnitude of the charge should be large enough to avoid precipitation. To 
complicate the picture, the curvature of the NP can also have an effect on the surface coverage 
25 
 
of stabilizing molecules, which may be different on sharp edges compared to other 
morphologies.  
  The composition of the surface coverage of NPs may also affect the stiffness of the 
NP, which is another factor determining interactions with cells. A review by Mu et al 
describes that the stiffness of the NP define the route of endocytosis; stiff NPs enter through 
clathrin-mediated endocytosis, soft NPs are taken up through macropinocytosis, while NPs of 
intermediate stiffness can enter through several routes. 
128
  A review by Zhang et al points to 
several studies showing that the membrane wrapping time and endocytosis may be related to 
the stiffness of the NP relative to the stiffness of the cell membrane. NPs stiffer than the 
cellular membrane were endocytosed faster than softer NPs, because soft NPs tend to spread 
onto the membrane rather than being engulfed. 
119
  
 All aspects of the nanoparticles appear to be important for their biological behavior: 
size, shape, surface charge, and softness of the nanoparticle are all factors that govern cellular 
uptake. Furthermore, NPs may have completely different affinities towards different cell 
types, which further complicate their biological characterization. Cells from different tissues 
may vary greatly in size, morphology, lipid membrane composition, membrane elasticity, 
concentration and presence of surface receptors, meaning that NP interactions most likely are 
tissue specific. Additionally, gravitational forces also play a role in in vitro studies as NPs 
may sediment onto the cells. This increases the likelihood of NP uptake and is an effect that is 
not translational to in vivo experiments. This is important to keep in mind when discussing in 
vitro results and before extrapolating ones conclusions to in vivo models.  
 However, if a nanoparticle is successfully taken up by a cell, the second challenge lies 
in inducing a desirable cellular response. If the aim is to induce cell death, then the 
nanoparticle must activate stress responses that push the cell into a spiral leading to apoptosis.  
 
4.2 Apoptosis: Programmed cell death 
 
A cell can die in two ways; either through necrosis or apoptosis. In necrosis, the cell bursts 
and spills all of its inner components to the surrounding environment. This can create an 
inflammatory response and tissue damage. However, controlled cell death, or apoptosis, is 
governed by intracellular caspaces that set off a cascade of other caspaces which destroy the 
intracellular compartments, before the cell shrinks and is engulfed by macrophages. In this 
way, the intracellular constituents of the cell are not spilled to surrounding tissue, but 
recycled.  
 Apoptosis is an all-or-nothing response, which means that once induced, it cannot be 
reversed. 
139
 Controlled cell death is a major part of sustaining a living organism, and cells 
with mutations leading to altered apoptosis are prone to develop cancer. 
140
  
 Mitochondria play important roles in control of apoptosis. If the mitochondrial 
membrane is damaged by nanoparticles, this may induce apoptosis by release of proteins that 
activate the caspace cascade.
141,142
 Oxidative phosphorylation is performed in the 
mitochondrial membrane, and involves formation of an oxygen radical, 
˙
O
-
, which is highly 
reactive and potentially very harmful if it escapes the mitochondria. This reactive oxygen 
creates several other reactive oxygen species (ROS). However, the oxygen radical is rapidly 
reduced by the enzyme superoxide dismutase to hydrogen peroxide, which is further reduced 
to water by the enzyme glutathione peroxidase. 
17
  
 A major concern regarding intracellular NPs is the generation of ROS and negative 
interactions with the cytoskeleton. 
143, 144
 SPIONs have been shown to induce oxidative stress 
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by generating reactive oxygen and nitrogen species. 
103
 Reduction of molecular oxygen inside 
the cell may occur due to reactions at the nanoparticle surface. 
141
 This means that 
nanoparticles can induce oxidative stress in the cell by increasing the concentration of ROS to 
levels higher than the turnover rate of superoxide dismutase and glutathione peroxidase, 
leading to increased cell death. 
131
  
 It was mentioned in the subsection above that the surface charge of the NPs should be 
either neutral or negatively charged. One reason that positively charged NPs are considered 
toxic is that they have high electrostatic attraction to the negatively charged cellular surface. 
As such, positively charged NPs will adhere faster to the membrane and increase the 
possibility to severely damage the membrane. However, a study performed by Arvizo et al on 
AuNPs with different surface charges suggested that positively charged AuNPs perturbed the 
membrane potential of cells to a larger extent than neutral or negatively charged AuNPs. They 
specifically found that positively charged AuNPs caused a depolarization of the membrane 
potential which caused an increased influx of Ca
2+
 ions. These ions are important regulators 
of cell growth, and may in the long term affect the viability of the cells. 
145
 Another effect 
ascribed to positively charged NPs was production of ROS. These NPs accumulated inside 
lysosomes, and from here induced production of ROS. However, the toxic effect was believed 
to be caused by release of lysosomal content rather than ROS production at the NP surface. In 
the same study, loss of membrane integrity and mitochondrial membrane potential was 
altered. Damage to the mitochondrial membrane and spilling of mitochondrial proteins can 
induce activation of apoptosis via activation of the proteins caspaces 3 and 9. 
146
 
 This chapter has highlighted that it is not only the elemental components of the 
nanomaterial that is important for its biocompatibility, but secondary effects caused by the 
surface chemistry and morphology. Therefore, in designing bioimaging probes, the researcher 
must keep in mind how the different characteristics can impact the final biological response. It 
also becomes especially important to describe the physical and chemical properties of the 
nanomaterials via several experimental methods.  
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5 Experimental Techniques 
 
This chapter gives a brief overview and description of the main experimental techniques used 
in this thesis. The focus will be direct applications for the work described herein rather than a 
general description. 
XII
 
5.1 UV-Visible spectroscopy 
 
A colloidal suspension of 20-30 nm AuNPs is red because AuNPs absorb light in the red 
region of the electromagnetic spectrum. With a higher concentration of AuNPs the solution 
becomes darker, i.e. the absorbance increases, as less light is transmitted through the 
suspension. The absorbance, A, is defined as the logarithm of the incident beam, P0, minus the 
logarithm of the transmitted beam, P:  
     
  
 
 
A molecule absorbs energy corresponding to its own characteristic frequency, and the emitted 
beam is attenuated based on concentration of molecules and the path length of which 
absorption occurs. 
XIII
 This relationship is called Beers law and describes that the absorbance 
is directly proportional to the concentration of species, c, and the path length, b: 
 
      
      
 
With the proportionality constant, ε, being the molar absorptivity. 147 
 The wavelength and intensity of AuNPs strongly depend on their physical size and 
shape, and a shift in the extinction band indicates a change in either of these properties. 
33
 An 
effect of the local refractive index can also be observed, for instance with absorption of 
proteins on the surface. 
148, 149
 UV-visible spectroscopy was used to describe the growth of 
Tf/BSA-stabilized AuNPs. In the case of BSA-stabilized AuNPs, the growth was monitored 
over time, by measuring the intensity in the LSPR extinction band at ~530 nm.  
 Proteins that contain the aromatic amino acids, phenylalanine, tyrosine and 
tryptophan, absorb light in the visible region, more specifically from 240-300 nm. 
150
 Thus, 
conformational changes in BSA and Tf upon growth of AuNCs and AuNPs can be monitored 
with UV-vis. However, a more accurate description of protein unfolding can be accomplished 
using fluorescence spectroscopy, as described in the following subsection.  
 
 
 
 
                                                 
XII
 AFM, (S)TEM, HRTEM and XRD was performed by Dr. Gurvinder Singh. XPS was performed by Sulalit 
Bandyophadyay. MR imaging and set-up was performed by Dr. Sjoerd Hak. Langmuir-trough studies were 
performed by Dr. Wilhelm Glomm and Dr. Sina M. Lystvet.  
XIII
 The refractive index of the solvent and the material of the cuvette also affect absorption. However, as the 
same type of cuvettes and aqueous buffers were consistently used, no effect on the LSPR intensity or wavelength 
maxima was detected and is therefore not discussed.  
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5.2 Steady-state Fluorescence Spectroscopy 
 
 
Figure 5.1: Jablonski diagram.  Adapted from Lakowicz. 
25
 
 
 
When an incident photon matches the frequency of an electron in a molecule, atom, or 
nanostructure, the electron is excited from its ground state to a higher vibrational energy level.  
Relaxation of the excited electron causes energy dissipation in the form of heat and release of 
a photon. The emitted photon will always emit at longer wavelengths than the excitation 
photon, and this reduction in energy is called a Stoke’s shift. The energy released as a photon 
is the luminescence, which is further subdivided into phosphorescence or fluorescence, 
depending on the processes in the excited state. 
 Jablonski diagrams are descriptions of the molecular processes that can occur in an 
excited state, and an example of such a diagram is shown in Figure 5.1. Transitions between 
states are always depicted as vertical lines, following the Franck-Condon principle of 
instantaneous absorption. The singlet ground electronic state, S0, has several vibrational 
energy levels (0, 1, 2...), but is substantially lower in energy compared to the first (S1) and 
second (S2) electronic states. To reach an excited state, light with photon energy hν is 
absorbed, where ν is the energy frequency and h is Planck’s constantXIV. Upon relaxation, 
molecules typically relax back to the S1 state, through internal energy conversion, but without 
release of a photon. Internal conversion happens within 10
-12 
seconds or less, and is much 
faster than the time it takes for emission of fluorescence (10
-8
 seconds). Excited electrons that 
have forbidden transitions back to the ground state can cross into a triplet state (T1), causing a 
                                                 
XIV
 h= 6.62607004 × 10
-34
 m
2
 kg s
-1
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further Stoke’s shift, and giving rise to slowly emitting phosphorescence (10-3 to 100 
seconds).   
 In the work described in this thesis, steady-state fluorescence spectroscopy was used 
to describe changes in protein conformation of BSA and Tf upon growth of AuNCs and 
AuNPs, as well as determining the size and growth of AuNCs situated on the protein 
backbone.  
 AuNCs are excited at 370 nm (λex=370nm), and depending on their size, emit at 450 
nm and 650 nm. Smaller AuNCs (Au8, Au10,…) typically have an emission maxima at 450 
nm, while it is 650nm for larger AuNCs (Au25+). The intensity of each peak is related to the 
concentration of each specie, meaning that the population ratio of either large or small AuNCs 
can be determined with steady-state fluorescence spectroscopy.
23, 47
 As was briefly mentioned 
in subsection 2.1, the aromatic amino acids are fluorophores in proteins and any changes in 
the emission profile can be explained due to changes in the microenvironment of the 
fluorophore. These are: changes in viscosity, exposure to solvent and/or rotational correlation 
time. Tryptophan is the dominating fluorophore in proteins and is selectively excited at 295 
nm and emit near 340 nm.
151-153
 Trp emission is a well-documented spectroscopic method for 
studying conformational changes such as partial unfolding in proteins.
25
 Unfolding changes 
the local environment of Trp residues, and depending on the number and location of Trp, this 
might lead to changes in fluorescence line shape, with respect to both emission maximum and 
intensity. While changes in the fluorescence intensity alone can be difficult to interpret, shifts 
in the emission maximum towards longer wavelengths are generally linked to protein 
unfolding
24, 25, 60, 61, 63, 154
 or exposure to an aqueous environment. 
9, 25, 152
  
 When only AuNCs are present in the protein backbone, quenching of Trp might be 
caused by emission/excitation overlap between AuNCs and Trp in addition to increased 
exposure to water. 
154
 When AuNPs are present in concert with AuNCs, interpretation 
becomes even more complex, as additional interactions between colloids and fluorophores 
can involve resonance energy transfer (RET) and further quenching.
25
  
 With the multiple quenching events that take place in a BSA/Tf-AuNC-AuNP system, 
it is useful to apply an additional spectroscopic method to determine how the average lifetime 
of the fluorophore changes upon growth of gold nano species. One of these methods is Time-
correlated Single-Photon Counting.   
5.3 Time-correlated Single-Photon Counting 
 
In steady-state fluorescence spectroscopy, the total amount of emitted photons is measured, 
which is useful for describing quenching and to characterize different populations of 
fluorophores. However, in a system involving several distinct fluorophores with overlapping 
emission spectra, it is not possible to distinguish the contribution of each fluorophore without 
time-correlated spectroscopy. For instance, BSA has two tryptophan residues, one situated in 
a hydrophobic pocket (Trp213) while the other is situated on the surface (Trp134).
18
 The two 
Trp residues are excited with the same wavelength (λex=295 nm) but the emission is 
dominated by Trp134. Thus, detecting the contribution form the buried Trp residue is difficult 
because it falls under the same emission spectra as the exposed Trp. Tf also has several Trp 
residues in its backbone, all of which contribute to the total emission spectra, but with 
different intensities. 
155
 However, with Time-correlated Single-photon counting (TCSPC), the 
contribution of each fluorophore can be determined, and as with steady-state fluorescence 
spectroscopy, a change in the Trp lifetime can give valuable insight into protein unfolding and 
quenching. 
30 
 
 In TCSPC, a short pulse of a single wavelength, corresponding to the hν of a specific 
fluorophore, is sent from a light emitting diode (LED) to the sample. Following the pulse, the 
intensity and time-dependent decay of the fluorescence is measured, the intensity being 
proportional to the number of excited molecules. The decay relaxation over time, Y(t), is 
described with the following formula:  
 
 ( )  ∑   
     
 
   
 
 
Where N is the total number of fluorescent molecules, α, is the relative fraction or amplitude 
of each component at t=0, ki is the rate constant of each component. τi is the lifetime of a 
fluorophore, which is the average time from an electron is excited until it returns to the 
ground state.
156
  
 Upon Trp excitation (λex=278 nm), the decay of Tf -and BSA stabilized AuNCs-
AuNPs was fit with a biphasic decay, as fitting at higher orders includes larger contributions 
from noise. A biphasic decay fitting yields one short (1) and one long (2) lifetime with their 
relative populations α1 and α2.
25
 In addition, the other aromatic amino acids will contribute to 
the emission when excited at λex=278nm, but these are neglected as Trp is the dominating 
fluorophore. 
25, 148
 
 
  
Figure 5.2: TCSPC. Adapted from Lakowicz.
25
 
 
The electronic set-up of a typical TCSPC instrumentation is shown in   
Figure 5.2. A sample is excited with a single pulse of light, and less than one photon is 
counted per laser pulse. The lifetime (Δt=τ) between the excitation pulse and the observed 
photon is measured and stored. The signal, S, is passed through a constant function 
discriminator (CFD) that measures the arrival of the pulse.  The signal is passed through a 
time-to-amplitude converter (TAC), where a voltage ramp is generated. The produced voltage 
is proportional to the length of the signal. A second CFD detects the emitted photon. 
XV
 The 
                                                 
XV
 In reverse mode, the signal from the emission is used to start the voltage ramp in the TAC, while the signal 
from the emitted photon is used to stop the voltage ramp 
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voltage produced in the TAC is amplified by a programmable gain amplifier (PGA) that 
converts the voltage to a numerical value via the analog-to-digital converter (ADC). A 
window discriminator (WD) removes any signals that are not within a given range of voltages. 
From the WD, the voltage is recirculated back to the TAC, where it is stored as a single event.   
 
5.4 Scanning transmission electron microscopy and High Resolution transmission 
electron microscopy  
 
In addition to UV-visible spectroscopy and TCSPC, the size and presence of AuNPs in a 
sample can be confirmed with scanning transmission electron microscopy (STEM), and 
AuNCs can be imaged with even higher resolution TEM (HRTEM). As the metallic NPs have 
higher electron density than proteins, the protein will not be visible in a TEM image, and the 
morphology of the NPs can be determined. It is however worth to keep in mind that when 
using UV-vis spectroscopy the collective signals of all NPs is measured, while with TEM and 
HRTEM, only a small portion of the sample is imaged. 
 In STEM, an electron beam is emitted from an electron gun and focused through 
several optical configuration lenses before it reaches the sample. The final focusing lens is the 
objective lens which is responsible for the largest demagnification of the beam and is the most 
important lens for acquiring images. With the scan coils the probe is scanned over the sample 
which makes it possible to form a magnified image (Figure 5.3). 
157
  
 
 
Figure 5.3: STEM aperture. Adapted from Pennycook. 
157
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Even higher resolution of images can be acquired with HRTEM, as shown in Figure 5.4 a and 
b. The resolution of the STEM used here, is 0.4 nm, while the HRTEM had a resolution down 
to 0.1 nm. Several signals from a sample can be collected with STEM, but in the context of 
the papers described here, bright field (BF) and annular dark field (ADF) images were 
acquired. In a BF image, transmitted electrons that leave a sample at a relative low angle to 
the optic axis are detected, while in ADF, transmitted electrons that leave a sample at 
relatively high angles are detected ( 
Figure 5.4 c and d).   
 
 
 
Figure 5.4: Example of a) HRTEM of AuNPs and AuNCs, scale bar = 5 nm, b) HRTEM of 
MONPs, scale bar = 5nm, c) STEM BF of FeO NPs, scale bar = 300 nm and d) STEM ADF 
of manganese oxide nanoparticles, scale bar = 200 nm. 
 
5.5 Dynamic light scattering 
 
While the dimensions and morphologies of NPs can be described with TEM, NPs in a solvent 
occupy volume larger than their diameter due to interactions with the solvent, or due to 
surface adsorbents such as proteins or other stabilizers. This volume is the hydrodynamic 
volume which can be measured using dynamic light scattering (DLS). This parameter is 
important to determine, as the hydrodynamic volume of NPs can govern cellular uptake.  
 Generally, when an incident beam of light hits a suspension of NPs, the beam scatters 
in several directions. A detector measures the scattered light at a particular angle of 
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observation. The scattered light depends upon the molecular weight (size) of the sample, the 
angle of observation, and the concentration of the NPs. 
158
  
 In the experiments described in this thesis, DLS was based on diffusion of NPs and by 
measuring the time-dependent intensities. NPs are not stationary in solution, but move in a 
random walk governed by Brownian motions. Therefore, the detected intensity of the 
scattered light will vary with the relative movement of the NPs. From these measurements, 
particularly small NPs that have a diameter much smaller than the wavelength of the incident 
beam can be detected (d<<λ). 159 The characteristic fluctuation times depend on the diffusion 
coefficient of the NPs, D0, as described by the Stoke’s-Einstein equation for spherical 
particles:
160
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Where kB is Boltzmanns constant, T is absolute temperature, η, is the viscosity of the solvent, 
and RH is the hydrodynamic radius of the sphere. Small NPs have a larger diffusion 
coefficient than bigger NPs, and will therefore have a more rapid fluctuating intensity.  
 The Stoke’s-Einstein equation does not take into account interparticle interactions, that 
can lead to changes in diffusion. In systems of finite dilution, the measured diffusion 
coefficient is thus an apparent diffusion coefficient, Dapp, which is related to the infinite 
dilution coefficient, D0, by: 
 
0[1 ]app DD D k c   
 
Where kD is the DLS interaction parameter or the diffusion virial coefficient, and c is the 
concentration of the NPs. By measuring the diffusion coefficients, the average size 
distribution of the NPs in a suspension is calculated. 
 
5.6 Zeta potential 
 
Nanoparticles are typically not stable in water by themselves, and are therefore surface 
functionalized for enhanced water stability. The molecules used for this purpose must be able 
to bind to the NP surface and have a hydrophilic moiety that causes the NP to be stable in 
water. The overall charge of the nanoparticle is determined by the charge of the stabilizing 
moiety, a value that can be determined with zeta potential measurements.  
 When a charged spherical nanoparticle is solubilized in an electrolyte solution, a cloud 
of coions and counterions immediately surrounds it. At the inner surface layer of the NP, the 
local concentration of counterions is significantly higher than the concentration of coions. The 
layer immediately surrounding the NP is called the electrical double layer. A charged NP in 
an electrolyte solution has an electrical potential that drops with the distance from its surface. 
The electrical potential ψ(r) at a position r outside the particle is related to the charge density 
at the same point, ρel(r), described by the Poisson equation:  
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Where Δ is the Laplacian, εr is the relative permittivity of the electrolyte solution, and ε0 is the 
permittivity of a vacuum. If the electrical potential is low: 
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The Poisson equation can be written as the linearized Poisson-Boltzmann equation, or the 
Debye-Hückel equation:  
2     
Where κ is the Debye-Hückel parameter and the reciprocal is the Debye length which 
corresponds to the thickness of the electrical double layer, illustrated in  
Figure 5.5a. 
161
 
 
 
 
Figure 5.5: a) ζ-potential. A moving particle in a medium will affect the field lines depending 
on its particle radius, Rs. b) large particle will affect the field lines to a greater extent, 
compared to c) small. Adapted from Hiemenz.
160
 
  
When an NP moves in a solution the layer of liquid immediately adjacent to the NP surface 
has the same velocity as the NP. The surface where there is relative motion between the NP 
and the liquid is called the surface of shear, and the electrical potential at the surface of shear 
is the zeta potential, illustrated in Figure 5.5. The numerical value and sign of the ζ-potential 
is used to describe colloidal stability, and values above |25| mV are considered sufficient for 
electrostatic repulsion between particles. 
160
 In the context of this thesis, ζ-potential 
measurements were used to evaluate the surface charge of iron and manganese oxide 
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nanoparticles after surface functionalization. The surface charge of an NP will dictate to 
which extent it interacts with a biological tissue. For instance, whether or not a nanoparticle is 
taken up by the cell or not, depends heavily on the surface charge of the particle. The 
extracellular matrix of human cells is negatively charged, and a positively charged NP may 
have unwanted electrostatic interactions with the membrane, 
162, 163
 hence a negatively or 
neutrally charged nanoparticle could be more favorable.     
 Depending on the ratio between κ and the particle radius, Rs, different equations for 
the ζ-potential can be obtained. If κRs >100, that is, when κ is small compared to the particle 
radius, the Helmholtz-Smoluchowski’s equation can be used to calculate the ζ-potential:  
 
0r


 
  
 
The Helmholtz-Smoluchowski equation is used for large particles in polar media. In the other 
case, when κRs<0.1, Hückel’s equation is applied:    
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The Hückel equation describes small particles in non-aqueous media.  
The Helmholtz-Smoluchowski and Hückel equations can be summarized to:  
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Where C represents the two limiting cases of κRs: 
 
1. Helmholtz-Smoluchowski: C = 1 
2. Hückel: C = 3/2 
 
The value of C shows the direct consequence of how the field lines surrounding a particle are 
affected by the particle radius (Figure 5.5 b and c). However, for all intermediate values of 
κRs, either the Helmholtz-Smoluchowski or Hückel equation describes the system adequately, 
or the more complicated Henry’s equation must be used. However, in this thesis the 
Helmholtz-Smoluchowski equation was used. The argument being that using the same 
approximation consistently would render the data sets relatively comparable. 
160
 
  
5.7 X-ray Photoelectron Spectroscopy 
 
It has already been established that the oscillation of valence/surface electrons in AUNPs 
cause LSPR that is detectable with UV-vis spectroscopy. Combined with TEM and HRTEM, 
the physical structure of a NP can be determined. However, the surface composition of the NP 
cannot be determined with microscopy; neither can UV-vis spectroscopy reveal any 
information about the inner electrons, i.e those situated closest to the atomic nucleus. 
Spectrometry must be employed to elucidate the surface properties of the NP, for instance to 
get information about the orientation of the stabilizer on the NP surface. The most common 
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technique for surface analysis is X-ray photoelectron spectroscopy (XPS) that provides 
information about the composition and chemical state 10 nm from the surface. 
164
 In the 
context here, XPS data provided information about molecules that were surface bound to a 
nanoparticle, such as L-DOPA bound to manganese oxide nanoparticles (MONPs), or AuNC 
surrounding AuNPs in a protein corona.  
 In XPS, the sample of interest is placed in a vacuum chamber where it is radiated with 
X-rays, UV light, or synchrotron radiation. Upon radiation, the emitted energy of the sample 
consists of three components. The first component is radiation with the same energy as the X-
ray source (hv), and the second component is radiation which is characteristic to the material 
being studied (hv’). The third component consists of electrons and these photoelectrons are 
the basis for XPS. The photoelectrons are collected and focused by an electrostatic lens 
system and trafficked to an electron analyzer, and a spectrum is produced (Figure 5.6).  
 
Figure 5.6:  XPS. The intensity (related to the amount of excited electrons) is plotted as a 
function of the binding energy (electron volt). The spectra show the binding energy of gold 
atoms in a sample of BSA-stabilized AUNCs. 
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Generally, a photoelectron is emitted by an incoming photon from the X-ray source. During 
the process of emission, the photon is annihilated and the energy is transferred to the electron. 
If the photon energy is sufficient, a photoelectron is emitted. The kinetic energy (KE) of the 
photon is the measured physical quantity that is related to the electron binding energy (EB) 
via the equation 
 
specKE hv BE     
 
Where spec is the work function. Specifically, spec is the energy difference between the 
electrons bound to atoms/ions in the gas phase (vacuum level) and electrons bound to 
atoms/ions in the solid state (Fermi level). The work function represents the minimum 
required energy to remove an electron from a solid. Electrons that suffer from kinetic energy 
loss from traversing the sample are observed as background noise. 
166, 167
 
 Valence electrons need less energy for excitation compared to core electrons. When an 
electron close to the core is emitted, it leaves a hole that is quickly filled by an outer-shell 
electron. The atom then ejects a second electron, named an Auger electron.  
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 In order to get information on the surface characteristics of NPs, the spectra of an 
unmodified NP is compared to a NP with a surface molecule. For instance, an unmodified 
MONP is compared to a MONP with L-DOPA. If L-DOPA is chemically bonded to a 
manganese atom at the NP surface, the valence electrons need to redistribute to form the 
chemical bond. In turn, this affects the bond strength of the inner core electrons, with the 
effect of a chemical shift in the recorded spectrum. 
165
  
5.8 X-ray Powder Diffraction 
 
As mentioned above, a sample that is excited with an X-ray source emit radiation and 
photoelectrons (Figure 5.6). The emitted photoelectrons are the basis for XPS, while the 
second component of the radiation, that is the specific material radiation, is the basis for X-ray 
diffraction (XRD).   
 In a typical XRD experiment, a sample is radiated with X-ray and the scattered 
radiation is collected through a moving detector. The different direction of the scattered 
radiation is directly related to the crystal structure of the material, and as such a material has 
its own characteristic XRD pattern. 
168
  
 
Figure 5.7: Interference geometry of a wave scattered from two planes, interspaced by d. 
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The incident X-ray waves must have wavelengths comparable to the spacing between the 
atoms in the material. The interatomic spacing is called the atomic periodicities. Crystals that 
have isotropic atomic periodicities give sharp diffraction peaks, while crystals with impurities 
have less precise periodicities and show diffraction peaks that are broadened or distorted. In 
the work described here, XRD was used to confirm the presence of crystalline AuNPs 
synthesized by proteins, as well as describing the composition of different oxidation states of 
manganese in MONPs.   
 Figure 5.7 show the principles of XRD. An incident light with an angle θ hits the 
sample and the emitted radiation has a difference in path length corresponding to 2dsinθ, 
where d is the interplanar spacing When the path length difference from the top and bottom 
rays is equal to one wavelength, λ, constructive interference causes strong diffraction from the 
sample. This wavelength is defined with Bragg’s Law: 
 
2 sind   
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In an XRD spectrum, the Miller indices are used to specify from which planar spacing the 
diffraction is coming from. Each face of a crystal is presented in Miller indices h, k, and l 
which are defined as  
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Where X, Y and Z are coordinates in a three dimensional coordinate system (Figure 5.8). The 
notation for Miller lattices is that (hkl) represents a crystal face or lattice plane. 
169
  
 
 
 
 
Figure 5.8: Miller indices. 
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The specific peaks in an XRD pattern of a non-characterized sample are compared to 
standards to determine its crystallinity and any impurities.   
 
5.9 Langmuir films and monolayer depositions 
 
Upon determining the physical properties of the nanoparticles, the next step is to investigate 
how the nanoparticles behave in biological systems, particularly with model membranes. 
Membranes that mimic biological systems are simple models, but they allow repeated 
experimentations in controllable environments. 
170
 Equally important, they allow continuous 
monitoring of membrane alterations, which is not possible with a cell.  
171
  
 Interactions between a monolayer and a surface active molecule can be performed 
with a Langmuir-Blodgett experiment, and the changes in the surface tension is continuously 
monitored and logged. There are several applications of the Langmuir-Blodgett technique, but 
the focus of this text will be on Langmuir film experiments and Langmuir-Schaefer 
depositions for microscopy.  
 In a typical experiment, water or an aqueous buffer is added in a through that has two 
compression barriers at the extreme edges. The barriers and the through are made of 
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hydrophobic materials (Teflon), which allow a water meniscus to form. The intrabarrier 
surface is separated from the extrabarrier space by a water meniscus. In the center of the 
through, a thin paper plate
XVI
 is submerged into the liquid in such a way that a water meniscus 
forms midway on its sides. This paper plate reacts to changes in the surface pressure, and its 
movements at the surface is monitored by an electrobalance.  
 After adding the water/buffer to the through, the surface is rinsed for dust or foreign 
particles before the lipid is deposited on the surface. This causes some perturbations in the 
surface pressure, and the system is set to equilibrate and normalize before start. When 
depositing lipids or surface active agents (surfactants) on a water surface, the hydrophilic 
head group spontaneously orients towards the water, while the hydrophobic tails will point 
towards the air. The intrabarrier space determines the available surface area that the lipid 
molecules can spread onto, and therefore determine the density of lipids at the surface (area 
per molecule). When the surfactants completely fill the interface, they are said to produce a 
monolayer, or a Langmuir monolayer. 
172
  
 
Figure 5.9: Langmuir monolayer. Compression of the film is done with barriers. After a 
monolayer is produced, a suspension of transferrin-stabilized gold nanoclusters is injected 
under the monolayer. 
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From the aqueous side of the monolayer, the interface resembles that of a cellular membrane, 
and after forming the membrane the nanoparticles of interest are injected underneath the 
barriers in what is termed the Injected method (Figure 5.9). 
170
  
 In paper I, Langmuir film interaction experiments were performed with a monolayer 
of phosphatidylserine (PBPS) and AuNCs stabilized with transferrin (Tf-AuINT). After 
forming a monolayer, the Tf-AuINT was injected under the barriers so as to not disturb the 
monolayer. With the paper plate, the change in the surface pressure was measured as a 
function of time, which revealed a remarkably high surface pressure compared to the lipid 
alone. This we interpreted as high interfacial interaction of the Tf-stabilized gold 
nanoconstruct that most likely penetrates the lipid film. To further investigate this, a part of 
the monolayer containing both Tf-AuINT and PBPS was deposited on a gold sputtered 
surface through a technique called Langmuir-Schaefer deposition, illustrated in Figure 5.10. 
 
                                                 
XVI
 A metallic Wilhelmy plate is also often used, but in paper I, a paper plate was used for all experiments.  
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Figure 5.10: Langmuir-Schaefer depositions of lipid monolayers with transferrin-stabilized 
AuNCs 
 
A gold sputtered plate was moved horizontally towards the surface, and kept there for 30 
seconds with the aid of a vacuum pump. This allowed for the lipids and Tf-AuINT to adsorb 
to the plate. The adsorbed layer was then dried, and the surface was imaged with atomic force 
microscopy, as described in the next subsection.      
5.10 Atomic Force Microscopy 
 
With Atomic Force Microscopy (AFM) forces on the atomic scale can be detected and images 
of a surface can be acquired. The principle of AFM is based on movements of a flexible 
atomically sized tip which is moved over the sample surface with a piezoelectric scanner 
(Figure 5.11). This tip is fixed to a flexible spring that is called the cantilever. The tip is very 
sensitive, and is affected by force interactions with the surface to which the cantilever is 
deflected. A laser is directed to the tip of the cantilever, and photodiode detectors monitor the 
fluctuations of the tip by measuring the angle of the deflected beam. In AFM there are two 
modes of action, the tapping mode or the contact mode. In the tapping mode, the tip oscillates 
with a set frequency and is scanned over the surface. The electrostatic interactions between 
the surface and the tip will lead to alterations in the amplitude and frequency of the 
oscillations, which is related to the physical properties of the surface. The magnitude of the 
interactions are 10
-11
 to 10
-6
 N, and when the tip is held 10-100 nm from the surface, van der 
Waals and electrostatic forces can be sensed. In contact mode, the tip moves over the surface 
and the topography of the surface is described based on the deflections of the tip. 
174-177
  
 One key advantage of AFM is that the images can be acquired in liquid, meaning that 
soft biological membranes can be imaged and characterized. Here, interactions between 
transferrin-stabilized AuNCs and a model biological membrane were investigated with AFM 
(paper I). A monolayer of lipids that had been exposed to Tf-AuNCs was deposited on a gold 
sputtered film with Langmuir deposition, as described in the previous subsection. Large 
perturbations to the lipid monolayer were observed in the sample where Tf-AuINT was 
present, which was not observable in the sample of pure lipid, and lipids that had interacted 
with the native protein. These changes were interpreted as incorporation of Tf-AuNCs into the 
lipid, which made it relevant to further describe these interactions with live cells.   
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Figure 5.11: AFM principles. 
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5.11 Cell cultures, labeling and viability assays 
 
Although Langmuir and AFM are great methods for investigating interface interactions, they 
lack the complex membrane functions found in living cells. Also, any uptake of nanoparticles 
can be described by co-incubating a nanoparticle suspension with a particular cell culture, 
before ultramicrotome sectioning and TEM (See subsection 5.4).  
 The in vitro studies described in this thesis were mainly performed on human cancer 
cells and rodent olfactory ensheathing cells. The main work was performed with co-
incubating nanoparticles with human glioblastoma-astrocytoma cell cultures and therefore the 
focus of this part will be on these cells.      
 Glioblastoma multiforme is the most common primary brain tumor in adults. 
178, 179
 It 
is highly aggressive 
180
 and exhibit low response to conventional chemotherapeutic drugs.
181
 
Cells acquired from a human donor show a more relevant biological response than 
commercially available cell lineages (e.g HeLa cells), that have been expanded for several 
generations. 
182
 Also, the rapid expansion and robustness of the glioblastoma-astrocytoma cell 
cultures makes them easy to work with.  
 Glioblastoma-astrocytoma cells (U-87 MG) were cultured in Eagle’s Minimal 
Essential Medium (EMEM) with 1.25% gentamicin and 10% fetal bovine serum. The medium 
was supplemented with 2mM L-Glutamine, 1% non-essential amino acids (NEAA), and 1mM 
sodium pyruvate (NaP). After reaching a confluence of 60-70%, the cells were co-incubated 
with nanoparticles at different concentrations, and incubation times. In all cases, three 
parallels for each parameter were used, and unlabelled glioblastoma-astrocytoma cultures, at 
the same stage of confluence, were used as controls. 
 After labeling, a LIVE/DEAD® (Life Technologies) cell viability assay was 
performed. This method is a qualitative method, and the viability is assessed by comparing 
control cultures of cells. A LIVE/DEAD-cell viability assay evaluates the membrane integrity 
of cells, and consists of two different dyes: calcein AM (excitation/emission: 494/517nm) and 
ethidium homodimer-1 (excitation/emission: 517/617nm). In live cells, intracellular esterases 
react with calcein AM and yield a cytoplasmic green fluorescence. Ethidium homodimer-1 
42 
 
(EthD-1) diffuses through damaged cell membranes of dead cells, where it binds to nucleic 
acids and emits red fluorescence (Figure 5.12).  
 
 
Figure 5.12: Glioblastoma-astrocytoma cells after LIVE/DEAD staining. Green cells are 
alive, while red cells are dead and indicated with arrows.  
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6 Results and Discussion 
 
In this chapter, the main data and conclusions from papers I-V will be presented.  
6.1 Paper I 
Self-assembly and characterization of transferrin-gold nanoconstructs and their 
interaction with bio-interfaces 
Nanoscale, 2015, 3, (17) p. 8062-8070 
  
The aim of Paper I was twofold. First we wanted to determine how adding a reducing agent 
affected the Tf structure and growth of gold nanoconstructs, and compare this to the intrinsic 
ability of Tf to reduce gold ions. 
XVII
 Previously, we have shown that a slight unfolding of the 
protein backbone have led to disruption of membranes, and the second aim was therefore to 
investigate if Tf-Au constructs had a higher membrane affinity compared to the native 
protein. 
61, 63, 148
   
 Two synthesis methods were employed, named the intrinsic and extrinsic. With the 
intrinsic method, no external reducing agent was added, while in the extrinsic method, 200μL 
of NaBH4 (1M) was added. Different concentrations of Au
3+
 (in the form of tetrachloroauric 
acid, TCAA) were also used, with Tf as controls. An overview of the samples is given in table 
6.1.  
 
Table 6.1: Sample name and reagents 
Synthesis method Sample name 1M NaBH4 (μL) TCAA (mM) 
 
Intrinsic 
Tf 
Tf-AuINT 
- 
- 
- 
5 
 
Extrinsic 
Tf-RED 
Tf-AuXL 
Tf-AuXH 
200 
200 
200 
- 
1 
5 
  
An absorption band at 530 nm revealed that AuNPs were mainly synthesized when a high 
concentration of TCAA was used in combination with NaBH4 (Tf-AuXH). However, 
broadened LSPR bands with lower intensities were also detected for Tf-AuINT and Tf-AuXL, 
indicating multimeric gold species. From these data, we concluded that NaBH4 increases the 
population of AuNPs, and that the size/amount of AuNPs increases with the amount of TCAA 
added (Figure 6.1a).  
 AuNCs were detected with steady-state fluorescence spectroscopy (λex=370 nm) and 
the emission spectra showed an intense peak at 450 nm and 650 nm for Tf-AuINT. This 
indicates small (Au8) and large (Au25+) AuNCs, respectively (Figure 6.1b). An AuNP that is 
in close proximity to an AuNCs in the excited state has the capacity to scavenge emitted 
photons from the AuNC and quench the fluorescence. AuNPs were confirmed in Tf-AuXH, 
which caused a complete quenching of the fluorescence emission. However this was not the 
case for Tf-AuINT, which had a dominant Near- IR emission. Although smaller AuNPs were 
present in the intrinsic samples, it is ultimately the concentration of AuNPs that will 
determine the amount of AuNC quenching. This again points to the main difference in adding 
NaBH4 or not; with a reducing agent, the concentration of AuNPs is higher, which increases 
the probability that an emitted photon from AuNC is quenched. Without a reducing agent, the 
synthesis was confined to produce mainly large AuNCs that were not quenched by AuNPs. 
                                                 
XVII
 Birgitte and Sondre are both first authors on this paper 
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Figure 6.1: a) UV-Visble spectra showing LSPR for AuNPs synthesized with a high (Tf-
AuXH) and low concentration of TCAA (Tf-AuXL) and AuNPs synthesized via the Intrinsic 
protocol (Tf-AuINT).  All samples were compared to the pure protein (Tf) and Tf with added 
NaBH4 (Tf-RED). b) Tf-AuNCs emission was measured with excitation λex= 370nm. c) Trp 
emission of native Tf has the highest fluorescence intensity at 350nm when excited at 
λex=295nm compared to Tf with NaBH4 (Tf-RED), Tf-AuNCs prepared with no (Tf-AuINT), 
high (Tf-AuXH) and low (Tf-AuXL) concentration of TCAA. When a high concentration of 
TCAA is used, the Trp emission is almost completely quenched (Tf-AuXL).  d) CD traces 
indicate structural changes in the protein backbone as the line shape changes when compared 
to the native protein (Tf), both with respect to NaBH4 and TCAA. 
 
HRTEM was used to complement the UV-visible and steady-state fluorescence spectroscopy 
measurements. AuNCs were observed in Tf-AuINT and Tf-AuXL samples, but not in Tf-
AuXH, which was consistent with the steady-state data. AuNPs dominated the images of Tf-
AuXH, which was expected due to the intensity of the LSPR band. 
 Changes in the protein structure upon AuNC and AuNP growth was assessed with 
steady-state fluorescence spectroscopy, circular dichroism (CD) and TCSPC.  Based on the 
acquired data, the main conclusion is that the protein structure was affected by NaBH4 and the 
amount of TCAA added. The combination of these two effects led to complete quenching of 
the Trp emission (Figure 6.1c, Tf-AuXH).  
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Figure 6.2: a) Surface pressure as a function of time show that compared to the native protein 
(Tf), the Tf-AuNCs prepared via the Intrinsic protocol (AuINT) is surface active. b) The delta 
surface area as a function of time indicates that Tf-AuINT has a higher surface activity 
compared to the pure lipid (PBPS) and the native protein (Tf).   
 
The protein is the steric stabilizer of the system, and in particular when larger gold species are 
present (Tf-AuXH), the structural integrity of the protein is crucial to obtain a miscible 
suspension. The results from Trp lifetimes and emission indicated that the Tf structure was 
highly altered, which caused the extrinsic samples to crash out. Due to the instability of the 
suspension, these samples were not further studied with model membranes or biological 
membranes in vitro as these experiments involve buffered solutions which further increases 
the instability of NPs (due to reduction of the electrical double layer). However, the Tf-
AuINT sample demonstrated sufficient solution stability and its interactions with a model 
biological membrane was investigated with Langmuir deposition and Atomic force 
microscopy (AFM).  
 The results show that Tf-AuINT had a large surface affinity compared to the native 
protein, which was explained as a direct result of protein unfolding (Figure 6.2). The 
perturbation of lipid monolayers were visualized with AFM by depositing a monolayer 
containing lipid and Tf-AuINT onto gold sputtered glass substrates (Langmuir-Schaefer 
method) and compared to lipid and Tf, and pure lipid. Compared to the other samples, Tf-
AuINT disrupted the lipid membrane which was consistent with the acquired Langmuir data. 
The reason for the enhanced interfacial interactions of Tf-AuINT is most likely caused by 
increased exposure of hydrophobic residues in the protein following AuNCs formation, which 
is in agreement with fluorescence, CD, and earlier studies.
24, 60, 61, 63, 154
  
 The next step was to advance from a model membrane to living cellular membranes. 
We wanted to see if a difference in the membrane structure affected the affinity/interactions 
between Tf-AuINT, and for that reason we chose three different cell types; olfactory 
ensheathing cells (OECs), ovarian cancer cells (OCCs), and glioblastoma-astrocytoma cells 
(GA cells). The cytotoxicity was assessed with a LIVE/DEAD assay after co-incubating each 
cell type with three different concentrations of either Tf or Tf-AuINT for 4 hours. For all cell 
types, there were no increased cell death after incubation with Tf-AuINT or Tf, compared to 
the blank. Partial co-localization of the calcein – and EthD1-derived fluorescence was 
observed for the OECs, which suggests that Tf-AuINT is associated with the cell membrane, 
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either blocking the entry of the LIVE/DEAD dyes, or due to photophysical interactions 
between the Tf-AuINT and the dyes. If the latter were to be the case, similar observations 
should also have been made for the glioblastoma-astrocytoma as well as for the OCCs. 
However, this was not observed. The strong monolayer interactions observed for Tf-AuINT in 
Langmuir and AFM suggests that the co-localization was due to an enhanced Tf-AuINT 
affinity towards the OEC membrane that was not observed for the other cell types. 
 The main conclusion from this paper was that a strong reducing agent such as NaBH4 
can be used to grow AuNPs, but that NaBH4 appear to cause a lot of damage to the Tf 
structure, which in turn leads to an unstable suspension. The most interesting constructs were 
synthesized with the intrinsic route. The capacity of Tf to intrinsically reduce TCAA resulted 
in AuNCs with high fluorescence intensity, and sufficient protein unfolding that gave 
radically different interfacial properties as compared to the native protein.  
 The reduction potential of NaBH4 appeared to be too strong for the purpose of 
synthesizing AuNPs in a Tf scaffold. Perhaps a weaker reducing agent would impart less 
structural damage to the protein? Varying the concentration of added TCAA seemed 
promising for tuning growth of different populations of AuNCs and AuNPs, and insight to the 
growth mechanism could be gained by investigating the ratio of reactants. To answer these 
questions, we chose to use a flexible and robust protein, bovine serum albumin, a protein 
which has been widely reported for its ability to synthesize AuNCs and AuNPs.  
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6.2 Paper II 
Controlling the self-assembly and optical properties of gold nanoclusters and gold 
nanoparticles biomineralized with Bovine Serum Albumin 
Manuscript under revision after peer-review in RSC Advances 
  
Synthesizing AuNCs and AuNPs seem to be dependent on the protein, reducing agent and 
amount of available gold precursor. 24, 47, 154 The incubation time for Tf-stabilized 
AuNPs/AuNCs were one week, and we have previously used the same incubation time for 
BSA- stabilized AuNPs/AuNCs. 154, 183 One week is a lot longer compared to the original 
synthesis of 12 hours23, but have the benefit of producing larger species of gold. 12 hours 
incubation time is also reported by several others,184-188 but overnight,189 15 hours,136 5 
hours,47, 187 and 2 hours154 have also been used for BSA-AuNCs synthesis. The different 
incubation times yield different populations of AuNCs, revealing that the synthesis is highly 
time-dependent. With the range of different synthesis procedures reported, it is difficult to 
describe a growth mechanism without changing one synthesis parameter at a time.  
 The main aim of paper II was to evaluate which factors affect the growth of AuNCs 
and AuNPs and to describe the mechanism of growth in order to gain control over the 
synthesis and the optical properties of the system.  
 In the Tf-paper above, NaBH4 appeared to alter the protein conformation to such an 
extent that the AuNP suspensions were destabilized. To avoid this, we chose to use ascorbic 
acid, which is a weaker reducing agent than NaBH4 and compare the extrinsic synthesis with 
the intrinsic synthesis imparted solely by BSA. The intrinsic reduction potential of BSA had 
previously been shown to yield highly fluorescent AuNCs. 24 BSA may also give a better 
scaffold for AuNC and AuNP stabilization, as it can undergo major transitions without 
denaturation (see subsection 2.1). From the Tf-paper we had indications that reducing agents 
favored the growth of AuNPs, but that this process also depended on the concentration of 
TCAA. Therefore, in paper II, five different concentrations of TCAA were used and the 
growth of AuNCs and AuNPs via the intrinsic and extrinsic synthesis protocols was 
compared. The different samples are listed in table 6.2.   
 
Table 6.2: Sample name and reagents 
 
 
BSA (mM) 
 
TCAA (mM) 
 
TCAA-Sample name 
 
2mM Ascorbic acid (μL) 
 
 
 
20 
 
0 
5 
7.5 
10 
15 
20 
 
Intrinsic  
 
 
- 
 
Extrinsic 
 
50 
  
 
 The results indicate that growth of AuNCs and AuNPs were affected by the amount of 
TCAA added, but that addition of ascorbic acid did not affect synthesis of AuNCs. However, 
synthesis of AuNPs seemed to be favored in the presence of ascorbic acid at high 
concentrations of TCAA. However, the standard deviation at 20 mM TCAA is very large 
compared to the other concentrations, which means lower reproducibility (Figure 6.3 a).    
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Figure 6.3:  Integrals of a) LSPR absorption peak (500-600 nm) as a function of TCAA. Also 
shown is the integral of the emission peak of large AuNCs (560-730 nm) and small AuNCs 
(385-540 nm) were calculated and the population ratio was calculated by dividing the integral 
of the large with the integral of the small AuNCs. The ratio is shown as a function of TCAA. 
b) Changes in Trp emission spectra (λex=295 nm) with incorporation of AuNCs and AuNPs.   
 
Trp emission steadily decreased with increased population of AuNCs, and the lowest emission 
was detected in samples with AuNPs. This could mean that as the population of AuNPs or 
AuNCs increase, BSA responds by unfolding. Interestingly, the hidden Trp residues of BSA, 
Trp213, appear to be exposed with growth of AuNCs or AuNPs (Figure 6.3b). Even the large 
conformational changes of BSA did not compromise the solution stability of BSA-AuNPs. 
The BSA-AuNP and AuNC suspensions have a very long shelf life, and samples were stable 
for more than a year. Also, samples could be freeze-dried and suspended again without 
substantial loss in solution stability. This is an advancement compared to the solution stability 
of the Tf-stabilized AuNPs that quickly destabilized in buffered solutions.  
 The high NIR effect observed for AuNCs at 10mM TCAA might be a result of a metal-
to-ligand/ ligand-to-metal charge-transfer (ML/LMCT) complex that is formed between the 
protein and the NIR AuNCs. This is believed to enhance the fluorescence intensities. 
However, in an ML/LMCT complex there is an exchange of electrons either from the metal to 
the protein or vice versa. If this was largely the case, either the protein or the AuNCs would 
be oxidized/reduced, which would destabilize the suspension with time. As the suspensions 
were very stable over long time periods (1 year), it is more likely that the high fluorescence 
intensity from NIR AuNCs is caused by capping of BSA. This would in turn cause shielding 
of the AuNC from water, which further would give a more intense fluorescence emission. 
 The main conclusion from the first part of the work was that no differences in size and 
population of AuNCs were found between the intrinsic and the extrinsic protocol. However, 
slightly larger AuNPs were observed when using the extrinsic protocol, which was also the 
case for the Tf-paper above. As with Tf, BSA appeared to be slightly affected by ascorbic 
acid, but not as drastically as that observed for Tf when using NaBH4.  
 During the incubation time of one week, the BSA-stabilized gold nanoconstructs 
change colors depending on the protein:TCAA ratio and incubation time. Although we have 
previously hypothesized on the mechanism of AuNC growth,24 we had never previously 
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measured the time-dependent changes to the protein and the time-dependent growth with 
spectroscopy. Due to the reproducibility of the data, we decided to follow the synthesis over 
one week. We chose the extrinsic synthesis method, as it had the tendency to produce larger 
AuNPs that would be easier to detect with UV-vis spectroscopy. The changes in Trp and 
AuNC emission were followed with steady-state fluorescence spectroscopy. 
 The results showed an increased LSPR intensity with time (Figure 6.4a), which means 
that growth of AuNP is a time-dependent process that depend upon the availability of gold 
ions. We interpreted the growth to be caused by shuffling and coalescence of AuNCs. 
Synthesis of AuNCs seems to be a very dynamic process that depend very much on the TCAA 
concentration and incubation time as well (Figure 6.4b and c). HRTEM images also revealed 
the coexistence of AuNCs and AuNPs, which we hypothesized from the time-resolved data 
(Figure 6.4d). The Trp emission is immediately affected by the onset of AuNC growth and the 
line spectra of the tryptophan emission remains the same during the whole week. But with 
time, the Trp emission appeared to increase, which could mean that BSA refolds to a more 
favorable position with less exposed hydrophobic parts. With time, there is an increase in the 
emission of AuNCs. Taking both these events into account, it seems likely that at thigh 
concentrations of TCAA, a reorganization of the protein backbone will bring AuNCs closer to 
each other, which would cause shuffling of AuNCs into AuNPs.   
 From these data, we were able to hypothesize on the following growth mechanism, 
illustrated in Figure 6.4e. When increasing the pH to above 10, BSA becomes 1) negatively 
charged which induce electrostatic interactions with positively charged gold ions (Au3+). Once 
in contact with amino acids (such as Tyr and His) Au3+ is reduced to small AuNCs. 2) Primary 
nucleation occurs when the local concentrations of gold ions are sufficiently high. Because 
reduction is performed by polar amino acids, it is likely that the primary nucleation occur at 
the protein surface, and not in the hydrophobic interior. The nucleation event causes an 
unfolding of the protein backbone. 3) When increasing the TCAA concentrations, small 
AuNCs are shuffled into larger AuNCs due to conformational refolding of the protein. Growth 
of large AuNCs is also driven by an increased influx of Au3+ from the bulk. 4) The growth of 
AuNCs continue until they collide and self-assemble into a central AuNP that is surrounded 
by BSA-AuNCs.24  
 The protein-nanogold system offers an interesting and simple approach to synthesis of 
AuNCs and AuNPs, and the protein offer steric stabilization without the need for further 
surface stability. However, their applicability in bioimaging may be slightly impaired. When 
we performed in vitro assays with the Tf-AuNCs/AuNPs, we observed spectral interferences 
with the dyes. Additionally, we observed no cytotoxicity of glioblastoma-astrocytoma cells 
after incubation with BSA-AuNCs/AuNPs, which is an indication of biocompatibility. 
However, we wanted to synthesize NPs that could be taken up by cells, and from previous 
literature these were nanoparticles prepared with chemical synthesis. We chose to focus on 
nanoparticles prepared from gold, iron oxide, and manganese oxide nanoparticles as these 
have interesting optical and magnetic characteristics. 
 
50 
 
 
 
 
Figure 6.4: Graph a) shows the intensity at 520 nm (corresponding to the LSPR band of gold) 
as a function of time for the sample incubated with 20 mM TCAA. No LSPR-band was 
observed for any other samples. Graph b) shows the integral of the emission peak for the 
small AuNCs (385-540 nm) after subtracting the signal of native BSA. Graph c) show the 
integral of the emission peaks of large AuNCs (560-730 nm) after subtracting the signal of 
native BSA. Both graph b and c are shown as a function of time. d) HRTEM image of central 
AuNP surrounded by BSA-AuNCs. The AuNCs are encircles. Scale bar= 5 nm. e) Suggested 
mechanism for growth of AuNCs to AuNPs as a function of incubation time and concentration 
of TCAA.16 
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6.3 Paper III 
Makura-shaped gold nanostructures show high cytotoxicity in cancer cells 
Manuscript in preparation  
 
The plasmon oscillations and subsequent absorption band of Au nanostructures (NS) is 
dependent on the size and aspect ratio of the NP, as well as the dielectric constant of the 
medium. Au NS that are non-spherical, can have plasmonic peaks longer than 700 nm, which 
is a significant bathochromic shift compared to the plasmonic peak of BSA-stabilized Au NPs 
at ~520 nm. In this region (near-IR), the autofluorescence from biological tissue is low, which 
gives a higher signal-to-noise ratio to Au NS absorption and making them easier to detect. 
3
 
The aim of paper III was to synthesize Au NS with different sizes and shapes, characterize 
their morphology and optical properties, and then assess their cytotoxicity and uptake in 
glioblastoma-astrocytoma cells. In this part, the synthesis methods will not be discussed in 
full detail as the synthesis of the nanostructures was performed by Sulalit Bandyopadhyay. 
XVIII
 The focus will be on uptake and cytotoxicity of the different Au NS with glioblastoma-
astrocytoma (GA) cells.  
 Five different shapes of Au NS were synthesized using a silver assisted seed growth 
mechanism assisted by cetyltrimethylammonium bromide (CTAB) which mediates the 
direction of growth. The resulting five different shapes and their absorption spectra are shown 
in Figure 6.5.   
 
Figure 6.5: Different shapes of Au NS. a) Rods, b) Tetrahexahedra, c) Nanomakura, d) 
Bipyramids, e) spherical. The spectra in f) show the absorbance spectrum for each 
nanostructure. 
 
 
                                                 
XVIII
 Birgitte is second author on this manuscript, and was responsible for the in vitro work. 
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Table 6.3: Aspect ratio, hydrodynamic volume and zeta potential of gold nanoconstructs 
 
 
Figure 6.5f shows the UV-vis spectra of all the gold nanoconstructs prepared in this paper. Au 
NS display tunable LSPR characteristics over the UV-Vis –visible- near IR range, with 
plasmon bands that split up into multiplets for anisotropic structures. The nanorods (Figure 
6.5a) show at least three distinct bands at 516 nm, 679 nm and 796 nm, the most intense band 
observed at 679 nm. The emergence of a third band can be associated with the polydispersity 
of the nanorods that is caused by an etching effect of oleic acid. This leads to the formation of 
nanorods with rough edges, and subsequently an alteration of the plasmon. Both transverse 
(557 nm) and longitudinal resonance peaks (760 nm) are observed for nanomakura (Figure 
6.5c), which has a more jagged surface compared to the nanorods. The larger structures 
(Figure 6.5b: tetrahexahedra and Figure 6.5d: bipyramids), single and broad LSPR peaks are 
observed at 568 nm and 593 nm respectively. CTAB is a positively charged surfactant that can 
have a strong electrostatic attraction to the negatively charged extracellular matrix. Its positive 
charge may induce proteins to adsorb on the surface, and as such alter the process of 
endocytosis. 162 Because of the unwanted effects of CTAB, it CTAB was removed from the 
surface by a two-step exchange procedure, primarily with PEG-SH and secondly with a 
displacing alkanethiol named 11-mercaptoundecanoic acid (MUA). Table 6.3 show the 
surface charge (zeta potential) of the AuNCs after surface exchange.  
 All nanostructures were negatively charged, except the nanorods. 190 This might be an 
effect of the sharp edges on the rods which may have made it difficult to exchange CTAB. 
DLS measurements are based on a spherical particle assumption, which means that DLS data 
may be inaccurate for non-spherical NS. This is also reflected in the size of non-spherical Au 
NS as S(T)EM data deviates from DLS measurements. NS have a higher rotational 
probability along the short axis, making the DLS data different than the S(T)EM.  
 Whether or not NS are taken up in cells depends on the physicochemical properties, 
aspect ratio (AR), and surface characteristics of the NS, as well as the cell type. 191-193 The 
surface charge and surface molecules (e.g Transferrin)134, 194 may be more determining than 
size, for specific or unspecific endocytosis.162 Moreover, the morphology of the NS will in 
turn determine the surface coverage of stabilizing or targeting molecules, and as such Au NS 
of various shapes are believed to interact differently with cells. 118 To get a better 
understanding on how morphology and charge affect cellular uptake, stable MUA-coated Au 
NS were co-incubated with GA cells for 24 hours, and the effect of shape and concentration 
on the cytotoxicity were assessed with a LIVE/DEAD assay supplemented with a nuclear 
stain (Figure 6.6a).    
 
 
 
 
Shape 
S(T)EM analysis  
 
 
 
DLS Size 
(nm) 
 
 
 
 
Zeta 
potential, 
MUA (mV) 
Long axis 
(nm) 
Short axis 
(nm) 
Aspect 
ratio (AR)  
Nanorods 45.1 ± 8.1 17.7 ± 6.3 2.8 ± 0.7 22.0 ± 0.3 24.1 ± 0.3 
Tetrahexahedra 180.1 ± 25.4 128.8 ± 27.2 1.4 ± 0.3 81.4 ± 1.4 -21.6 ± 0.6 
Nanomakura 107.8 ± 15.3 71.0 ± 12 1.6 ± 0.3 72.1 ± 0.6 -18.7 ± 0.2 
Bipyramids 643.9 ± 84.7 266.1 ± 19.2 2.4 ± 0.3 156.4 ± 2.1 -25.8 ± 2.1 
Spheres 14.9 ± 4.4 14.9 ± 4.4 1.0 ± 0.0 16.6 ± 1.2 -36.8 ± 0.4 
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 We hypothesized that the rod-shaped Au NS would cause more damage to the cells, 
due to their high aspect ratio and apparent positive charge. However, the highest cell death 
was found for the NS shaped as nanomakura at the highest concentration of NS/cell media 
(Figure 6.6a). All types of Au NS were found to associate with the cell membrane, but Au NS 
shaped as nanomakura and nanorods appeared to be taken up by the cells as they were 
observed close to the nucleus. Au NS taken up via receptor-mediated endocytosis may 
eventually end up in the Golgi apparatus, 118, 195 and this may explain the apparent trafficking 
of nanomakura NS towards the nucleus (Figure 6.6 g). However, uptake of Au NS cannot be 
confirmed with light microscopy, as it is not possible to confirm if NPs are taken up or if they 
are simply associated with the extracellular matrix. However, the concentration-dependent 
cytotoxicity of GA cells with incubation of nanomakura Au NS indicated some kind of 
cellular interaction/uptake.196 Due to this, uptake of nanomakura Au NS was followed with 
TEM for 2, 6, 12 and 24 hours after co-incubation with GA cells. XIX  
 TEM-results confirmed that nanomakura Au NS were taken up by the cells. 2 hours 
after co-incubation nanomakura with glioblastoma-astrocytoma cells, the nanomakura appear 
to be invaginated by the cellular membrane in a mechanism which resembles receptor-
mediated endocytosis (Figure 6.6b). At later stages, what looks like macropinocytosis is 
observed (Figure 6.6h). The latter is believed to occur when large objects enter a cell, and 
macropinocytosis may have been induced by aggregation of NS. At 24 hours, the uptake of 
nanomakura Au NS appeared to continue, which may have been caused by the high 
extracellular concentration of the NS (Figure 6.6k, l). At 24 hours, the cells seem to detach 
from the surface, which is an indication of cellular death (Figure 6.6 m).  
 This paper demonstrates that Au NS of different shapes can be taken up by human 
cancer cells, and their optical properties nominate them for applications in bioimaging.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
XIX
 Ultramicrotome sectioning and TEM (80 kV) was performed by Nan E. Tostrup Skogaker at the Cellular and 
Molecular Imaging Core Facility (CMIC), Norwegian University of Science and Technology (NTNU). 
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Figure 6.6: a) Percentage cell death of GA cells as a function of concentration of Au NS. The incubation time 
was 24 hours. Images b)-m) are acquired after incubation of nanomakura-shaped gold nanostructures in 
glioblastoma-astrocytoma cells taken at several time points up to 24 hours. b) TEM show an invagination of the 
cellular membrane (error bar=1 μm), and c) halogen and d) fluorescence images show association of 
nanomakura Au NS at the cellular membrane. e) Uptake of nanomakura Au NS were observed after 6 hours 
(error bar=500 nm), f) with uptake in intracellular vesicles (error bar=2μm). g) staining of the nucleus suggest 
that nanomakura Au NS were excluded from the nucleus. h) TEM images taken after 12 hours suggests uptake 
via macropinocytosis (error bar=500 nm), with i) intravesicular location of nanomakura Au NS (error bar=500 
nm). j) Intracellular compartmentalization was also visible from the microscopy. Uptake of nanomakura Au NS 
continued at 24 hours as seen in TEM images k) (error bar=2 μm) and l) (error bar=5 μm). m) Detachment of GA 
cells from the surface was observed, which most likely is an indication of cell death. 
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6.4 Paper IV 
Pentatwinned iron oxide nanoparticles as glioblastoma-astrocytoma cell actuators
XX
 
Manuscript in preparation 
 
It has been established that AuNPs of different shapes and sizes have optical properties in the 
visible region of the electromagnetic spectrum, as was shown in paper III.  Another material 
that is emerging as a promising candidate for bioimaging applications is iron. NPs of iron 
oxide (IONPs) can be used as CAs in MRI due to their strong magnetic susceptibilities that 
can give a hypointense/negative signal in an MR image. Due to the high resolution of MRI, 
IONPs can also be visualized inside cells, which may for instance become important for 
studies involving regeneration of the central nervous system. 
99
  
 The aim of this paper was threefold. The first aim was to synthesize and characterize 
novel IONPs. The second aim was to investigate shape-dependent uptake of IONPs in 
glioblastoma-astrocytoma cells, and the third aim was to see if IONPs could actuate these 
cells when under the influence of a static magnetic field. Thus, the third aim involves 
describing novel IONPs for hyperthermia applications.  
 As the shape and size of gold nanoparticles show different optical responses, the 
magnetic properties of IONPs may also seem to be size, - and shape-dependent. In recent 
years, synthesis of IONPs can be tuned in such a way to give structures that are non-spherical, 
for instance cubic, rod-shaped, or pyramidal. Four types of IONPs with different shapes and 
sizes were synthesized: spherical, cubic, octahedral and pentatwinned. All shapes synthesized 
here are depicted in Figure 6.7, except the spherical IONPs. A novel shape was synthesized 
by Dr. Gurvinder Singh, and the shape has been termed pentatwinned. A pentatwinned 
structure has five facets (Figure 6.7 a) that appear to have assembled from two separate 
structures (encircled in Figure 6.7 b).  
 
                                                 
XX
 Birgitte and Gurvinder contributed equally to this work. 
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Figure 6.7: Image a) shows HRTEM image of pentatwinned structure. TEM image b) show 
that pentatwinned IONPS seem to assemble from two smaller structures. Images c) show 
TEM image of cubic IONPs, while d) show TEM image of octhaedra shaped IONPs. The 
spherical IONPs are not shown.  
 
 The focus on the discussion will be on the in vitro data, as they were performed by 
Birgitte Hjelmeland McDonagh.  
 The interactions of IONPs were investigated in vitro on glioblastoma-astrocytoma 
cells. The aim was to determine if cellular interactions and uptake were shape-, and 
concentration dependent. Two different concentrations were used (100 and 500 μg/mL, v/v: 
NP suspension/cell media), as we had indications from paper III that the uptake of NPs appear 
to be concentration dependent. A LIVE/DEAD assay supplemented with a nuclear stain was 
added to the cell cultures 24 hours after co-incubation with IONPs (Figure 6.8). However, the 
dyes were not used to determine the cytotoxicity, but used to visualize the cell nucleus and 
cellular membranes to give sufficient contrast between the cells and the nanoparticles.  
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Figure 6.8: Uptake of IONPs of different shapes 24 hours after co-incubation with 
glioblastoma-astrocytoma cells. Images in the first column to the left show cells stained with 
calcein. Images in the mid column show the same cells stained with nuclear stain, and the 
column to the right show the cells imaged with halogen light. Images a)-c) show cubic IONPs 
(500 μg/mL), d)-f) octahedral IONPs (500 μg/mL), g)-i) spherical IONPs (100 μg/mL), and 
j)-l) pentatwinned IONPs (500 μg/mL).   
 
 Uptake of NPs is hypothesized to be size-dependent, and only a small difference in 
size may determine if the NP is taken up or not. 
130
 From the in vitro data, the spherical 
IONPs appeared to center around the perinuclear region of the cells (Figure 6.8 g-i), while this 
is movement was less clear for the pentatwinned IONPs (Figure 6.8 j-l). Translocation of NPs 
has previously been shown to accumulate in the perinuclear region, which is associated with 
NPs internalized in endosomal and or lysosomal vesicles. 
135
 In addition to size, surface 
functionalization has been shown to be very important for the uptake of NPs in cells. 
145, 197
 
One widely used method for surface functionalization is attachment of poly(ethylene)glycol 
(PEG). PEG is hydrophilic and is generally accepted to withstand protein adsorption and is 
broadly used for surface stabilization of iron oxide nanoparticles.
198,199
  
 
58 
 
 
Figure 6.9 Alignment of IONPs in magnetic field. Cells incubated with pentatwinned IONPs 
a) before and b) after placement in magnetic field. Arrows indicate the NPs. Cells with 
spherical IONPs c) before and d) after placement in magnetic field also show tendency 
towards field alignment.  
 
However, when the shape of the NPs is different than spherical, surface functionalization may 
not be homogeneous and the orientation of PEG molecules may be different on surfaces with 
different curvature. Particularly, the orientation of PEG-molecules on IONPs has been shown 
to be important for protein adsorption. 
144
  
 IONPs of cubical and octahedral shape appeared to cluster outside of the cells (Figure 
6.8 a-f), which probably is an effect of unsuccessful stability in the cell medium. However, 
less clustering was observed with spherical (Figure 6.8 g-i) and pentatwinned (Figure 6.8 j-l) 
IONPs and images gave indications of uptake in glioblastoma-astrocytoma cells. Due to the 
sharp edges of the cubic and octahedral IONPs, the surface coverage and stability from PEG-
molecules may not have been sufficient, which would have caused destabilization in cell 
media. For instance, the facets of cubic IONPs would allow for a different orientation of PEG-
molecules compared to spherical IONPs, and the shape effect might here be more important 
than the size. 
  As the cubic and octahedral IONPs did not appear to be taken up by the glioblastoma-
astrocytoma cells, they are less likely to give motility to cells under a magnetic field. 
Therefore, glioblastoma-astrocytoma cells were again incubated with spherical and 
pentatwinned NPs for 24 hours, before imaging under a constant magnetic field. 
XXI
   
                                                 
XXI
 Two magnets were placed on each side of the incubation flask and placed under a fluorescence microscope. 
Images were acquired as a function of time.  
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 Hyperthermia is a therapeutic procedure based on heating specific tissue up to 41-43° 
C with an alternating magnetic field with the aim of destroying the tissue. Particularly, 
malignant cancer cells that tend to be resistant towards radiation therapy seem to be more 
susceptible to hyperthermia compared to normal tissue.
200
 However, one reason that 
hyperthermia is not an established protocol is because achieving sufficient local heating of 
cancer cells without affecting surrounding healthy tissue is problematic. One way of solving 
this problem is do directly inject IONPs into the tumor and then apply an alternating magnetic 
field. 
201
  
 Comparing the time-dependent movement of cells under a static magnetic field 
showed that cells incubated with pentatwinned IONPs showed a higher tendency for motility 
compared to cells incubated with spherical IONPs and cells without IONPs. Also, alignment 
of pentatwinned IONPs appeared to be stronger than spherical IONPs, which may be caused 
by their different magnetic properties. Additionally, the magnetic responses suggest that the 
pentatwinned structures are capable of producing more heat than the spherical IONPs, which 
would be beneficial for the intended application.  
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6.5 Paper V 
L-DOPA coated manganese oxide nanoparticles as dual MRI contrast agents and drug 
delivery vehicles 
Accepted in SMALL 
 
Although iron nanoparticles seem to be readily taken up by cells, iron oxide NPs are 
superparamagnetic and have a strong impact on the magnetic field. This leads to a 
hypointense signal, which could be confused with other artefacts, such as bleeding and 
calcification.
78, 105
 Surface functionalization of iron oxide NPs is well established, but drug 
release is slightly harder to accomplish as the drug is usually covalently bound to the surface.  
Also, the issue of clearance of the NPs still remains to be solved. In paper V we have tried to 
address these issues by synthesizing manganese oxide nanoparticles (MONPs) that dissolve in 
an aqueous environment, releasing T1 active Mn
2+
 ions. The MONPs are T2 CAs, meaning 
that we have a system able to provide dual contrast and complementary MR images. 
Concomitantly, the degradation of the NPs offers the possibility for passive drug release, as 
the surface gradually disappears, the surface-bound drug will be released.    
 
 
Figure 6.10:  MONPs degrade in water and release L-DOPA. a) TEM of MONPs in organic 
phase b) HRTEM image of MONPs before surface modification c) TEM of L-DOPA coated 
MONPs, 1 hour in water (pH=6.8). Inset shows dark field image of hollow MONPs after 1 
hour in water d) Size and ζ-potential of MONPs as a function of time e) Hydrodynamic 
volume and concentration of L-DOPA as a function of time  f) T1 and T2 relaxation time in 
pig eyes upon injection of MONPs, as a function of time. “Lateral” refers to the opposite side 
of the injection site, while “Center” refers to the mid part of the pig eye. Conductance as a 
function of time is also shown.  
 
Characterization of MONPs was performed with TEM, HRTEM, magnetic measurements, 
XRD and XPS. Release of L-DOPA was performed with UV-visible spectroscopy and XPS, 
while the degradation of MONPs was studied with ζ-potential measurements, conductance, 
DLS, TEM, HRTEM and finally MRI. Figure 6.10 show the main results from the 
characterization of MONPs and the drug release. Our main finding from the characterization 
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of MONPs was that they appear to have a core-shell structure, with an Mn2O3 core, and a shell 
comprised of MnO ( Figure 6.10 a and b). Measurements on their magnetic properties showed 
ferromagnetic contributions from Mn2O3 and antiferromagnetic contributions that were 
ascribed to a small quantity of MnO in the shell. Upon surface functionalization, dark-field 
and bright-field TEM images ( Figure 6.10c), combined with DLS and conductance 
measurements, strongly suggested that MONPs dissolve in water and release Mn
2+
 ions as 
well as L-DOPA.  
 One obvious way of determining release of Mn
2+
 was to visualize the degradation with 
MRI, where the T1/T2* effect would be visible. Due to long scan times, a model matrix such 
as agarose gels could be used, but since the ultimate in vivo study was to be carried out in 
rodent eyes, dead pig eyes were used as a matrix instead. Pig eyes are similar to human eyes, 
their size allows for a good signal-to-noise ratio, and they offer a more biologically relevant 
matrix compared to agarose gels, which are more widely used.
202
 For this study, MONPs 
coated with L-DOPA were freshly prepared, injected into pig eyes, and scanned with MRI 
over a period of 35 hours. The acquired T1 and T2* weighted images are shown in Figure 
6.11  a-f, and demonstrate the gradual release of T1 active Mn
2+
 ions as well as a decrease in 
the T2 contrast. From these data, we concluded that the MONPs can work as time-dependent 
T1/T2* CAs and we ultimately tested their contrast switch in vivo in rats.  
 The rodent visual system is an established model for investigating damage and repair 
in the central nervous system (CNS), 
99, 203 
as it is easily accessible and immune privileged.
204, 
205
 Visualizing the optic nerve (ON) tract is accomplished by administering contrast agents 
into the vitreous body of the eye. The hypothesis was that with time, released Mn
2+ 
would 
diffuse across the retinal ganglion cells and ultimately be transported through the ON and 
onwards in an anterograde manner. 
88, 203, 88, 203, 206
 The presence of Mn
2+
 would in such case 
be visible due to the inherent T1 contrast. Our main findings were that the contrast in the rat 
retina was significantly enhanced compared to the contralateral control eye immediately after 
injecting a suspension of MONPs (Figure 6.12g). 
 
Figure 6.12: Ex vivo and in vivo degradation of MONPs. Images a) and b) show the T1w 
images of a pig eye injected with MONPs, acquired immediately after injection and after 34 
hours, respectively. “L” refers to the lateral side of the injection site “I”, while “C” refers to 
the central part of the pig eye. Images d) and e) show the complementary T2*w images 
immediately after injection and 34 hours post injection, respectively. Image c) is the T1w and 
image f) is the T2*w image of the control eye, immediately after injection and 34 hours after 
injection, respectively. g) T1w and i) T2*w image of rat ON and retina, 1 hour post injection. 
h) T1w and j) T2*w image of rat ON and retina, 24 hours post injection. 
a) b) c)
d) e) f)
L
C
I
I
ON
ON
Retina
Retina
g) h)
i) j)
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With time, the contrast in the ON increased as well, supporting the hypothesis of anterograde 
Mn
2+
 transport (Figure 6.12h). MONPs appeared to stay in the vitreous body, but appeared to 
move closer to the retina with time, which was observed as negative contrast in the T2*w 
images. However, high local concentrations of Mn
2+
 are also prone to give T2/T2* contrast, 
and it is likely that these contribute to the negative contrast as well.   
 The main conclusions from paper V is therefore that MONPs can function as dual 
contrast agents in MRI, and that they also release L-DOPA upon degradation. However, one 
challenge that we did not manage to solve was to determine the exact concentration of 
MONPs in a suspension. The complex degradation of MONPs appears to take place in contact 
with air and in contact with water. Thus, estimating the exact relaxivities in a suspension of 
MONPs as a function of MONP concentration was not possible or reproducible.  
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7 Concluding remarks and future work 
 
 
This thesis aimed at synthesizing a range of multifunctional nanoparticles for bioimaging 
applications, mainly focusing on plasmonic and superpara- and paramagnetic nanomaterials.  
 The first part of this thesis concerned biomineralization of gold from the proteins 
human transferrin and bovine serum albumin. Gold nanomaterials synthesized in transferrin 
showed fluorescent gold structures with near infrared emission that make them highly 
applicable for bioimaging. Also, the transferrin-gold nanoconstructs showed a remarkable 
increase in surface affinity compared to the native protein, which we ascribe to unfolding of 
hydrophobic residues that are more prone to perturb monolayers. The in vitro data also 
suggests increased membrane affinities, but that these might be cell type specific. From the 
work in paper I, we had indications that changing NaBH4 to ascorbic acid could potentially be 
favorable for the protein stability, and that differences in gold precursor concentration could 
be important to tune the size of the gold nanoclusters and nanoparticles. These hypotheses 
were tested and largely confirmed in paper II, but we were unable to describe the same 
membrane perturbations for BSA-stabilized gold as we described for the Tf-stabilized gold. 
This might be explained based on differences in the biological properties of the proteins. Tf 
can bind to Tf receptors and should therefore have a higher affinity towards cancer cells 
compared to BSA. Although the protein-stabilized plasmonic and fluorescent structures have 
very strong absorbance and emission properties, spectral overlap with the cell assay dyes 
made it difficult to argue the applicability of these constructs as bioimaging probes. Rather, 
the optical properties could be utilized in for instance sensing applications, which are based 
on quenching or enhancement of emission intensities or absorbance. Several studies on 
sensing with BSA-stabilized gold have been described, 
70, 72, 184
 and we are currently planning 
to study if these constructs can be used as sensors as well.  
 For both protein-systems we were unable to observe endocytosis of protein-stabilized 
gold nanostructures. As we were interested in describing cellular interactions with 
nanomaterials, we shifted our attention to chemically synthesized AuNPs and superpara- and 
paramagnetic NPs. These will most likely be easier to observe in vitro as they have a higher 
density than the cells. The aim of paper III and IV was to synthesize nanomaterials of 
different sizes and shapes, investigate how these properties affect interactions and uptake in 
glioblastoma-astrocytoma cells, and describe how their optical and superpara- and 
paramagnetic properties can be used for bioimaging.   
 In paper III, five nanostructures of gold were synthesized that showed several 
plasmonic peaks according to their aspect ratio. A novel structure named nanomakura was 
synthesized which had a plasmonic peak from 650-850 nm. This is a substantial bathochromic 
shift compared to BSA-stabilized AuNPs that had their maximum absorbance around 520-530 
nm. In addition to the shift in LSPR peak, the nanomakura also showed high cellular 
cytotoxicity in glioblastoma-astrocytoma cells that was subtantially different than any of the 
other structures in this paper. The interactions were further described with TEM imaging, and 
confirmed that the nanomakura were taken up by the glioblastoma-astrocytoma cells. These 
promising results nominate the nanomakura for further work in vivo as they can be used for 
instance in hyperthermia
207, 208
 and drug delivery, 
209
 while being simultaneously imaged.  
 The interesting shape-effects observed from the gold nanoparticles led us to 
investigate whether the glioblastoma-astrocytoma cells had similar responses to iron oxide 
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nanoparticles. In paper IV, four types of IONPs with different shapes were synthesized and 
their uptake and actuation in vitro was described. The initial results suggest that the 
pentatwinned IONPs had a high uptake in the cells, and were able to actuate the cells to a 
greater extent than spherical IONPs, when placed under a static magnetic field.  
 IONPs are T2 CAs, that some argue are less beneficial for bioimaging. Existing 
literature on manganese oxide nanoparticles suggested that they could degrade in vivo and 
release Mn
2+
 ions. We surface functionalized the NPs with L-DOPA with the hypothesis that 
degrading nanoparticles would give a release of the surface bound drug. We were able to 
demonstrate degradation of MONPs ex vivo and in vivo and that this caused a simultaneous 
hyper-, and hypointense signal in MRI while at the same time releasing a therapeutic drug. 
Although the physiological effect of L-DOPA was not investigated, future studies with L-
DOPA functionalized MONPs should involve a Parkinson’s disease model system.  
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Self-assembly and characterization of transferrin–
gold nanoconstructs and their interaction with
bio-interfaces
Birgitte H. McDonagh,*†a Sondre Volden,†a Sina M. Lystvet,a Gurvinder Singh,b
Marit-Helen G. Ese,c Joseph A. Ryan,d Mikael Lindgren,e Axel Sandvig,f,g
Ioanna Sandvigg,h and Wilhelm R. Glomm*a,i
Transferrin (Tf) conjugated to gold nanoparticles and clusters combine the protein’s site-speciﬁc receptor
targeting capabilities with the optical properties imparted by the nano-sized gold. We have described two
diﬀerent synthesis protocols, one yielding ﬂuorescent Tf-stabilized gold nanoclusters (AuNCs) and one
yielding Tf-stabilized gold nanoparticles that exhibit localized surface plasmon resonance. We demon-
strate that the synthetic route employed has a large inﬂuence both on the gold nanostructure formed,
and also on the structural integrity of the protein. A slight protein unfolding allows stronger interaction
with lipids, and was found to signiﬁcantly perturb lipid monolayers. Interactions between the protein–
gold nanostructures and three diﬀerent cell types were also assessed, indicating that the enhanced mem-
brane aﬃnity may be attributed to intercellular membrane diﬀerences.
Introduction
The optical properties of nanosized gold are size-dependent.
The small gold nanoclusters (AuNCs) range from a few to tens
of atoms and exhibit size-dependent molecular fluorescence.
At 3 nm and above, the nanosized gold becomes plasmonic
nanoparticles that absorb light in the visible region of the elec-
tromagnetic spectrum.1,2 AuNCs and AuNPs can be synthesized
via a biomineralized synthesis using proteins, resulting in
AuNCs and AuNPs being stabilized in a protein template. This
class of hybrid nanomaterials has potential applications in
bioimaging,3–8 targeted drug delivery4,5,8 and sensing.9–12
Synthesis of protein–AuNC constructs is typically achieved
via incubation of a protein solution with tetrachloroauric acid
(TCAA) either in the presence of a reducing agent such as
ascorbic acid5,6,13,14 or sodium borohydride (NaBH4),
15,16 or by
utilizing the intrinsic redox potential of amino acid residues
in the polypeptide chain such as tyrosine and
histidine.3,4,8–12,15,17 Irrespective of the synthesis procedure,
growth of protein–AuNCs has been revealed to be protein-
mediated as well as highly protein-dependent.16,17
While much emphasis has been placed on the properties
and applications of the embedded metal nanoclusters, little
has been reported on the eﬀect of AuNC incorporation into the
structure and properties of the protein scaﬀold. Recently, we
have reported that functionalizing proteins with AuNCs results
in tunable, protein-dependent changes in structure and func-
tion of the polypeptide scaﬀold.16,17 Moreover, we have demon-
strated that combining proteins and gold on the nanoscale
might result in emergent properties (i.e., properties not charac-
teristic of either protein or gold) such as enhanced membrane-
aﬀecting properties15,18,19 and even anticancer activity.15
Transferrin (Tf) is a multi-tasking iron-binding protein
which has been much researched for active drug delivery due
to its eﬃcient site-specific targeting of receptors that are over-
expressed on cancer cell surfaces.20–22 See e.g. McCann20 and
references therein for a review of the clinical applications of
Tf. The ability of Tf to successfully target its specific receptor†These authors contributed equally to this work.
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has been observed while it is conjugated to drug carrier
systems such as quantum dots,23 liposomes24 and gold nano-
particles.25 Recently, Schneider and coworkers reported that
Tf-stabilized AuNCs display similar targeting and cellular
uptake characteristics as the native protein. Here, we have
used iron-free transferrin as a scaﬀold for AuNC synthesis via
two synthetic routes; one relying solely on the reduction poten-
tial of the protein, and one wherein an extrinsic reducing
agent (NaBH4) was added (these protocols are hereafter
referred to as intrinsic and extrinsic, respectively). For the Tf–
AuNC constructs presented here, we have characterized the
photophysical properties, the eﬀect on the Tf structure, how
the incorporation of AuNCs results in enhanced membrane-
aﬀecting properties compared to the native protein, and the
concomitant eﬀect on cell membrane interaction.
Materials and methods
Preparation of Tf–AuNCs
Intrinsic protocol. Apo-transferrin (Sigma) was dissolved in
MQ-water to obtain a total concentration of 10 mg mL−1. Tf–
AuNCs were prepared by adding 1 : 1 (v/v) of tetrachloroauric
acid (5 mM, TCAA, Sigma) before adjusting the pH to above 10
(250 μL, 1 M NaOH). As a reference, Tf (10 mg mL−1) was
mixed 1 : 1 (v/v) with MQ-water and the pH adjusted as
described. The samples were left to react for one week at
37 °C. In order to remove excess TCAA, the samples were dia-
lysed against deionized (MilliQ) water for two hours, before
water exchange and dialysis overnight. The samples prepared
for cell viability studies were dialysed as described, but against
phosphate buﬀer (pH = 7.4). The samples prepared using the
intrinsic protocol are named Tf–AuINT. The phosphate buﬀer
was prepared by mixing dipotassium hydrogen phosphate
(K2HPO4, 50 mM, Merck) and potassium dihydrogen phos-
phate (KH2PO4, 50 mM, Merck) to a final pH of 7.4.
15
Extrinsic protocol. Samples were prepared and dialysed as
described for the intrinsic protocol, but in addition, an extrin-
sic reducing agent (NaBH4, 200 μL, 1 M) was added immedi-
ately after TCAA. The same Tf stock solution as described for
the intrinsic protocol was used. The reference was prepared as
for the intrinsic protocol, except that 200 μL NaBH4 (1 M) was
added. This sample was named Tf-RED. Two diﬀerent concen-
trations of TCAA were used in order to form AuNCs and
AuNPs. For Tf–AuNCs, a low concentration of TCAA (1 mM)
was added 1 : 1 (v/v) to the Tf-stock solution before adding
200 μL NaBH4. These samples were named Tf–AuXL. For extrin-
sic synthesis of Tf–AuNPs, the same concentration of TCAA as
Tf–AuINT was used (5 mM), with the addition of 200 μL NaBH4
(1 M). These samples were named Tf–AuXH.
Scanning transmisison electron microscopy (STEM). A
Hitachi S-5500 electron microscope operating at 30 kV
accelerating voltage was used to record TEM images. Prior to
TEM imaging, samples were prepared by placing a few micro-
liters of Tf–AuNC solution on a TEM grid, before drying and
imaging.
High resolution transmission electron microscopy (HR-TEM)
images were acquired on a JEOL JEM-2100 (200 kV). The
samples were prepared by depositing a few µl drops of nano-
particle or nanocluster solution on a copper grid coated with an
amorphous carbon layer, and allowed to dry prior to imaging.
UV-visible spectroscopy. UV-visible spectroscopy was per-
formed on a Shimadzu UV-2401PC spectrophotometer using
UV probe 2.10 software. The Tf-concentration was 10 μM.
Steady-state fluorescence spectroscopy. Steady-state fluo-
rescence was measured on a Fluorolog-3 HORIBA Jobin Yvon
apparatus, using excitation wavelengths λex = 295 and 370 nm.
The Tf concentration was 3.6 μM, and all samples were
measured in triplicate.
Time correlated single photon counting (TCSPC). For
TCSPC, an IBH TCSPC spectrometer was employed. The
prompt was recorded by setting the emission monochromator
at the same wavelength as the light source (λem = 280 nm). For
the lifetime measurement of the samples, the emission mono-
chromator was set to λem = 360 nm, with a bandpass of 8 nm
for both prompt and samples.
Circular dichroism (CD). Circular dichroism (CD) was
measured on an Olis DSM 1000CD apparatus, equipped with a
lamp power supply LPS-220B from Photon Technology Inter-
national. The user interface was an Olis online instrument
system, and the software was OLIS GlobalWorks. For CD
measurements, the scan range was set from 290 to 200 nm,
with 720 increments. The Tf concentration was 2.3 μM, and
the cuvette path length was 10 mm. The grid was 2400 lines
per mm, and the slit width was 6.32 mm. Each sample was
scanned three times, using the phosphate buﬀer as blank.
Langmuir film experiments. A KSV Langmuir Minitrough
double barrier system (KSV LTD, Finland) was used and the
experiments were controlled through the manufacturer’s own
software. The Langmuir was equipped with a Teflon trough
(250 mL) and Delrin barriers. The surface pressure probe was
made of paper (pre-soaked in buﬀer media). Prior to all of the
experiments, any surface impurities were removed with a
Pasteur pipette connected to a vacuum pump. The AuNC
samples prepared using the extrinsic protocol were not stable
in aqueous solutions and were determined to be unfit for
Langmuir film experiments. However, samples of Tf and Tf–
AuINT (1 mL, 12.5 μM) had greater stability in solution and
were found suitable for Langmuir film experiments. The inter-
facial activity of the air/buﬀer surface for each Tf–gold con-
struct was studied by filling the trough (250 mL) with
phosphate buﬀer, closing the barriers to 90 mm, and zeroing
the balance. The sample was then injected underneath the
lipid surface, from outside of the barriers using a syringe with
a ∼90° needle.26 The barriers were kept in a constant position,
and the surface pressure was recorded over time. For lipid
interaction studies, PBPS (60 μL, 0.25 mg mL−1 dissolved in
CHCl3) was compressed with a barrier speed 5 mm min
−1
until it reached a surface pressure of 10 mN m−1. The system
was set to have a constant surface pressure of 10 mN m−1
before Tf or Tf–AuINT was injected as described above. The
required surface area was then measured as a function of time.
Paper Nanoscale
Nanoscale This journal is © The Royal Society of Chemistry 2015
Pu
bl
ish
ed
 o
n 
30
 M
ar
ch
 2
01
5.
 D
ow
nl
oa
de
d 
by
 N
or
w
eg
ia
n 
U
ni
ve
rs
ity
 o
f S
ci
en
ce
 an
d 
Te
ch
no
lo
gy
 o
n 
16
/0
4/
20
15
 1
1:
33
:4
6.
 
View Article Online
Langmuir–Schaefer deposition. Gold-covered glass plates
were prepared for film deposition by immersion in Piranha
solution (H2SO4–H2O2, 3 : 1)
27 for 20 minutes before flushing
with deionized (MilliQ) water and drying with pressured air.
The Tf and Tf–AuINT samples (1 mL, 12.5 μM) were injected as
described above, under a lipid film of PBPS. The protein–lipid
mixture was left to equilibrate for one hour before the Lang-
muir–Schaefer deposition was made. The gold-sputtered glass
plate was introduced horizontally towards the lipid/air surface,
using a vacuum pump to hold the plate. The gold-covered
plate was kept at the surface for 30 seconds before it was lifted
up again. The adsorbed layer was then dried in air, and
imaged with AFM.
Atomic force microscopy (AFM). ScanAsyst mode AFM
images were acquired by multimode atomic force microscopy
(Nanoscope V controller) and digital instruments at room
temperature. AFM tips with a spring constant ∼0.4 N m−1 were
purchased from Bruker AFM probes. Samples were prepared as
described by the Langmuir–Schaefer deposition method.
Cell viability studies. Low passage rat olfactory ensheathing
cells (OECs, P = 6), human glioblastoma–astrocytoma cells
(U-87 MG, P > 8) and ovarian cancer cells (OCCs, TOV112D)
were expanded in six well plates (Costar® 3335, Corning Cell-
BIND® surface, Corning Inc., NY, USA) at 37 °C, with 7% and
5% CO2, respectively, until 70% confluence.
OEC culture. OECs purified from neonatal Fischer rats at
P7, were seeded on poly-L-lysine-treated multi-well plates
(Costar® 3335, Corning CellBIND® surface, Corning Inc., NY,
USA) at a density of 1 × 104 cells cm−2. The cultures were fed
with Dulbecco’s modified Eagle’s medium (DMEM) Gluta-
MAX® (Sigma) with 1.25% gentamicin (Sigma) and 5% fetal
bovine serum (Autogen Bioclear, Wiltshire, UK) supplemented
with 41.6% SATO, 2.7% fibroblast growth factor (FGF, Pepro-
tech), 0.27% heregulin (hrgβ1, R&D Systems Europe Ltd,
Abingdon, UK) and 0.05% forskolin (Sigma).
Glioblastoma–astrocytoma culture. Human glioblastoma–
astrocytoma cells (U-87 MG, ECACC, Salisbury, UK) were cul-
tured in Eagle’s minimal essential medium (EMEM) with 1.25%
gentamicin (Sigma) and 10% fetal bovine serum (Autogen Bio-
clear, Wiltshire, UK). The cultures were supplemented with
2 mM L-glutamine, 1% non-essential amino acids (NEAA,
Sigma), and 1 mM sodium pyruvate (NaP, Sigma).
OCC culture. Human ovarian cancer cells (OCCs,
CRL-11731, ATCC, USA) were cultured in a 1 : 1 (v/v) solution of
Medium 199 (Invitrogen) and Medium 105 (Invitrogen) with
15% fetal bovine serum (Autogen Bioclear, Wiltshire, UK).
Cell labeling with Tf–AuNCs and Tf. Cells at 70% con-
fluency were labeled with Tf and Tf–AuINT at concentrations
of nanoparticles/media volume of 1 μg mL−1, 100 μg mL−1 and
1 mg mL−1, and incubated at 37 °C for 4 hours. Unlabeled
OEC, OCC and glioblastoma–astrocytoma cultures, at the same
stage of confluence, were used as controls.
LIVE/DEAD® assay. A LIVE/DEAD-cell viability assay (Invi-
trogen, Life Technologies) evaluates the membrane integrity of
cells, and consists of two diﬀerent dyes: calcein AM (exci-
tation/emission: 494/517 nm) and ethidium homodimer-1
(excitation/emission: 517/617 nm). In live cells, intracellular
esterases react with calcein AM and yield a cytoplasmic green
fluorescence. Ethidium homodimer-1 (EthD-1) diﬀuses over
damaged cell membranes of dead cells, where it binds to
nucleic acids and emits red fluorescence. After labeling with
Tf–AuINT and Tf, LIVE/DEAD-cell viability was performed on
OECs, glioblastoma–astrocytoma cells and OCCs as described
by the manufacturer, with one exception. Instead of adding
both dyes in one solution, two separate solutions of EthD-1
(12 μL EthD-1) in PBS (Sigma, 4.5 mL), and calcein (2.7 μL) in
PBS (Sigma, 4.5 mL) were prepared for visualization of dead
and live cells, respectively. The reason for this was based on
the observations of spectral interactions between the fluo-
rescent dyes and the Tf–AuNCs. Three parallels of each cell
culture were assayed with either calcein or EthD-1 solutions in
1 : 1 (v/v), and left to react for 30 min at 37 °C before imaging.
Imaging of the LIVE/DEAD-cell viability assay was performed
on an Axiovert 200M fluorescence microscope (Zeiss,
Germany), at 40× or 10× magnification, using AxioVision Rel.
4.3 software. Images were later processed with ImageJ 1.46.
Results and discussion
The results are grouped into the following categories: photo-
physical properties of the Tf–AuNC constructs, the eﬀect of
incorporation of AuNCs on the Tf structure, interaction with
lipid monolayers, and cellular interaction studies.
Photophysical properties of the Tf–AuNC constructs
Synthesis of protein-stabilized gold can yield several gold
species that coexist in or around the protein backbone. In
samples where only AuNCs are present, the AuNCs can be
detected with fluorescence spectroscopy. When the availability
of gold precursors is high or when an extrinsic reducing agent
is added, growth of larger AuNPs can occur wherein AuNC-
stabilized proteins self-assemble around gold nanoparticles
exhibiting localized surface plasmon resonance (LSPR).16
When AuNPs and AuNCs are in close proximity, the AuNPs can
quench the fluorescence emitted from AuNCs.28
Thus, in a sample with predominantly AuNPs, fluorescence
emission of AuNCs is quenched, while the UV-visible absor-
bance of plasmonic AuNPs increase.
UV-visible spectra of the diﬀerent Tf–AuNCs studied here,
as well as the reference systems (Tf only and Tf treated with
NaBH4), are shown in Fig. 1a. While the spectral line shape
was found to vary both with respect to the synthetic route and
concentration of TCAA, all the Tf-stabilized nano gold systems
displayed a broad absorption band from ∼450 to 600 nm, com-
pared to the protein alone. This is an indication of multimeric
gold species.15–17 While the LSPR feature is prominent in the
Tf–AuXH system, the band observed for Tf–AuINT has lower
absorbance and occurs at shorter wavelengths, indicating
smaller AuNPs. The larger AuNPs synthesized via the extrinsic
route is thus most likely a result of the added extrinsic redu-
cing agent (NaBH4).
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The fluorescence profile of protein-templated AuNCs upon
excitation at ∼370 nm is typically assigned to contributions
from gold nanoclusters containing 8 atoms (Au8, λem ∼
450 nm) and gold nanoclusters with 25 atoms (Au25, λem ∼
650 nm).3,5,7,9,11,13 In order not to overstate the accuracy of our
obtained results, we have opted to classify the AuNCs as either
“small” (∼Au8, λem ∼ 450 nm) or “large” (Au25+, λem ≥
600 nm).15–17 Steady-state emission spectra of the Tf–AuNCs
upon excitation at 370 nm are shown in Fig. 1b. Emission
spectra from Tf and Tf treated with NaBH4 (Tf-RED) are shown
as references. From the emission spectra shown in Fig. 1b, the
fluorescence line shape of the Tf–AuNCs varies both with
respect to the synthetic route and the concentration of TCAA
added. The Tf–AuNCs obtained using the extrinsic synthesis
route (Tf–AuXL and Tf–AuXH) and the lowest concentration of
TCAA (Tf–AuXL) resulted in modest fluorescence emission at
∼450 nm, indicating the presence of small AuNCs (Au8),
whereas no fluorescence at this wavelength could be detected
for the higher TCAA concentration (Tf–AuXH). From the
spectra acquired for Tf–AuXL, the concentration of gold pre-
cursors (TCAA) will have an eﬀect on the size of the AuNCs. We
attribute the absence of emission at 450 nm for Tf–AuXH to
eﬃcient quenching from AuNPs that are in close proximity to
the AuNCs (see Fig. 1a for the UV-visible spectrum of the poten-
tial energy acceptor). Synthesis of Tf–AuNCs via the intrinsic
synthesis route resulted in Tf–AuNCs with vastly improved fluo-
rescence intensity, as seen from the Tf–AuINT spectrum in
Fig. 1b. In addition to the contribution from small AuNC emis-
sion at ∼450 nm, the fluorescence of the Tf–AuINT is domi-
nated by emission above 600 nm. The exact determination of
the number of gold atoms associated with each emitting
protein-embedded AuNCs population is very complex, and the
emission attributed to the larger AuNCs often comprises at
least two contributions. This can be observed from the bimodal
peak at 650 nm in Fig. 1b (Table 1).
Because of the complex interactions between fluorescent
AuNCs and colloidal gold, HRTEM can be used as complemen-
tary to UV-visible and steady-state fluorescence spectroscopy.
Indeed, for the intrinsic protocol (Tf–AuINT, Fig. 2a, b) both
AuNPs and AuNCs were found. A larger population of AuNPs
was found for Tf–AuXH, while no AuNPs were found for Tf–
AuXL. The only diﬀerence between Tf–AuINT and Tf–AuXH is
the addition of NaBH4 in the latter. From UV-visible, steady-
Fig. 1 (a) UV-Visible spectra showing LSPR for AuNPs synthesized with a high (Tf–AuXH) and low concentration of TCAA (Tf–AuXL) and AuNPs syn-
thesized via the intrinsic protocol (Tf–AuINT). All samples were compared to the pure protein (Tf ) and Tf with added NaBH4 (Tf-RED). (b) Tf–AuNC
emission was measured with excitation λex = 370 nm.
Table 1 Overview of excitation and emission wavelengths used in
steady-state ﬂuorescence spectroscopy and TCSPC
Excitation (λex) Emission (λem) Species
λex = 370 nm λem = 450 nm AuNCs(Au8)
λex = 370 nm λem = 650 nm AuNCs(Au25+)
λex = 295 nm λem = 350 nm Tryptophan in Tf
λex = 278 nm λem = 350 nm Tryptophan and tyrosine in Tf
Fig. 2 (a) HR-TEM image of AuNCs prepared via the Intrinsic protocol
(Tf-AuINT). (b) Co-existance of AuNPs and AuNCs synthesized via the
intrinsic protocol (Tf-AuINT). The inset show a Tf-stabilized AuNP syn-
thesized from the Tf only. Image (c) show HRTEM images of AuNCs and
AuNPs synthesized via the extrinsic protocol, with high (Tf-AuXH) and
(d) low (Tf-AuXL) amount of TCAA added. The red circles indicate
AuNCs.
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state fluorescence spectra and HRTEM images, the addition of
NaBH4 clearly increases the amount of AuNPs in the sample.
Although AuNPs are also present in the intrinsic samples, it is
ultimately the concentration of AuNPs that will determine the
amount of AuNC quenching. Tf–AuINT has a dominant near-
infrared (NIR) fluorescence together with weak LSPR (Fig. 1a),
indicating that the concentration of AuNPs is less compared to
Tf–AuXH.
In order to further investigate the photophysical properties
of the Tf-stabilized AuNCs, time-correlated fluorescence data
were collected at λem = 650 nm using time-resolved single
photon counting (TCSPC) spectroscopy with an excitation
wavelength of λex = 373 nm. The steady-state emission (Fig. 1b)
of Tf–AuXL is very low at 450 nm and is completely absent for
Tf–AuXH. Because of this, no lifetimes could be obtained for
these samples. However, time-resolved fluorescence data for
Tf–AuINT (λem = 650 nm) were collected, and fitted with a
biphasic decay.
The fractional contribution of each decay time to the
steady-state intensity, f, can be determined from the decay
times, τ, and α which is the relative population of the com-
ponents at t = 0, and is shown in eqn (1).28
f i ¼ αiτiP
j
αjτj
ð1Þ
All the Tf systems studied here were best fit by biphasic
decay, yielding one short (τ1) and one long (τ2) lifetime and
their relative populations α1 and α2.
28 Lifetimes of 0.49 ns and
1.78 ns, with corresponding populations 33.7% and 66.3%
were determined for Tf–AuINT. Peak broadening and bimodal
fluorescence at ∼650 nm with steady-state fluorescence emis-
sion (Fig. 1b) combined with two observable lifetimes at
650 nm, could reveal the presence of at least two diﬀerent-
sized AuNCs.
The eﬀect of AuNC formation on the transferrin structure
Tryptophan (Trp) emission is a well-documented spectroscopic
method for studying conformational changes such as partial
unfolding in proteins.28 Unfolding changes the local environ-
ment of Trp residues, and depending on the number and
location of the Trp residues, this might lead to changes in the
fluorescence line shape, with respect to both emission
maximum and intensity. While changes in fluorescence inten-
sity alone can be diﬃcult to interpret, shifts in the emission
maximum towards longer wavelengths are generally linked to
protein unfolding.15–19,28 Trp emission spectra (λex = 295 nm)
of the systems studied here are shown in Fig. 3a. For the Tf–
AuNCs synthesized by the extrinsic route, it is apparent that
NaBH4 aﬀects the local environment of Trp residues, leading
to a reduction of Trp emission intensity compared to that of
the native protein. While the exact eﬀect of NaBH4 on Tf con-
formation cannot be elucidated from the Trp fluorescence
alone, the spectra in Fig. 3a reveal that the synthesis of Tf–
AuNCs via the extrinsic protocol employed here leads to
changes in Trp emission not attributable to the reducing agent
alone, but is strongly dependent on TCAA concentration.
Specifically, a low concentration of TCAA resulted in a red-shift
as well as a severe attenuation of Trp fluorescence (Tf–AuXL).
Increasing the TCAA concentration while at the same time
adding NaBH4 resulted in complete quenching of Trp emis-
sion (Tf–AuXH). Within this sample, large AuNPs were formed,
which implies that the larger the gold species, the greater the
change in protein conformation.
Using a biomineralization-inspired synthesis protocol (no
NaBH4, Tf–AuINT) a red-shift and broadening of the fluo-
rescence line shape and an overall attenuation of the signal
was observed. Although not as severe as was found for Tf–
AuXL, the partial unfolding of the polypeptide chain is attribu-
ted to incorporation of large AuNCs.
The eﬀect of AuNC formation on the Trp environment was
also studied using TCSPC with λex = 278 nm, the results are
summarized in Table 2. As for Tf–AuINT, the time-resolved
fluorescence data were best fit with biphasic decay (eqn (1)). In
addition, the average lifetime, τˉ, was calculated as shown
in eqn (2):28
τˉ ¼ α1τ1
2 þ α2τ22
α1τ1 þ α2τ2 ¼ f 1τ1 þ f 2τ2 ð2Þ
Fig. 3 (a) Trp emission of native Tf has the highest ﬂuorescence intensity at 350 nm when excited at λex = 295 nm compared to Tf with NaBH4 (Tf-
RED), Tf–AuNCs prepared with no (Tf–AuINT), high (Tf–AuXH) and low (Tf–AuXL) concentration of TCAA. When a high concentration of TCAA is
used, the Trp emission is almost completely quenched (Tf–AuXL). (b) CD traces indicate structural changes in the protein backbone as the line shape
changes when compared to the native protein (Tf ), both with respect to NaBH4 and TCAA.
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It should be noted that by using an excitation wavelength of
278 nm, the collected signal also contains minor contributions
from other aromatic amino acid residues such as tyrosine in
addition to Trp fluorescence.28 From the results shown in
Table 2, neither the lifetimes nor the associated populations
are significantly aﬀected by the addition of NaBH4. No life-
times could be obtained for the Tf–AuXH sample, which is in
agreement with the complete quenching observed from steady-
state fluorescence (Fig. 3a). For the Tf–AuXL system, there is a
minor decrease in the average lifetime compared to the native
protein. This is attributed to a decrease in Trp lifetimes, in
particular τ1, whereas the associated populations remain rela-
tively unchanged. We attribute this to quenching from
increased solvent exposure due to partial unfolding, energy
transfer (FRET) to the embedded AuNCs, or a combination of
these eﬀects.15,16 The biggest change in the average lifetime
was calculated for Tf–AuINT. This indicates larger changes in
the local environment of Trp compared to native Tf.
Specifically, both population and lifetime of τ2 increases
relative to Tf only, whereas the opposite is seen for τ1. The
complex structure of the Tf–AuINT system with AuNCs of
diﬀerent sizes in each protein, with multiple proteins
assembled around a central AuNP core (9.42 ± 0.16 nm),
makes the interpretation of the TCSPC results with respect to
the eﬀect on the protein structure qualitative at best.
In order to better elucidate the eﬀect of AuNC incorporation
on the protein structure, circular dichroism (CD) measure-
ments were performed on the systems studied here. The CD
spectra shown in Fig. 3b reveal that the Tf secondary structure
is significantly aﬀected by incorporation of AuNCs and by the
reducing agent used in the extrinsic protocol. These findings
are consistent with what we have reported earlier.15,16 In order
to ascertain that the observed changes in CD profiles did not
emanate from signal attenuation, scattering contribution or
reduction in protein concentration due to aggregation and sub-
sequent precipitation, changes in the CD line shape were esti-
mated via the ratio of mean residual ellipticity at 200 nm and
222 nm (I200/I222, Table 2). A reduction of protein concentration
or signal attenuation due to scattering from gold species is
expected to result in a signal reduction without aﬀecting the
line shape. However, since the line shape varies between the
species studied here as shown in Table 2, it is likely that the
changes in the CD profile compared to Tf only are due to struc-
tural changes in the protein, which is also in agreement with
steady-state and time-resolved Trp fluorescence results.
Interaction with lipid monolayers
We have previously demonstrated that modification of proteins
with gold nanoparticles and clusters can significantly alter
lipid interaction compared to the native protein.15,18,19
The change in surface pressure upon injecting Tf and Tf–
AuINT under an air/water interface (phosphate buﬀer, pH 7.4)
is shown in Fig. 4a. The AuNC samples prepared using the
extrinsic protocol were not found to be suﬃciently stable for
the Langmuir experiments. Consequently, only Tf and Tf–
AuINT results are shown here. Injecting Tf only into the PBPS
lipid layer did not yield any measurable changes in the surface
pressure even after an hour, indicating that the native protein
has negligible surface activity under these conditions. On the
other hand, the injection of Tf–AuINT resulted in a rapid and
significant surface pressure increase, revealing that modifi-
Table 2 TCSPC data for Tf, Tf-RED and Tf–AuNC emission (λex =
278 nm, λem = 360 nm) and CD data. Tf refers to pure transferrin, while
Tf-RED is Tf with added NaBH4. Tf–AuXL was prepared by adding a low
concentration of TCAA (extrinsic protocol), while Tf–AuINT was syn-
thesized via the intrinsic protocol. τ1 and τ2 is the short and long lifetime,
respectively, while α1 and α2 is the corresponding population. τ¯ is the
average lifetime calculated from the relative populations and their
respective lifetimes. The CD measurement is a ratio of the mean residual
ellipticity at 200 and 222 nm
TCSPC (λex = 278 nm, λem = 360 nm) CD
τ1 (ns) τ2 (ns) α1 (%) α2 (%) τˉ (ns) I200/I222
Tf 1.45 3.52 55 45 2.8 1.7
Tf-Red 1.47 3.62 56 44 2.9 1.8
Tf–AuXL 0.64 3.11 54 46 2.6 2.7
Tf–AuINT 1.06 4.03 36 64 3.6 4.0
Fig. 4 (a) Surface pressure as a function of time shows that compared
to the native protein (Tf), the Tf–AuNCs prepared via the intrinsic proto-
col (AuINT) is surface active. (b) The delta surface area as a function of
time indicates that Tf–AuINT has a higher surface activity compared to
the pure lipid (PBPS) and the native protein (Tf).
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cations with AuNCs result in increased surface activity of the
protein. This is likely due to the increased exposure of hydro-
phobic residues in the protein following AuNC formation,
which is in agreement with fluorescence and CD results pres-
ented above, as well as earlier studies.15–19
The average changes in the trough area upon injection of Tf
and Tf–AuINT under a precompressed phospholipid film are
shown in Fig. 4b. The lipid used here, porcine phosphatidyl-
serine (PBPS), is negatively charged and is partly dissolved
(∼20%) during the experimental time frame used here
(60 minutes at 10 mN m−1). Thus, the traces shown in Fig. 4b
are corrected for phospholipid drift by normalizing with
respect to time-dependent surface area behavior of PBPS only.
While using the injection method to investigate protein–lipid
interactions in a Langmuir trough, the reproducibility is
strongly dependent on the injection rate as well as the injec-
tion depth, i.e. the distance between the tip of the needle and
the lipid monolayer.29 In particular, the experiment must be
discarded if the needle penetrates the lipid film, or if air
bubbles are injected into the subphase and are disturbing the
monolayer. Despite the systematic uncertainties introduced
by the injection method, the injection of Tf under a lipid
film results in a slight loss of surface area, indicating loss of
film material compared to PBPS only. Conversely, the injection
of Tf–AuINT results in a significant surface area increase, indi-
cating a larger amount of film material at the air–water surface
compared to PBPS only. We attribute the increased surface
area upon injection of Tf–AuINT to intercalation into the lipid
monolayer due to the increased surface activity of the protein–
AuNCs construct, as has been reported for similar constructs
based on alpha-lactalbumin interacting with PBPS.15
As Tf only did not reveal any measurable surface activity,
the apparent loss of film material when injecting Tf under the
PBPS monolayer is likely due to bulk interactions between Tf
and dissolved lipids. Binding of PBPS molecules to Tf shifts
the equilibrium between monolayer-bound and dissolved
lipids, leading to further loss of film material.
Atomic force microscopy was further employed to visualize
morphological changes in the lipid film upon introduction of
Tf and Tf–AuINT. Fig. 5a shows a monolayer of pure anionic
PBPS lipid uniformly deposited onto the gold surface via the
Langmuir–Schaefer method in contrast to the bare gold sput-
tered surface as shown in Fig. 5b, confirming the monolayer
deposition of lipid molecules. The lipid film is made from the
assembly of small regions with an average height and width
∼1.7 nm and ∼16 nm respectively, as displayed in Fig. 5c and
d. Inserting Tf and Tf–AuINT underneath the lipid film held at
10 mN m−1 causes a perturbation in the film where the lipid
regions severely collapse (Fig. 5e, f ). AFM results reveal a large
extent of disruption in the case of Tf–AuINT, with no discern-
ible packing of lipid regions and only the collapsed film with
gold nanoclusters having a wide size distribution. Therefore,
Tf–AuINT has a high propensity to intercalate into the nega-
tively charged lipid film as compared to Tf only. This is also in
agreement with a recent study of alpha-lactalbumin protected
gold nanoclusters.15
Cell viability studies
Three diﬀerent cell types were chosen to assess the interaction
with Tf–AuINT. Two human cancerous cell lines, ovarian
cancer cells (OCCs) and brain cancer cells (glioblastoma–astro-
cytoma cells), and non-cancerous cells (olfactory ensheating
cells, OECs) were incubated with three diﬀerent concentrations
of Tf and Tf–AuINT and the viability was assessed with a LIVE/
DEAD assay. For all cell types, there was no increased cell
death after incubation with Tf–AuINT or Tf, compared to the
blank. One of the dyes in the LIVE/DEAD assay, ethidium
homodimer, chelates with DNA and emits red light when
excited at 430 nm. The dye can only move through compro-
mised cell membranes, and will therefore stain dead cells red.
A typical dead cell is shown in Fig. 6e. Live cells express
calcein AM (λex = 495, λem = 515), as they have esterases that
cleave calcein AM to a green fluorescent molecule. Live cells
therefore typically have an even intracellular distribution of
Fig. 5 AFM topographical images of lipid ﬁlms deposited by the Lang-
muir–Schaefer method at 10 mN m−1 onto gold sputtered glass sub-
strates. (a) Pure PBPS lipid ﬁlm showing uniform deposition. (b) Gold
sputtered surface prior to lipid deposition. (c) High resolution view of
lipid ﬁlm and (d) section analysis of lipid regions. (e) Disruption in the
PBPS lipid ﬁlm caused by insertion of Tf protein and (f ) Tf protein
modiﬁed gold nanocluster.
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green fluorescent dye, as can be seen in Fig. 6f. However, for
the OEC cell culture, incubation with Tf–AuINT results in
partial colocalization of the calcein and EthD1-derived fluo-
rescence. This might indicate that Tf–AuINT is associated with
the cell membrane, blocking the entry of ethidium homodimer
and calcein, or that there is some photophysical interaction
between the Tf–AuINT and the dyes. If the latter were to be the
case though, similar observations should have also been made
for the glioblastoma–astrocytoma cells as well as for the OCCs.
In the absence of such evidence, and given that Tf–AuINT
showed a strong tendency towards the monolayer surface
(Fig. 4), we attribute the colocalisation of the dyes to an
enhanced Tf–AuINT aﬃnity with the OEC membrane (Fig. 6b).
However, unlike OECs, glioblastoma–astrocytoma cells and
OCCs did not exhibit colocalisation of calcein with EthD-1
after incubation with Tf–AuINT (Fig. 6e, f and i–j). Assuming
that colocalisation of the dyes may indeed be attributed to
enhanced Tf–AuINT aﬃnity towards the cell membrane, the
diﬀerent interactions of the Tf–AuINT with the diﬀerent cell
types may be attributed to intercellular membrane diﬀerences
between glioblastoma and astrocytoma,30,31 as well as OCC-
cells and OECs.
Conclusions
We have synthesized Tf-stabilized gold nanostructures using
two synthesis routes – with and without the aid of an extrinsic
reducing agent (NaBH4). From our results, we can conclude
that the amount of AuNPs synthesized strongly depends on
whether or not NaBH4 is added, and that the concentration of
TCAA is important (Tf–AuXL). Not just the size of the AuNCs
and AuNPs seems to be aﬀected by the TCAA concentration
and reducing agent, but also the solution stability of Tf–Au
constructs appear to be aﬀected. There is a delicate balance
between the reducing agent aiding nanostructure formation
and causing irreversible unfolding of the polypeptide chain.
However, it seems as though a slight unfolding of the protein
backbone is favourable for membrane interactions, as Lang-
muir experiments and AFM clearly show that Tf–AuINT has a
greater tendency to interact with biological films, compared to
Tf alone. These findings are in agreement with previously pub-
lished results.15,18,19 In vitro membrane interaction studies on
three diﬀerent cell types indicate that Tf–AuINT might have a
diﬀerent aﬃnity towards diﬀerent cell types.
Abbreviations
Tf Transferrin
TCAA Tetrachloroauric acid
Tf–AuINT Transferrin stabilized gold prepared via the intrin-
sic protocol
Tf–AuXL Transferrin stabilized gold prepared with low
concentration of TCAA, via the extrinsic protocol
Tf–AuXH Transferrin stabilized gold prepared with high
concentration of TCAA, via the extrinsic protocol
Tf-RED Transferrin incubated with NaBH4
Fig. 6 Colocalization of dyes at the membranes of OECs. All cells were incubated for four hours with diﬀerent concentrations of Tf (1 μg mL−1,
100 μg mL−1 and 1 mg mL−1) and Tf–AuINT (1 μg mL−1, 100 μg mL−1 and 1 mg mL−1) before staining with the LIVE/DEAD assay. (a) Live and (b) dead
OECs with 1 μg per mL Tf–AuINT, control (c) live and (d) dead OECs. Glioblastoma cells are imaged from (e)–(h), with (e) and (f ) displaying cells after
incubation of 1 mg per mL Tf–AuINT, and (g) and (h) show the control. Images (i)–(l) show (i) live and ( j) dead OCCs after incubation of 1 mg per mL
Tf–AuINT, and the control (k) live and (l) dead cells.
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AuNCs Gold nanoclusters
AuNPs Gold nanoparticles
Trp Tryptophan
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While the size-dependent optical properties of BSA-stabilized gold nanoclusters are well known, the time-dependent 
growth mechanism remains to be described. Herein, we systematically compare two synthesis methods with and without 
ascorbic acid, and show that tuning of BSA-stabilized gold nanoclusters (AuNCs) of different sizes can be performed 
without the aid of an extrinsic reducing agent and with good reproducibility. We also show that adding ascorbic acid yields 
larger BSA-stabilized gold nanoparticles (AuNPs), and that AuNPs can only form above a threshold gold precursor 
concentration. Using computed tomography, we describe how these biomineralized AuNPs show size-dependent X-ray 
attenuation. Growth of BSA-stabilized AuNCs and AuNPs, over a range of gold precursor concentrations, was followed with 
steady-state fluorescence and UV-vis spectroscopy for one week, constituting the first study of its kind. Based on our 
results, we propose a mechanism for BSA-stabilization of AuNCs and AuNPs that can further aid in selective growth of 
discrete AuNCs and AuNPs.   
Introduction 
 
Applications of protein-stabilized gold nanoparticles (AuNPs) and 
particularly gold nanoclusters (AuNCs) have increased dramatically 
since the introduction of the latter in 2009. 
1
 The main feature of 
nanometer sized gold is their remarkable size-dependent optical 
properties. 
2, 3
 The molecular sized AuNCs fluoresce, while AuNPs 
(>2nm) exhibit localized surface plasmon resonance (LSPR), 
resulting in absorbance of visible light. 
4-7
 Stable, biocompatible 
fluorescent probes with large Stoke’s shifts that emit fluorescence 
in the Near IR (NIR) range are particularly interesting, as emission is 
outside the emission region typical of biological tissue.  
The amount of atoms in AuNCs follows a shell model named the 
Jellium model with the corresponding magic numbers 2, 8, 10, 20, 
26, 34, 40. An analogy to the Jellium model is the electronic 
structure of atoms, in which each shell is stable with an optimal 
amount of electrons. As the stability of an atom is governed by 
closed valence shells, so is the stability of magic numbered 
nanoclusters.  
8-10
  
The size-dependent fluorescence of AuNCs can be measured 
using steady-state fluorescence spectroscopy. However, the actual 
origin of fluorescence is not clear, as it can arise from the metal 
core, or from interactions between the metal core and surface 
ligands. 
4
 Particularly, electron-rich atoms appear to affect the 
fluorescence intensity in a positive manner. Wu et al suggests that 
this can occur in two ways; either as a charge transfer or direct 
donation of delocalized ligand electrons. 
11
 Proteins offer a plethora 
of energy donating atoms, such as S, N and O, and can therefore 
collectively enhance the fluorescence intensity via surface 
interactions if they are used as capping agents.  
The blood plasma protein bovine serum albumin (BSA) was the 
first protein shown to synthesize and stabilize AuNCs. 
1
 BSA is the 
major transporter of drugs and metals in the body, and as such has 
a high affinity for metals.
12, 13
 BSA is also documented to have an 
affinity for planar and curved gold surfaces. 
14-16
 
Biomineralization of gold with BSA can give a range of different-
sized AuNCs, which in turn show size-dependent fluorescence. The 
reduction potential of BSA is also strong enough to synthesize 
AuNPs, and the surface stability imparted by BSA makes these 
AuNPs more stable in biological buffers compared to citrate-
covered AuNPs (Figure 1 b-d).  
AuNCs and AuNPs are increasingly being used for a range of 
different applications in bioimaging, 
17
 such as optical labels in drug 
delivery, 
18, 19
 diagnostics,  
20
 and as sensors of heavy metal ions, 
21, 
22
 to mention a few. In particular, applications of colloidal AuNPs 
with diameters less than 100 nm are emerging as promising 
contrast agents for Computed Tomography (CT)
23
.  
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a) b)
c) d)
 
Figure 1:  BSA acts as a scaffold for growth of AuNCs and AuNPs. 
a) Image of BSA-AuNCs and BSA-AuNPs excited with UV-lamp 
(λex=365 nm). The size of the AuNCs increase from left to right. The 
dark sample to the right contains AuNPs which do not fluoresce. 
b,c) High resolution TEM (HR-TEM) images reveal polycrystalline 
AuNPs with different domains that are surrounded by Vis AuNCs. d) 
HR-TEM image of AuNCs.  
 
However, the key to all of these applications remains controlling 
the size of the AuNCs and AuNPs.   
Gold nanoparticles can be prepared via several methods. For 
instance, adding an extrinsic reducing agent such as NaBH4 can be 
used for preparing gold nano rods, and different aspect ratios can 
be obtained by changing the concentration of NaBH4.  
24
 However, 
recent reports indicate NaBH4 as an extrinsic reducing agent of 
protein stabilized AuNCs and AuNPs may perturb the solution 
stability of the protein-AuNC complex due to alterations of the 
protein structure. This again may be caused by interactions with the 
NaBH4 and the protein, or that larger gold species are synthesized 
in the presence of NaBH4, causing the protein to unfold in a greater 
extent. 
25, 26
 
The synthesis of AuNCs and AuNPs with BSA has previously been 
studied with respect to pH,
27
 dependences on gold precursor 
concentrations, 
25
 and temperature. 
1, 22
 Ascorbic acid is sometimes 
added as an extrinsic reducing agent in order to reduce the BSA 
concentration required,
27
 but the effect of ascorbic acid is not 
completely understood. In fact, studies have shown that ascorbic 
acid can associate with BSA 
28-30
 and even quench AuNCs’ 
fluorescence 
31
 if not removed via e.g dialysis. Different incubation 
times have also been reported, but more thorough studies 
revealing how the incubation time affects size-tuning of BSA-AuNCs 
or AuNPs are needed. Protein-directed growth of AuNCs is protein 
dependent, and addition of an extrinsic reducing agent may be 
redundant to obtain fluorescent AuNCs. 
32
 
The mechanism of AuNC growth is still not fully understood 
despite many reports on the synthesis of BSA-stabilized AuNCs and 
AuNPs. Since different synthesis protocols and conditions are 
typically being used between studies, it is problematic to deduce an 
overall mechanism, which in turn makes it difficult to describe and 
control the size of BSA-stabilized gold. In order to get a better 
understanding of the mechanism, there is a need for studies that 
systematically change one synthesis parameter at a time.  
This paper has two aims. First we want to ascribe which 
parameters are important for self-assembly of gold nanostructures 
in BSA. This we investigate by varying the concentration of gold 
precursor, and the presence of an extrinsic reducing agent. The 
effect of an extrinsic reducing agent (ascorbic acid) is determined by 
comparing two synthesis methods named the extrinsic and intrinsic 
method. The former refers to reduction of gold ions with the aid of 
ascorbic acid as an extrinsic reducing agent, while the latter method 
solely depends on the intrinsic reduction potential of BSA. The 
second aim is to describe a growth mechanism for AuNCs and 
AuNPs in the BSA scaffold, by using time as the dependent variable.  
This paper demonstrates that we can influence the size and thus 
the optical properties of BSA-AuNCs and AuNPs by varying the 
above mentioned synthesis parameters. We also describe how 
synthesis of either BSA-stabilized AuNCs and/or AuNPs can be 
achieved, and show that size-tunability of AuNCs can be achieved 
without the presence of ascorbic acid. Finally, we suggest a 
description of the growth mechanism from AuNCs to AuNPs that 
can be used to not only get a better understanding of the 
underlying mechanisms, but also for size-tunability of fluorescent 
AuNCs or AuNPs with LSPR.  
Experimental 
Bovine Serum Albumin (67kDa), hydrogen tetrachloroaureate 
(ІІІ)·3 H2O (TCAA) and L-ascorbic acid were purchased from Sigma. 
Stock solutions of BSA (20mg/mL) were freshly prepared in MilliQ-
water for each experiment. TCAA (1.18g, 3mmol) was dissolved in 
MilliQ-water (34.7mL) to make a stock solution (100mM).  The TCAA 
stock solution was then diluted with MilliQ-water to 5, 7.5, 10, 15 
and 20mM. BSA from the same batch was used for all samples 
described. Prior to the reaction, protein TCAA solutions were 
heated to 37°C. Here, two methods were used for synthesis in the 
absence and presence of an extrinsic reducing agent, hereafter 
labelled as the intrinsic method and the extrinsic method, 
respectively. The intrinsic method: TCAA (2.5mL; 5, 7.5, 10, 15 and 
20mM) was added to BSA (2.5mL) at 37°C and stirred (300 rpm) for 
five minutes. 0.1M NaOH (100-300uL) was added until the solution 
had a pH of 11. Tyrosine is the amino acid in BSA which is thought 
to reduce TCAA to NCs and NPs 
1
. The phenol group of tyrosine has 
a pKa of 10.1,
33
 meaning that the synthesis of protein-gold must be 
performed at high pH-values for maximum reducing capacity. The 
pH has previously been shown to have an effect on growth of larger 
NCs, particularly at high pH-values a more prominent growth of 
large gold NCs has been reported. 
27
 The reaction was kept in an 
incubator (37°C) for 1 week followed by dialysis (MWCO: 14kDa) in 
MilliQ-water. The dialysis was performed with an exchange of the 
dialyzing solution after two hours, before leaving it overnight to 
remove excess TCAA. The extrinsic method: Ascorbic acid 
(0.35mg/mL, 50uL) was added immediately after TCAA before pH 
adjustment.  Samples were diluted in MilliQ-water to 1mg BSA/mL 
before spectroscopic measurements, assuming that the protein 
concentration did not change with dialysis.  
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Steady-state fluorescence spectroscopy was performed using a 
Fluorolog-3 HORIBA Jobin Yvon spectrofluorometer with the 
excitation wavelengths λex=295nm and λex=370nm.  The slit widths 
were kept at 3 nm and 5 nm, respectively.  
Time-correlated single-photon counting was performed on the 
same apparatus as steady-state fluorescence spectroscopy.  The 
protein concentration was 1mg/mL. For measuring tryptophan 
lifetimes and populations, a 280 nm NanoLED was used as the light 
source and the emission wavelength was set to λem=360nm. The 
bandpass was kept at 14.5nm.  
UV-visible spectroscopy was performed on a Shimadzu UV-
2401PC spectrophotometer in the range 200-800nm. The data were 
analyzed using UVProbe2.1 software. 
X-ray photoelectron spectroscopy (XPS) analyses were 
performed using a Kratos Axis Ultra DLD spectrometer (Kratos 
Analytical, UK), equipped with a monochromatized aluminum X-ray 
source (Al, hυ = 1486.6 eV) operating at 10 mA and 15 kV (150 W). 
A hybrid lens (electrostatic and magnetic) mode was employed 
along with an analysis area of approximately 300 µm X 700 µm. 
Survey spectra were collected over the range of 0-1100 eV binding 
energy with an analyzer pass energy of 160 eV, and high resolution 
spectra of  Au 4f were obtained with an analyzer pass energy of 20 
eV. XPS data were processed with Casa XPS software (Casa Software 
Ltd., UK). 
High-resolution inductive coupled plasma-mass spectrometry 
(ICP-MS) measurements were performed on an ELEMENT 2 from 
Thermo Electronics with ArCH4 plasma and tested against three 
blanks. Samples were autoclaved under high pressure with an 
UltraClave (Milestone) in 50% HNO3 (v/v) at 80°C.  
High resolution transmission electron microscopy (HR-TEM) 
images were acquired on a JEOL JEM-2100 (200 kV). The samples 
were prepared by depositing a few drops of nanoparticles or 
nanoclusters suspension on a copper grid coated with amorphous 
carbon layer, and allowed to dry prior to imaging  
X-ray powder diffraction (XRD) patterns of lyophilized BSA-
AuNPs and BSA- AuNCs  were obtained from a Bruker DaVinci2 
diffractometer using Cu Kα (λ= 1.54056 
◦
A) in the 2θ range with 10–
75 degree.  
    Computed tomography (CT) imaging was performed with a 
Skyscan 1176 micro-CT scanner (Bruker micro-CT, Kontich, BE). 
Samples of BSA-AuNPs were dialysed against phosphate buffered 
saline (pH=7.4) before measurements. A phantom consisting of 
three 0.3 ml centrifuge tubes filled with saline and two BSA-AuNP 
solutions with concentrations of 15 mg/ml and 30 mg/ml was 
scanned using the following parameters: 0.5 mm Al filter, 50 kVp, 
500 μA, 63 ms exposure, 5 averages, 0.7° rotation step, 180° 
rotation, 35 μm voxel size. Another, similar phantom containing 
three samples of BSA-AuNPs (20mg/mL) with different average sizes 
(6nm, 26nm and 36nm) were scanned with the same imaging 
parameters. The central 20 slices were reconstructed using the 
Feldkamp cone-beam reconstruction algorithm to measure the 
attenuation coefficients (AC) of each suspension. Regions of 
interest (ROI) were 
defined around the inner circumference of each tube in each image 
slice. The means and standard deviations (s.d) of the ACs within the 
ROIs were computed. 
Results and Discussion 
 
Immediately after adjusting the pH to 11 for the BSA-TCAA mixture, 
the solutions changed colour from yellow to orange, brown or red, 
depending on the amount of TCAA added. After one week 
incubation time, the most prominent colour change was observed 
for samples incubated with the highest concentration of TCAA, 
going from red to dark purple. This change in colour is attributed to 
AuNPs (>2nm) large enough to exhibit LSPR. 
4
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Figure 2: Integrals of a) LSPR absorption peak (500-600 nm) as a function of TCAA synthesized via intrinsic and extrinsic method. The 
integrals of the fluorescence emission (λex=370 nm) of NIR AuNCs (560-730 nm) and Vis AuNCs (385-540 nm) was calculated. The integral of 
the NIR AuNCs was divided by the integral of Vis AuNCs to show the relative growth of the two sizes of AuNCs. This was done for both the 
intrinsic and the extrinsic protocol. b) Changes in Trp emission spectra (λex=295 nm) as a function of gold precursor (TCAA).   
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LSPR appears when the frequency of the incident light matches 
the oscillation frequency of the surface electrons, relative to the 
positively charged metallic lattice, leading to an enhancement in 
the amplitude. 
4-7
 AuNPs with a dark purple color show an intense 
UV-visible light extinction band centered at 520nm (Figure S1). 
Under the conditions reported here, we found that there is a 
threshold for appearance of AuNPs that lies in between 15 and 20 
mM TCAA (Figure 2a). Larger AuNPs were formed when ascorbic 
acid was added, implying that ascorbic acid contribute to the 
reduction of TCAA. This is in agreement with earlier studies (see e.g. 
Le Guèvel
27
) and is also expected, as the presence of an extrinsic 
reducing agent lowers the energy barrier towards nucleation and 
growth of nano crystals. The presence of AuNPs was confirmed with 
HR-TEM (Figure 1b and c), and crystallinity was observed with X-ray 
powder diffraction (Figure S4), and is also in accordance with values 
determined in previous studies. 
34, 35
 
 
Size of BSA-gold is dependent on gold precursor concentration 
In contrast to AuNPs, AuNCs have discrete electronic structures 
such as HOMO-LUMO band gap openings with transitions smaller 
than the Fermi wavelength.
4
 This results in molecule-like properties 
such as size-dependent fluorescence (Figure 1a). 
36, 37
 AuNCs vary in 
size from 0.2nm to 2nm, which for gold corresponds to a few atoms 
up to several hundreds of atoms. 
2, 38
 The amount of gold atoms in 
AuNCs likely follows the Jellium model, which describes clusters as 
being of a magic number of atoms (=2, 8, 13, 25, 38, 55…). 
Populations of AuNCs can be described by fluorescence 
spectroscopy. AuNCs are excited at 370 nm (λex=370nm) and emit at 
450 nm and 600-700 nm, depending on their size (Figure S2). Here, 
the peak at 450 nm is attributed to populations of smaller AuNCs 
(Au8, Au13 etc) which are hereon referred to as Vis AuNCs as they 
emit in the visible region of the electromagnetic spectrum. The 
fluorescence between 600 and 700nm is attributed to populations 
of larger AuNCs (Au25), hereon referred to as NIR AuNCs. 
1, 27
  
The large NIR fluorescence intensity observed for AuNCs at 
10mM TCAA might be a result of a metal-to-ligand/ligand-to-metal 
charge-transfer (ML/LMCT) complex that is formed between the 
protein and the NIR AuNCs. This is hypothesized to enhance the 
fluorescence intensities. However, in an ML/LMCT complex there is 
an exchange of electrons either from the metal to the protein 
or vice versa. If this was largely the case, either the protein or the 
AuNCs would be oxidized/reduced, which would destabilize the 
suspension with time. Thus, as the suspensions were very stable 
over long time periods (>1 year), it is more likely that the high 
fluorescence intensity from NIR AuNCs is caused by capping of BSA. 
This would in turn cause shielding of the AuNC from water, which 
further would give a more intense fluorescence emission. 
The AuNCs prepared with the intrinsic method show the same 
intensity and reproducibility as samples synthesized with ascorbic 
acid. Given that the concentration of ascorbic acid used was in 
accordance with previous literature. 
27, 39
 This finding suggests that 
the concentration of ascorbic acid used here does not significantly 
aid BSA in reducing Au
3+
 to AuNCs. At low concentrations, there are 
predominantly Vis clusters present, but as the concentration of 
TCAA increases, so does the population of NIR AuNCs (Figure 2b).  
However, as AuNPs emerge, detecting the presence of AuNCs with 
fluorescence spectroscopy becomes highly complex as the 
interactions between colloids and fluorophores can involve 
resonance energy transfer and quenching. 
7
 The Vis AuNCs on the 
other hand, seem to be unaffected by the presence of AuNPs as 
their fluorescence intensities continue to increase with TCAA 
concentration. The most probable reason for this is that the 
emission from Vis AuNCs is out of range of AuNP quenching  or that 
Vis AuNCs are too far away from AuNPs. Appearance of AuNPs 
occurs only at high concentrations of TCAA (20mM, Figure 2a). At 
20mM TCAA, there is a substantial decrease in the emission of NIR 
AuNCs (Figure 2b), as well as a bathochromic shift of the emission 
peak at 650 nm (Figure S2). This could be caused by NIR AuNCs 
being quenched by AuNPs, coalescence of NIR AuNCs into AuNPs, or 
a combination of both.  
With X-ray photoelectron spectroscopy, the binding energy of 
surface photoelectrons can be measured. Higher binding energies 
indicate that the surface electrons are more associated with the 
metal, and less prone to movement between metallic surfaces. 
27, 40, 
41
 A lower binding energy means that the surface electrons have 
less affinity to the metallic core. Here, BSA-AuNCs show gold peaks 
at 80.1 and 83.8eV, while BSA-AuNPs show a shift to higher binding 
energies (84.9eV and 81.2eV, respectively. Figure S5). The peaks for 
BSA-AuNPs are also broadened, and show higher intensities 
compared to the BSA-AuNCs. Because XPS can only detect 
elemental compositions of surfaces down to 10nm
42-44
, a shift to 
higher binding energies with higher concentrations of TCAA, means 
that Vis AuNCs are present on the surface of the protein. It also 
implies that NIR AuNCs are not on the surface and (i) has either 
coalesced into NPs or (ii) are buried in BSA. The XPS spectra, 
combined with HR TEM images (Figure 1b and c) strongly suggests 
that AuNCs coexist with AuNPs, and imply that the AuNPs are 
covered with BSA-AuNCs as passivating ligands.  
 
Tryptophan emission is altered due to size of BSA-stabilized 
AuNCs and AuNPs.  
BSA is a very flexible protein and can undergo major 
conformational changes without denaturation.
45-47
 The flexibility is 
important for the amount of gold that can be loaded onto the 
protein backbone. Changes in the conformation of BSA can be 
described by steady-state fluorescence spectroscopy by exciting the 
amino acid tryptophan (Trp). The indole ring in Trp is the dominant 
fluorophore in proteins, absorbing light near 295 nm and emitting 
near 340 nm.
48, 49
 Indole is very sensitive to solvent polarity and can 
reveal the location of tryptophan residues in proteins. Typically, 
emissions from exposed Trp residues are red-shifted, while buried 
Trp residues will have a blue-shifted emission.
7, 50
 Stoke’s shifts and 
quenching of tryptophan emission is usually explained by an 
exposure to the aqueous environment. 
7, 49, 51
 BSA has two 
tryptophan residues; one situated in a hydrophobic pocket (Trp213) 
while the other is situated on the surface (Trp134).
47
 Because 
Trp213 is hidden inside native BSA, the tryptophan emission (λex 
=295 nm) is thought to be dominated by Trp134. Therefore, any 
changes in the emission are ascribed to structural changes in the 
protein. 
25, 49, 52
 Steady-state fluorescence spectroscopy was used to 
measure Trp emission in BSA containing different sizes and 
populations of nano-sized gold. Trp134 in native BSA has an 
emission maximum at approximately 350 nm in water. This 
maximum was steadily quenched and shifted towards longer 
wavelengths as the size of the nano-sized gold increased (Figure 
2b). No differences between the intrinsic and extrinsic methods 
were observed with TCAA concentrations above 5mM. However, 
the emission of BSA incubated with ascorbic acid had the largest 
standard deviations (Figure S3), which could imply that not all of  
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Figure 4: Graph a) shows the LSPR intensity at 520nm as a function 
of time for the sample incubated with 20mM TCAA. No LSPR-band 
was observed for any other samples. Graph b) shows the integral of 
the emission peak for the Vis AuNCs (385-540 nm) after subtracting 
the signal of native BSA. Graph c) show the integral of the emission 
peaks of NIR AuNCs (560-730 nm) after subtracting the signal of 
native BSA. Both graph b and c are shown as a function of time. The 
lines for 15 and 20 mM TCAA have been highlighted as they show 
the most consistent changes.  
the ascorbic acid was removed via dialysis because it was bound 
to the protein.  
The Trp emission (Figure 2b) curve has an inflection point 
approximately at 360 nm, which is best observed with the 5mM 
curve (red). As AuNCs are excited at 370 nm, it is likely that the 
decrease in Trp emission is not only caused by exposure to the 
surface, but also by quenching of adjacent AuNCs. After 360nm, the 
Trp emission intensity slowly increases to 450 nm, before it 
decreases again.   
The whole emission profile of BSA is drastically altered from 
TCAA concentrations of 10mM and above, meaning that the protein 
has undergone large conformational changes. At 10mM TCAA there 
is a dramatic change in the Trp emission from 300 to 400 nm. At 
this particular concentration of TCAA, the highest ratio of NIR 
AuNCs was determined (Figure 2a). This means that with a bigger 
population of NIR AuNCs, the probability that a quencher is 
adjacent to a Trp residue increases. However, Trp quenching cannot 
only be explained by AuNC quenching alone. With increased 
population of nano-sized gold, BSA unfolds and exposes Trp134 to 
water, which will be a large contributor to quenching.
25
 Unfolding 
also leads to exposure of the buried tryptophan residue (Trp213), 
which emission emerge at ~320nm for samples containing 10-20mM 
TCAA.  
 From time-correlated single photon spectroscopy (TCSPC) a 
large difference in the Trp lifetimes of native BSA and BSA with 
AuNPs (20mM TCAA) was detected (Table S2). This indicates that 
the fluorophore on average spends less time in the excited state, 
which is probably caused by an increased exposure to water or 
energy transfer to BSA-gold, or a combination of the two. 
25
   
Combining the TCSPC data with steady-state fluorescence data, 
we ascribe quenching of Trp emission as concomitant effect of 
increased size of BSA-AuNCs/AuNPs. Interestingly, even though the 
Trp emission reveals large structural changes in BSA, the BSA-AuNP 
solution did not show any signs of aggregation after 12 months of 
storage. This means that the conformational changes induced by 
nano-sized gold are not large enough to severely denature BSA, and 
compromise its solution stability. The long shelf-life of BSA-AuNP 
suspensions enhances their utility e.g in sensing and imaging 
applications.
53-55
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Figure 5: Proposed mechanism for growth of AuNPs stabilized by BSA. 1) Increasing the pH to above 10 causes BSA to be negatively 
charged which induces electrostatic interactions with the gold ions. 2) Vis AuNCs that emit in the visible region of the EM spectrum start to 
form, 3) and depending on time and concentration of TCAA, larger NIR AuNCs and 4) AuNPs are formed via a shuffling of NIR AuNCs.    It 
should be noted that the structure of the denatured protein is used only as illustration, and not as an accurate description of the 
conformation 
 
Proposed mechanism for biomineralization of AuNCs and AuNPs 
We have established that changing the ratio of BSA/TCAA yields 
different populations of nanometer-sized gold, and that ascorbic 
acid is not needed for synthesis of AuNCs, but that it is beneficial for 
biomineralization of AuNPs. 
The incubation time for the samples prepared above was one 
week, 
25, 32
 which is much longer compared to the original synthesis 
of 12 hours.
1
 12 hours incubation time is also reported by several 
others,
39, 56-59
 but overnight,
60
 15 hours,
22
 5 hours,
27, 39
 and 2 hours
25
 
have also been used for BSA-AuNCs synthesis. The different 
incubation times yield different populations of AuNCs, revealing 
that the synthesis is highly time-dependent.   
We wanted to elucidate the time-dependent changes in the 
protein and what appears to be a dynamic interchange between Vis 
and NIR AuNCs that could give further insight to the nucleation and 
growth processes. In order to address this issue, biomineralization 
of AuNCs and AuNPs with BSA was followed for one week.  
In Figure 5 we have illustrated what we suggest as the self-
assembly mechanism of BSA-stabilized AuNCs and AuNPs. Initially, 
the pH is raised to above 10 so that BSA becomes negatively 
charged (step 1, Figure 5). 
61
 Positively charged gold ions are then 
electrostatically attracted to BSA, particularly in areas rich in 
tyrosine and histidine which are the major reducing amino acids. 
Once the local concentration of gold ions is high enough, nucleation 
occurs (step 2), and further growth of AuNCs is caused by an 
increased influx of gold ions, or due to coalescence, or both (step 
3). If the concentration of TCAA is high enough, AuNPs are 
synthesized most likely due to coalescence of several proteins 
surrounding an AuNP core (step 4).  The work described herein 
appears to follow the general mechanism described by Volden et.al. 
32
  
The initial electrostatic interactions of Au
3+
 ions will favor 
nucleation at sites high in concentration of negatively charged 
amino acids. This in turn suggests that nucleation is likely to take 
place in these regions as well. Indeed, the reduction in Trp emission 
observed in Figure 2b (5 and 7.5mM TCAA) could be an effect of 
exactly that. Nucleation that takes place close to a dominating 
fluorophore would in turn cause quenching, as AuNCs can interact 
with the emitted photons from Trp213. This also leans towards the 
fact that nucleation does not take place in the central hydrophobic 
regions of the protein, as Trp134 emission is not quenched with 
increased concentration of gold ions (Figure 2b, 10-20 mM TCAA, 
Trp peak at 320 nm).  
 Biomineralization of AuNPs is highly time-dependent, with 
AuNPs of 20 nm occurring after one week of incubation with BSA, 
but only at high concentrations of TCAA (20 mM, Figure 4a).  
Synthesis of AuNCs, however, is not equally linear and straight-
forward. Up until 60 hours of incubation time, there are large 
fluctuations in the populations of Vis AuNCs (Figure 4b). Beyond 60 
hours, the population sizes decrease but at different rates. The 
largest changes are seen with the highest concentration of TCAA, 
which seem to inversely follow the growth of AuNPs (Figure 4a), 
suggesting increased quenching of AuNCs with appearance of 
AuNPs. For samples containing 15 and 20 mM TCAA, decrease in 
populations of Vis AuNCs is followed by growth of NIR AuNCs, which 
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is not equally observed for the other samples (Figure 4c). This 
suggests that Vis AuNCs coalesce into NIR AuNCs, and that this is 
most prominent when high concentrations of TCAA are added. For 
samples containing 5-10 mM TCAA, there are particularly large 
fluctuations in the emissions for NIR AuNCs up until approximately 
100 hours. During the time course of the experiment, peak 
shoulders were consistently observed for the NIR AuNCs, but not 
for the Vis AuNCs. Emission peaks of AuNCs that broaden and have 
shoulders indicate that different discrete AuNC populations of 
magic Jellium numbers are present in the protein backbone.
25, 62
 
This means that there are at least two populations of NIR AuNCs 
present, and that the population sizes are changing based on the 
available amount of Au
3+
. The spectral line shape of 7.5mM TCAA is 
particularly interesting (Figure S9). In the beginning of the reaction, 
the peak at 650 nm has a shoulder that lies to the left, but after 62 
hours of reaction time, the shoulder has shifted to the right, 
meaning that AuNCs of higher magic Jellium numbers are formed. 
At 62 hours, there are minor changes in the population of Vis 
AuNCs, which could mean that growth of larger AuNCs is caused by 
an influx of Au
3+ 
to the protein surface from the bulk, rather than 
coalescence of Vis AuNCs as the latter would have revealed a 
decrease in the population of Vis AuNCs.  
 It is very important to point out that emission of AuNCs tend to 
be higher at short incubation times, with the exception of NIR 
AuNCs for samples containing 15 and 20 mM TCAA. This suggests 
that synthesis of AuNCs with high quantum yields should be 
performed with incubation times below 40 hours.  
 Volden et al also points to the flexibility of the protein as a key 
feature for synthesis of AuNCs. The Trp emission was also followed 
with time, and revealed how BSA rapidly undergoes conformational 
changes during the biomineralization process. The Trp emission line 
shape did not change after 24 hours incubation time (Figure S10) 
but had the same shape as that observed after one week (Figure 
2b). With the sample prepared at 20 mM TCAA, the changes during 
the week were less prominent, which indicates that the protein has 
less chances of conformational changes due to the NIR AuNCs and 
AuNPs present in its backbone. However, changes to the emission 
of the other samples were observed and is worth highlighting. The 
samples containing 5-15 mM TCAA actually showed an increase in 
the Trp emission at the end of the week compared to 24 hours. 
Increased emission of Trp represents a refolding of the BSA with 
time. As size and amount of AuNCs grow, BSA is forced to stretch 
and expose hydrophobic pockets to the aqueous environment. At 
some point, the unfavorable interactions between hydrophobic 
residues and water will force the protein to change conformation. 
Refolding of BSA may in turn bring Vis AuNCs closer to each other, 
which would increase the probability of coalescence into NIR 
AuNCs. The concomitant decrease in the Vis AuNCs (Figure 4b) 
could therefore be an effect of refolding of BSA that is greater with 
time.  It is likely that NIR AuNCs also remain in the protein backbone 
as they can be visualized with HR TEM (Figure 1 b-c) and measured 
with steady-state fluorescence spectroscopy.  
The easy size tuning, low toxicity, excellent stability, and optical 
properties of BSA-stabilized AuNCs and AuNPs render these 
constructs highly useful in several applications. For instance, we 
have initial data suggesting that BSA-AuNPs show size-dependent X-
ray attenuation, which can be used in computed tomography 
(Figure S7).   
 
Conclusions 
We have systematically compared the role of BSA in reducing 
Au
3+
 to AuNCs of different sizes using two different synthesis 
protocols – with and without the addition of ascorbic acid as an 
extrinsic reducing agent. Our results demonstrate that the presence 
of ascorbic acid plays a minor role in the formation of BSA-AuNCs, 
but that ascorbic acid yields larger BSA-AuNPs. We have also shown 
that the size of BSA-AuNCs and BSA-AuNPs is in turn dependent on 
the TCAA concentration and the incubation time. BSA is a robust 
and flexible protein that can carry a substantial amount of AuNCs in 
its backbone, and can even stabilize AuNPs without denaturing, 
showing great solution stability even after one year. We suggest 
that gold nanoparticles grow at the expense of NIR nanoclusters, 
and that this is enabled by the flexibility of BSA. We have also 
shown that at lower TCAA concentrations, Vis and NIR AuNCs co-
exist in the protein backbone, and that this ratio is tunable. The 
mechanism described here can be easily applied for size-selection 
of BSA stabilized AuNCs and AuNPs, tuning the growth towards 
different applications.  
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   LSPR absorption of BSA-stabilized AuNPs and steady-state fluorescence emission of AuNCs 
Figure S1 show the appearance of gold conduction band as observed with UV-Visible for both intrinsic and extrinsic 
synthesis. The spectrum shows the absorbance of gold nanoparticles at ~520nm for the extrinsic synthesis route. 
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Figure S1: LSPR of BSA-stabilized AuNPS 
 
 
Figure S2 show the Steady-state fluorescence spectra of fluorescent gold nanoclusters (λex  =370 nm) prepared via the 
extrinsic method. Figure S3 show the integral of the Trp emission (λex  =295 nm) as a function of TCAA.  
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Figure S2. Spectra in a) show the emission of AuNCs with the contributing emission from BSA. Spectra b), the emission 
from BSA has been subtracted from all spectra, to show the contribution of only AuNCs.  
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Figure S3: Integral of Trp emission (310-450 nm) as a function of TCAA. The red lines show the extrinsic Trp emission, 
while the black line show the intrinsic integral of Trp emission.  
 
 
X-ray powder diffraction of BSA and BSA AuNPs 
 
Figure S4 show the XRD-patterns for pure BSA (red line) and for BSA-AuNPs (black), and reveal crystalline structures of 
the BSA stabilized AuNPs.  
 
 
 
 
 
 
 
 
 
 
 
 
High-resolution inductive coupled plasma-mass spectrometry (ICP-MS) 
Figure S4: XRD patterns of BSA and BSA stabilized AuNPs
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Time-correlated single-photon counting (TCSPC) measures the intensity decay of fluorophores on a nanosecond timescale.7 
Fluorescence lifetime measurements can give information about variation in the local environment of a fluorophore 8,9 and  
conformational changes in proteins. 10,11  TCSPC was performed with a 280 nm LED (λex=280nm), and measuring the 
emission at 360 nm (λem=360nm). The fractional contribution of each decay time to the steady-state intensity, f, is 
determined from the decay times, T, and B which is the relative population of the components at t = 0, as shown in equation 
S1. 7 
 
ࢌ࢏ ൌ ࡮࢏ࢀ࢏∑ ࡮࢐ࢀ࢐࢐         (S1) 
 
All samples were best fit by biphasic decay, yielding one short (T1) and one long (T2) lifetime and their relative 
populations B1 and B2.   
   
Table S2: Lifetimes and Populations 
Synthesis TCAA (mM) T1 (ns) B1 (%) T2 (ns) B2 (%) 
 
Intrinsic 0 1.5±0.021 33.2±0.18 4.9±0.027 8.1±0.0049 
 
 5 1.1±0.021 37.5±0.22 4.4±0.030 8.3±0.0048 
 
 7,5 0.91±0.015 41.6±0.23 4.3±0.033 7.0±0.0043 
 
 10 0.47±0.020 69.6±0.40 3.5±0.047 5.7±0.0041 
 
 15 0.38±0.018 91.8±0.48 3.6±0.088 3.1±0.0029 
      
 20 0.24±0.0083 160.4±0.85 3.7±0.095 1.8±0.0022 
 
Extrinsic 0 2.04±0.031 22.7±0.13 5.9±0.028 
 
8.68±0.0046 
 5 1.63±0.027 26.5±0.14 4.7±0.033 
 
6.9±0.0038 
 7,5 1.45±0.027 27.6±0.15 5.4±0.033 
 
7.03±0.038 
 10 1.09±0.021 35.0±0.17 5.1±0.047           4.5±0.030 
 15 0.81±0.017 40.9±0.20 5.5±0.052 
 
3.6±0.023 
 20 0.43±0.013 68.9±0.37 5.0±0.058 
 
3.7±0.023 
 
From 7.5mM-10mM TCAA, there is a large decrease in T1 and T2 for both the intrinsic and extrinsic synthesis. At 10mM 
TCAA, steady-state fluorescence data show an increased growth of large AuNCs, indicating that large AuNCs induce more 
prominent conformational changes compared to small AuNCs. From 7.5-10mM, the T1 for the intrinsic synthesis is reduced 
by a factor of 2.7, while the extrinsic T1 is reduced by a factor of 2. Since the protein is the sole reducing agent in the 
intrinsic synthesis, shorter lifetimes could indicate that there are larger changes in the polypeptide chain when ascorbic acid 
is not present.   
The lifetime populations for the intrinsic and extrinsic samples show that as the size of gold increases, there is an 
increased short lifetime population (B1), and a concerted decreased long lifetime population (B2). The short and long 
populations show the relative percentage of fluorophores for the short and long lifetimes, respectively. At concentrations 
below 7.5mM TCAA chi-squared values (χ2 ~1) indicated a good fit, while above 7.5mM TCAA chi-squared values (χ2 >2) 
were less ideal. Increasing the exponential fit for samples with concentrations above 7.5mM, would give a better fit, but with 
more contribution from noise. 7 The data above 7.5mM TCAA can therefore not be used quantitatively, but qualitatively to 
indicate what happens to the protein when the concentration of TCAA is increased.  
The prominent increase in B1 at 10mM could be an effect of the large conformational changes in BSA that takes place 
when large AuNCs appear. At 10mM TCAA, steady-state data of Trp emission reveal large changes in protein conformation, 
which would greatly affect TCSPC data as well. Because the lifetimes were measured with a 280 nm LED, it could be that as 
BSA changes conformation, tyrosine residues are exposed and contribute to the emission, thus increasing the overall lifetime 
populations. 7,12 Overall, the results reveal the same trend of lifetimes and populations for BSA with or without ascorbic 
S6 
 
acid. With increased size of BSA-gold, the short (T1) and long (T2) lifetimes decreased, while the short lifetime populations 
(B1) increased and the long lifetime populations (B2) decreased. There is a large difference in the short and long lifetimes of 
native BSA and BSA with AuNPs (20mM TCAA) indicating that the fluorophore on average spends less time in the excited 
state, which is probably caused by an increased exposure to water or energy transfer to BSA-gold, or a combination of the 
two. 13 Increased quenching of Trp emission with size of BSA-gold was also observed with steady-state fluorescence, 
showing that the protein gradually changes conformation as a result of the gold size.  
 
 
Toxicity assay on glioblastoma-astrocytoma cells 
 Misfolded proteins are usually devoid of normal biological activity and can aggregate or interact with cells in an 
unwanted manner. 14,15 For example, in Alzheimer’s disease, neurodegeneration is caused by amyloid plaques formed by 
misfolded β-amyloid protein aggregation.16,17 As shown earlier, the tryptophan emission intensity was found to be inversely 
proportional to the size of gold, meaning that the folding of BSA is more affected with larger species of gold. If BSA-
AuNCs or BSA-AuNPs either do or do not aggregate or interact with cell membranes, they could be used in different 
applications. Biocompatible constructs of BSA-stabilized gold can be used as drug delivery vehicles, while BSA-stabilized 
gold that aggregate and interact with cell membranes can be used as a drug in itself.    
 To this end, we tested the interaction of our BSA stabilized AuNCs and AuNPs with glioblastoma-astrocytoma 
cells in vitro and thus assessed their suitability as potential drug delivery vehicles in the therapy of glioblastoma multiforme. 
Glioblastoma multiforme is the most common primary brain tumor in adults. 18,19 It is very aggressive 20 and exhibit low 
response to conventional chemotherapeutic drugs.21 Despite advances in therapy, 19  the estimated median survival of 
affected patients is one year.20 To our knowledge, this is the first reported study on BSA-stabilized gold interaction 
performed on brain cancer cells. Previously, we have shown that the protein is important for the stability and size-tunability 
of the gold nanoconstructs. 13 Recently, we showed that synthesis of Transferrin-stabilized AuNCs had large surface 
affinities towards monolayers, and tended to localize on cell membranes in vitro. 22  
 Human glioblastoma astrocytoma cells (U-87 MG, Sigma Aldrich) were cultured in Eagle’s Minimal Essential 
Medium (EMEM) with 1.25% gentamicin (Sigma) and 10% fetal bovine serum (Autogen Bioclear, Wiltshire, UK). The 
cultures were supplemented with 2mM L-Glutamine, 1% non-essential amino acids (NEAA) (Sigma), and 1mM sodium 
pyruvate (NaP) (Sigma). Cells were labelled with BSA, BSA-AuNCs and BSA-AuNPs at concentrations of BSA/media 
volume of 1mg/mL, and incubated at 37°C for 24 hours. Unlabelled glioblastoma-astrocytoma cultures, at the same stage of 
confluence, were used as controls. After labeling, a LIVE/DEAD® cell viability assay (Invitrogen, Life Technologies) was 
performed on glioblastoma-strocytoma cultures. LIVE/DEAD® solution was prepared in 4.5mL PBS with 2.7μL calcein 
(InVitrogen), and 12μL ethidium homodimer (Invitrogen), was added to each well at 1:1 (v/v) and left to react for 30 
minutes at 37oC. A LIVE/DEAD assay is a method for quickly assessing if there is a substantial cell death in one cell 
population compared to another. By taking images of the same magnification in the same area for all samples (i.e in the 
centre of the cell plate), it is possible to get information of the overall cell death. In Figure S6, dead cells were counted and 
the average amount of dead cells per image was calculated.  
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Figure S6: Dead glioblastoma-astrocytoma cells after incubation with BSA-AuNCs and BSA-AuNPs. a) Dead glioblastoma-
astrocytoma cells counted with different concentrations of TCAA. The number of images counted per sample were 5. b) 
Glioblastoma astrocytoma cells grow very fast, and can therefore have multinucleate cells. In the example given, cell nuclei 
that lay very close to each other is counted as one cell.  
No increased cell death was observed for any BSA-stabilized gold when compared to blank samples. This suggests that the 
BSA-stabilized gold described here do not aggregate or negatively impact cell membranes, which opens up for drug delivery 
applications. Compared to previous work on different proteins, these results indicate that the membrane affinity is also 
dependent on the protein. 13,22 
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Computed Tomography 
X-ray computerized tomography is a diagnostic imaging technique based on different tissue absorptions. For improved 
diagnostics, organic contrast agents (CAs) containing iodine is commonly used for enhanced attenuation. However, these 
CAs have very short circulation times. Because of their surface plasmon resonance, and inherently high attenuation 
coefficients (at 100keV gold has an attenuation coefficient of 5.16, while iodine has 1.94) AuNPs below 100nm have 
attracted a lot of attention as potential CT CAs. 48, 49 Here, three batches of large BSA-stabilized AuNPs were synthesized 
and their X-ray attenuation coefficients were measured (Figure S7). The size of the BSA-AuNPs determined the CT 
attenuation, with the smallest AuNPs giving the best attenuation. This is most likely caused by an increase in the surface area 
with decreasing size50. The mechanism of BSA-AuNP growth presented here can be used to determine the optimal size for 
CT imaging. The attenuation coefficient increase linearly with BSA-AuNP concentration which is comparable to what has 
been reported in previous studies with PEG-coated AuNPs for in vivo CT imaging. 51, 52  
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Figure S7: X-ray attenuation of BSA-AUNPs.  a) With increasing size, the attenuation coefficient decrease. Saline is shown 
as a control. b) A slice of the reconstructed attenuation coefficient map of the CT phantom consisting of saline and three 
BSA-AuNP solutions (20 mg/ml) with different average sizes (6nm, 26nm, and 36nm). The scale bar  is equal to 1 mm. c) 
Plot of the mean attenuation coefficient vs. BSA-AuNP concentration for the sample with the highest attenuation coefficient 
in a), i.e the sample containing average sized AuNPs of 6nm. Error bars indicate standard deviations. Solid line represents 
the linear regression line. d) Reconstructed image slice of the phantom from suspensions plotted in c).  
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Time-resolved steady-state fluorescence spectra of Trp (λex=295nm) and AuNC emission (λex=370nm)  
Figure S9 displays steady-state fluorescence emission spectra (λex=370nm) for six samples incubated with different amounts 
of TCAA and ascorbic acid (i.e the extrinsic method). Figure S10 show the tryptophan emission (λex=295nm) from the same 
samples. Spectra were recorded over the time span of one week. The blue lines in each specter show the emission after 24 
hours incubation time, while the red lines show the emission after 1 week (169 hours).  The emission from Trp residues in 
BSA did not change much over the time course of 169 hours.  
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Figure S9: Time-dependent growth of gold nanoclusters followed by steady-state fluorescence, λex=370nm.  The six graphs 
show spectra of six different samples incubated with the extrinsic method taken over a time-period of one week. The BSA 
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spectra were subtracted for all samples to show only the contribution of the AuNC emission. The arrow indicates a shift in 
the shoulder from left to right after 62 hours. 
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Figure S10: Changes in tryptophan emission with time and different gold precursor concentrations.  Red line is after 
24 hours, blue line is after one week. The purple line in graph Native BSA is the emission of tryptophan after 52 hours.   
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The integral of the Trp emission as a function of time is given in figure S11. 
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Figure S11: Trp emission integral as a function of time and concentration of TCAA.  
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Imaging soft tissue of the human body with magnetic resonance imaging (MRI) is sometimes 
crucial for determining an accurate diagnosis. Acquired images can reveal obstructed blood 
flow, abnormal tissue structure and vascularization. To improve the accuracy of diagnosis, the 
contrast can be altered by administering magnetically active contrast agents (CAs), typically 
comprised of chelated ions such as gadolinium (Gd
3+
) and manganese (Mn
2+
).
  
CAs can either 
enhance or decrease the contrast in the tissue depending on their magnetic susceptibilities, and 
CAs are referred to as either positive or negative, respectively. With the upsurge in synthesis 
and characterization of magnetically active nanoparticles (NPs), new nanoparticle-based 
systems with potential applications towards theranostics are emerging. NPs have longer blood 
circulation times as compared to chelates, 
1 
and the large surface-to-volume ratio of NPs 
results in a greater contact area between magnetically active centers and the tissue. Moreover, 
     
2 
 
the large surface area of NPs can be modified with biologically compatible molecules and 
drugs, which allows for simultaneous diagnostics and therapy.  
 Superparamagnetic iron oxide NPs (SPION) are widely used as they produce a 
dark/negative contrast in a T2/T2*-weighted image. SPIONs are used commercially 
(Lumirem®/Gastromark®), 
2-4
 and can be targeted to cancer tumors and as such provide 
therapy and diagnostics. 
5-8
 However, the hypointense signal can be confused with e.g 
magnetic susceptibilities, bleeding or calcification which can lead to inaccurate diagnosis.
9-11 
In light of this, positive T1 CAs are generally preferred because they give a hyperintense 
signal that is easier to distinguish from surrounding tissue and is less likely to be confused 
with artefacts. T1 CAs are typically prepared from paramagnetic elements, such as Gd
3+
 and 
Mn
2+
, as they effectively shorten the local spin-lattice relaxation time (T1 time). While 
chelates of gadolinium are used in the clinics (e.g Gadovist, Magnevist),
1,9
 they suffer from 
challenges such as short circulation times, and severe side effects in patients with poor kidney 
function. 
12, 13 
Novel T1 CAs must address these issues and simultaneously give equal or 
better contrast. Gadolinium NPs or polymeric nanoparticles conjugated with Gd
3+
 show good 
signal-to-noise ratio and have been shown to target and visualize tumors. 
14-17
 However, there 
are several interesting benefits with using manganese-based CAs for MRI applications and 
drug delivery.  
 Mn
2+ 
ions are Ca
2+
 analogues and can enter neurons through voltage-gated Ca
2+
 ion 
channels, 
18
 which enables in vivo neuronal tract tracing in Manganese Enhanced MRI 
(MEMRI). 
19, 20
 Administrating high concentrations of Mn
2+
 ions can affect the T2/T2* times 
as well, 
21,22
 however, high doses of Mn
2+
 can accumulate in the brain and cause a toxic 
condition named manganism. 
23 
Because of the toxicity, manganese-chelates are still regarded 
as alternative CAs in MRI. However, recent synthesis of manganese oxide-based NPs could 
lead to a resurgence of manganese as an MRI contrast agent, 
24-27
 and a recent report by 
Zhang et al demonstrate the efficacy of Mn
2+
 ions as imaging probes for visualizing delivery 
of cancer therapeutic drugs. 
28
 Also, manganese oxide NPs (MONPs) are T2/T2* active CAs, 
but they also degrade in water within a reasonable time-frame (hours to days). 
25, 29-31
 This is 
interesting for MR applications because MONPs that degrade, release Mn
2+ 
ions, which are 
very efficient T1 CAs. 
32-35
 MONPs therefore offer a potentially very useful time-dependent 
T2/T2* to T1 contrast switch that allows both complementary MR images and improved 
diagnostics.  
32
 
 Generally, metal oxide NPs are surface functionalized to be stable in water, by 
attaching either a stabilizing ligand, or a functional molecule which not only imparts colloidal 
stability but also an additional diagnostic/therapeutic function to the NP. The neurotransmitter 
dopamine is frequently used as a surface anchor connecting the surface oxide layer of the 
metal oxide NP with an outer polymer shell. 
36-38
 The hallmark of Parkinson’s disease (PD) is 
gradual degeneration of dopaminergic neurons in the Substantia Nigra pars compacta (SNpc), 
leading to deficient dopamine content and severe cognitive and motor deficits. Dopamine is 
an important neurotransmitter for the function of the human retina and optic nerve (ON) 
39, 40 
and visual impairments in PD are common. 
41
 The symptoms can be caused by deficient 
dopamine content, 
41
 or from fiber layer thinning of the optic nerve. 
42,43 
Although dopamine 
is biologically relevant, the properties of its precursor, L-3,4-dihydroxyphenylalanine (L-
DOPA), are far more interesting. L-DOPA is carried across the BBB via the LAT1 
transporter, and is decarboxylated to dopamine in capillary endothelial cells. 
44, 45
 L-DOPA is 
orally administered and currently the drug of choice for patients suffering from Parkinson’s 
disease (PD). 
 In the current work we aimed to develop L-DOPA stabilized MONPs which release 
Mn
2+
 ions and L-DOPA simultaneously, a combined release which has not been reported 
previously. While L-DOPA can act as a scaffold for attachment to other functional 
molecules,
46
  L-DOPA used both as a stabilizer and active drug is a novel concept.  
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Figure 1: MONPs degrade in water and release L-DOPA. a) TEM of MONPs in organic 
phase b) HRTEM image of MONPs before surface modification c) TEM of L-DOPA coated 
MONPs, 1 hour in water (pH=6.8). Inset shows dark field image of hollow MONPs after 1 
hour in water d) Diameter of MONPs and ζ-potential of MONPs as a function of time e) 
Hydrodynamic volume and concentration of L-DOPA as a function of time  f) T1 and T2 
relaxation time in pig eyes upon injection of MONPs, as a function of time. “Lateral” refers to 
the opposite side of the injection site, while “Center” refers to the mid part of the pig eye. 
Conductance as a function of time is also shown.  
 
 
The objectives of this study were as follows: First, we wanted to characterize how fast and in 
what way the MONPs degrade in water. Second, we wanted to determine the magnetic 
properties of MONPs, and whether release of Mn
2+
 from MONPs is efficient enough to gain 
complementary images in vivo. Finally, we wanted to determine whether L-DOPA is released 
from the NPs, which may be of value for potential applications in Parkinson’s disease (PD).  
 In a typical synthetic procedure, MONPs (15±5 nm) were synthesized via thermal 
decomposition of Mn-oleate in a high boiling point organic solvent (Figure 1a). 
47, 48
 High 
resolution transmission electron microscopy (HRTEM) suggests a core-shell morphology of 
Mn2O3-MnO NPs (Figure 1b). The lattice fringe spacing of the core (~2.49 Å) corresponds to 
the separation between the (211) lattice planes of tetragonal Mn3O4. The lattice spacing of the 
shell (~2.2 Å) corresponds well to (200) interplanar spacing of MnO. The MnO shell has an 
average thickness of ~2.1 nm. The X-ray diffraction (XRD) pattern also suggests the presence 
of mixture of phases in MONPs (Figure S2).
49
 The investigation of magnetic properties 
confirms the morpho-structural characterization, suggesting the presence of Mn3O4-MnO 
phases. Bulk Mn3O4 is a ferrimagnetic spinel-type compound (Curie temperature, TC,Mn2O3=43 
K), while MnO is an antiferromagnetic compound (Néel temperature, TN, MnO=100 K). 
49
 
Temperature dependence of magnetization measuring in Field Cooling (FC) condition shows 
a transition around 40 K (close to TC of Mn3O4) suggesting that the magnetic behavior of the 
sample is dominated by the ferrimagnetic Mn3O4 (Figure  S3). This is supported by the field 
dependence of magnetization, showing a quasi-static behavior at 5 K and paramagnetic 
behavior at 80 K (above TC).  It is important to underline that the hysteresis loop at 5 K shows 
a clear non-saturating character at high field, suggesting the presence of an antiferromagnetic 
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contribution that can be ascribed to the presence of a small quantity of MnO in the shell. 
49-51
 
In addition, X-ray photoelectron spectroscopy (XPS) showed mixed oxidation states of  
MONPs (Figure  S4-6), that further support the HRTEM, XRD and magnetic measurements 
described above.  
 A simple one-step protocol was used to functionalize the MONPs with L-DOPA and 
transfer the NPs from organic to water phase.
52
 After functionalization, MONPs were 
collected with centrifugation and dispersed in MilliQ water (5mg/mL). Earlier studies have 
shown that when anchoring dopamine on metallic NPs, the two hydroxyl groups in the 
aromatic ring bind to the oxide layer of the NP surface, and the amine group is oriented 
towards the bulk.
36-38
 At the pH used here (pH=6.8), the carboxylic acid moiety of L-DOPA is 
deprotonated, and functionalized MONPs were found to be negatively charged (Figure 1d). 
As L-DOPA only differs from dopamine by a carboxylic group, the surface organization of L-
DOPA is most likely identical to that of dopamine, i.e.; with its carboxylic group pointing 
outwards. From XPS measurements, MONPs surface functionalized with L-DOPA showed 
the presence of nitrogen, which was absent prior to functionalization (Figure S.5). Also, high 
resolution C1 spectra showed contribution of C-O, C-N, C-C and O-C=O, which combined 
with the N-peak suggests that the L-DOPA molecules are anchored to MONPs via its two 
hydroxyl groups. Thus, bulk-oriented carboxylic acid groups can act as anchor points for 
addition of secondary molecules onto NPs by covalent bonding with amine groups, e.g. via 
carbodiimide chemistry. 
  After one hour in water, the average MONP diameter is halved (Figure 1d). TEM 
images reveal that MONPs are no longer dense particles, but smaller structures with a 
quadratic edge and a hollow interior (Figure 1c). This indicates that MONPs degrade via 
oxidation and dissolve in water, releasing Mn
2+
. 
33
 Oxidation of NPs that leads to hollow or 
porous structures is caused by the Kirkendall effect, which describes that atomic diffusion is 
caused by an exchange of vacancies, and not by an interchange of atoms. 
53
 Here, the outward 
diffusion of Mn
2+
 ions is exchanged with an inward flux of vacancies. With time, the 
manganese oxide shell breaks and the fragments continue to degrade until they are completely 
dissolved (Figure S1).  
 The hydrodynamic diameter (Figure 1e) is significantly larger than the diameter 
estimated from TEM images (Figure 1d), which is expected. This is an effect of the high 
charge density of the MONPs measured by the ζ- potential (Figure 2a), which contributes to a 
higher hydration. The increase in ζ-potential with time (Figure 2a) could also be an effect of 
changes in adlayer concentration, reorientation, or change in the surface affinity of L-DOPA.  
  Functional molecules are usually attached to NPs with a covalent bond, and a 
successful drug delivery vehicle must not only carry the drug, but also release it. Breaking the 
covalent bond in vivo can be a challenge, and may impair drug delivery efficiency. Since 
MONPs disintegrate in water, L-DOPA will eventually be released form the MONPs. The 
bulk concentration of L-DOPA steadily increases with decreasing NP diameter (Figure 1e). 
Our results show that the MONPs disintegrate in water within 50 hours, releasing L-DOPA 
into the surrounding medium.  
 In order to assess their use as CAs in biological systems, the time-dependent contrast 
switch of MONPs was described in pig eyes, ex vivo. Pig eyes are similar to human eyes, the 
specimen size allows for a good signal-to-noise ratio, and they offer a more biologically 
relevant matrix compared to agarose gels, which are more widely used.
54
 MONPs coated with 
L-DOPA were freshly prepared, injected into pig eyes, and scanned with MRI over a period 
of 34 hours.  
 Release of Mn
2+
 is clearly visible in the T1w image, as it takes the form of a bright 
hyperintense cloud surrounding the hypointense injection site (Figure 2a). In the T2*w image, 
the Mn
2+
 ions and MONPs give rise to negative contrast as well, proving the dual properties 
of manganese as active T1 and T2* CAs (Figure  2d). 
32
 With time, the negative contrast  
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 Figure 2: Ex vivo and in vivo degradation of MONPs. Images a) and b) show the T1w 
images of a pig eye injected with MONPs, acquired immediately after injection and after 34 
hours, respectively. “L” refers to the lateral side of the injection site “I”, while “C” refers to 
the central part of the pig eye. Images d) and e) show the complementary T2*w images 
immediately after injection and 34 hours after injection, respectively. Image c) is the T1w and 
image f) is the T2*w image of the control eye, immediately after injection and 34 hours after 
injection, respectively. g) T1w and i) T2*w image of rat ON and retina, 1 hour post injection. 
h) T1w and j) T2*w image of rat ON and retina, 24 hours post injection. 
 
 
decreases in both the T1w (Figure 2b) and T2*w (Figure 2e) images, while the positive 
contrast in the T1w image completely fills the whole intravitreal space (Figure 2b). The T1 
and T2 relaxation times in the pig eyes rapidly decrease after injection of MONPs. In 
particular, the T1 relaxation time at the center of the eye decreases with a simultaneous 
increase in the conductance (Figure 1f). A change in the conductance indicates a change in the 
ionic strength of the suspension. 
55 
The change in conductance and the concomitant effect on 
relaxation times and ex vivo contrast, suggests that MONPs disintegrate into Mn
2+
.  
 The rodent visual system is an established model for investigating damage and repair 
in the central nervous system (CNS), 
3, 56, 57 
as it is easily accessible and immune privileged.
58, 
59
 Enhanced visualization of the ON tract can be achieved by administering contrast agents 
into the vitreous body. Additionally, the retina may act as a barrier to the MONPs while at the 
same time allowing the Mn
2+
 ions to traverse through and visualize the optical nerve. This 
will spatially separate the T1 contrast obtained from Mn
2+
 ions from the T2* contrast of the 
MONPs that will be trapped in the vitreous body.  
 The contrast in the rat retina is significantly enhanced compared to the contralateral 
control eye immediately upon injection of MONPs (Figure 2g). The T2* contrast (Figure 2i, j) 
is not clearly separated from the rodent lens, but after 24 hours, the contrast moves towards 
the retina. This movement is also seen in the complementary T1w images (Figure 2 h). With 
time, the contrast in the ON increases as well (Figure 2h). MONPs are likely too large to be 
taken up by the retinal ganglion cells, but Mn
2+
 ions can.
22, 56
 We have previously used MnCl2 
to study optic nerve regeneration in several animal models. 
22, 56, 60
 However, using MONPs 
opens up for complementary and long term imaging without injecting additional doses of 
CAs.  
 In conclusion, we have developed MONPs functionalized with L-DOPA that 
gradually degrade in biological media, releasing Mn
2+
 ions and L-DOPA. A combination 
which has not been described previously. As CAs in MRI, MONPs give negative contrast, but 
as they disintegrate in water, a concomitant release of Mn
2+
 ions gives a positive contrast. The 
system described here, thus offers a time-dependent switch in the MR contrast from dark to 
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bright, which allows for complementary imaging and enhanced diagnosis. While further 
studies are needed to determine the effect of L-DOPA coated MONPs in a PD model, we have 
herein described a system that can release L-DOPA and that has potential as a drug delivery 
vehicle. 
 
Experimental Section  
Chemicals. L-DOPA (3,4-dihydroxy-L-phenylalanine), anhydrous n-hexane (95%), 
chloroform, dimethyl sulfoxide (DMSO) and hexadecane was purchased from Sigma. Mn(II) 
chloride tetrahydrate. (99.0%) was purchased from Fluka. Sodium oleate (97.0%) was 
purchased from TCI. Oleic acid (90%) was purchased from Alfa Aesar.  
Synthesis of MONPs from Mn-Oleate. First, Mn-Oleate was prepared by reacting MnCl2. with 
sodium oleate as reported in the literature. 
[
[
1]]
  Briefly, MnCl2..4H2O (9.96 mmol, 3.95g) and  
sodium oleate (60.76 mmol, 18.5 g) were added into the mixture of water (40mL), ethanol 
(30mL) and anhydrous n-hexane (70mL). The mixture was left to react for 4 hours at 70°C. 
Mn-Oleate was washed twice with water and collected with a separation funnel. MONPs were 
synthesized by thermal decomposition of a Mn-oleate complex.
 [2]
 Briefly, 1.32 g Mn-Oleate 
was dissolved in the mixture of 600µL oleic acid and 20 mL hexadecane. The solution was 
slowly heated up to 300°C with 3.0°C/min under vigorous stirring and argon atomsphere. The 
solution was left to react for 40 minutes before cooling to room temperature. MONPs were 
precipitated with 20mL hexane and 80 mL acetone followed by centrifugation. After 
discarding the supernatant, the precipitated solid was washed twice with hexane and acetone. 
Finally, MONPs were dispersed in toluene.      
Surface coating of MONPs with L-DOPA.  A modified procedure based on Xie et al 
[3]
 was 
used to coat MONPs with L-DOPA. Briefly, 5mg of dried MONPs were dissolved in 
chloroform and mixed with 20mg L-DOPA and 2mL DMSO and stirred to form a 
homogeneous solution. The suspension was heated to 70°C and left to react for one hour 
under inert atmosphere. MONPs surface coated with L-DOPA were collected by 
centrifugation (4500rpm, 10 min). After removal of the chloroform and DMSO, the product 
was re-dispersed in acetone and centrifuged again to remove unbound L-DOPA. This step 
was reiterated until the product adhered to the centrifuge tube. The product was left to dry 
overnight before characterization.  
UV-visible spectroscopy was performed on a Shimadzu UV-2401PC spectrophotometer in the 
range 200-800nm using UVProbe2.1 as software. 
Scanning (Transmission) electron microscopy (STEM) images were acquired in bright-field 
S(T)EM mode using a Hitachi S-5500 electron microscope operating at 30 kV accelerating 
voltage. TEM grids were prepared by placing a drop (20 µL) of the MONP solution on a 
Formvar carbon coated copper grid (Electron Microscopy Sciences) and allowing the solvent 
to evaporate at room temperature, prior to imaging. The average sizes of NPs were 
determined with log normal fitting using OriginPro 9.0 64bit software.  
High resolution transmission electron microscopy (HR-TEM) images were acquired on a 
JEOL JEM-2100 (200 kV). The samples were prepared by depositing a few µl drop of 
nanoparticle solution on a copper grid coated with amorphous carbon layer, and allowed to 
dry prior to imaging.  
X-ray powder diffraction (XRD) patterns of dried MONPs were obtained from a Bruker 
DaVinci2 diffractometer using Cu Kα (λ= 1.54056 ◦A) in the 2θrange with 10–75 degree. 
X-ray photoelectron spectroscopy (XPS) analyses were performed using a Kratos Axis Ultra 
DLD spectrometer (Kratos Analytical, UK), equipped with a monochromatized aluminum X-
ray source (Al, hυ = 1486.6 eV) operating at 10 mA and 12 kV (150 W). A hybrid lens 
(electrostatic and magnetic) mode was employed along with an analysis area of approximately 
300 µm X 700 µm. Survey spectra were collected over the range of 0-1100 eV binding energy 
with analyzer pass energy of 160 eV, and high resolution spectra of C 1s, O 1s, N 1s, and Mn 
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2p were obtained with an analyzer pass energy of 20 eV. XPS data were processed with Casa 
XPS software (Casa Software Ltd., UK). 
 ζ-potential, mobility and conductance measurements were performed with a Malvern 
Zetasizer Nano-ZS instrument at 20°C and results analyzed using DTS software.  
Magnetic measurements.  The dc magnetization measurements were performed by a Quantum 
Design SQUID magnetometer (Hmax = 5 T). To avoid any movement of the nanoparticles 
during the measurements, the sample, in form of powder, was immobilized in epoxy resin. 
Magnetization versus temperature measurements were performed using the zero-field-cooled 
(ZFC) and field-cooled (FC). ZFC− FC magnetization measurements were carried out by 
cooling the sample from room temperature to 5 K in zero magnetic field; then a static 
magnetic field was applied. MZFC was measured during warming up from 5 to 300 K, whereas 
MFC was recorded during the subsequent cooling. 
 In vivo and Ex vivo Magnetic Resonance Imaging was performed on a 7T Bruker Scanner 
(Biospec 70/20 AS, Bruker Biospin MRI, Ettlingen, Germany). All animal procedures were in 
accordance with the Norwegian Ethics Committee for the use of laboratory animals. For in 
vivo imaging, a 86 mm volume resonator for RF transmission, and a receive only actively 
decoupled rat head quadrature surface coil was used. Rats were put to sleep with 2% 
isoflurane (Sigma) in 30% O2 and 70% N2 before intraperitoneal injection of Haldol (Janssen, 
0.4mg/100g rat) for complete anesthesia. 12 Sprague Dawley rats (n=12) received a 
unilateral, intravitreal injection of 5μL of either MONP-L-DOPA (865nmol, n=2, 433nmol, 
n=1, or 18.2nmol, n=3) or Fe2O3-PEG nanoparticles (179nmol n=1 or 17.9nmol n=5) as 
control. The contralateral eye was used as control. Because MONPs-L-DOPA immediately 
starts to degrade once dissolved in water, the nanoparticles were dissolved by sonication right 
before injection. Rats were placed in an animal bed with water heating (37° C), and the 
respiration rate was continuously monitored using a pressure-sensitive probe (SA Instruments, 
New York, NY, USA). In order to reduce artifacts from eye movements, eye gel (Viscotears
®
, 
Novartis) was applied before sealing the eyelids using medical tape (3M). T1 FLASH and 
MGE specifics. Using paravision 5.1 (Bruker, Bruker Biospin MRI, Ettlingen, Germany), rats 
were imaged with a T2*-weighted  multi gradient echo (MGE, echo time (TE) of 6 ms 
repetition time (TR) of 1000 ms, flip angle (FA) of 30°, field of view (FOV) of 28x25 mm, 
matrix (MTX) of 224x200, 20 slices of 0.667 mm, and 5 averages, lasting 16 min and 40 s) 
and  a T1 weighted 3D-FLASH (TE of 3.53 ms, TR of 12 ms, FA of 30°, FOV of 35x27x22 
mm, MTX of 224x173x141, zero fill acceleration of 1.34, 12 averages, lasting 33 min and 38 
s).Rats injected with MONPs-L-DOPA were imaged 1, 24 and 48 hours post injection, while 
rats injected with Fe2O3-PEG nanoparticles were imaged 24 and 48 hours post injection.  
Ex vivo studies in pig eyes. 500μL of either Fe2O3-PEG (10g/L, 89.5μmol) or 500μL MONPs-
L-DOPA (9.5g/L, 86.5μmol) were injected in the intravitreous body of pig eyes (Noroc, 
Duroc or Norwegian Farm pig, obtained from Nortura). A third eye was used as a control. 
The three eyes were placed in a 2ml centrifuge tube, with the reference eye in the middle. T1-
FLASH and MGE images and T2 and T1 maps were continuously collected at room 
temperature over a time span of 50 hours, using a 72 mm transmit receive volume resonator. 
T1- weighted images were collected using a3D FLASH sequence (TE of 3.65 ms, TR of 12 
ms, FA of 30°, FOV of 72x32x30 mm, MTX of 240x107x100,  zero fill acceleration of 1.34, 
12 averages, lasting 14 min and 46 s) and  T2*-weighted images were obtained with a MGE 
sequence (TE of 6 ms), TR of 2600 ms, FA of 30°, FOV of 32x30 mm, MTX of 107x100, 65 
slices of 1 mm, and 3 averages, lasting 13 min). Note that these sequences are very similar to 
the sequences used in vivo. T1-maps were obtained with a spin echo sequence (TE of 8.45 
ms, TR of 225, 230, 250, 300, 500, 1000, 2000, 5000, 12000 ms, FOV of 72x32 mm, MTX of 
144x64, 15 slices of 1 mm, 1 average, lasting 22 min and 56 s) and T2-maps were obtained 
with a multi slice multi echo sequence (TE of 11.2 ms, echo spacing of 11.2 ms and 50 echos, 
TR of 12000 ms, FOV of 72x32 mm, MTX of 144x64, 15 slices of 1 mm, 1 average, lasting 
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12 min and 48 s). All MR images were processed using in-house developed software in 
MatLab R2012a and Image J 1. 
 
Supporting Information 
Supporting Information is available from the Wiley Online Library. 
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Degradation of MONPs  
The aqueous degradation of MONPs coated with L-DOPA was followed with STEM. 
Representative images are shown in Fig. S.1.  
 
 
 
Fig. S1: Bright field STEM images of MONPs after a) 0 hour, b) 0.5 hour (dark field (DF) 
STEM image in inset shows the formation of hollow NPs, c) 1 hour (DF-STEM image in 
inset shows the formation hollow or c-shape type NPs), d) 4 hours (DF-STEM image in inset 
shows degradation of small MONPs), e) 12 hours, and f) 54 hours.      
 
 
X-ray diffraction, X-ray photoelectron spectroscopy and magnetic properties of MONPs 
 
a) b) 
c) d) 
e) f) 
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X-ray diffraction patterns of MONPs suggests the presence of two species of manganese 
oxide; Mn3O4 and a small quantity of MnO (Fig S.2) 
 
 
Fig. S2:  XRD data for MONPs 
Bulk Mn3O4 is a spinel- type compound with ferromagnetic structure (Tc = 43 K). The spinel 
structure is based on a closed-packed oxygen lattice, in which tetrahedral (Td) and octahedral 
(Oh) intesryicial sites are occupied by the cations (i.e.Mn
2+
, Mn
3+
). In this structure 
ferrimagnetic ordering occurs because the JTO negative exchange interaction between 
magnetic cations occupying Td and Oh sites dominates the negative intra-sublattice exchange 
interactions JTT and JOO, causing each of the two magnetic sublattice sites Td and Oh to be 
aligned
1
. The net magnetization is then proportional to the difference between the Td and Oh 
sublattice magnetization. On the other hand, MnO shows completely different magnetic 
properties with and antiferromagnetic magnetic structure (Néel temperature 100 K)
[4]
 and zero 
magnetic moments in bulk system. Small magnetic moments can be observed in nanoparticles 
due the presence of  uncompensated surface spins.
2
 Temperature dependence of 
magnetization has been investigated by means of zero field cooling (ZFC), and field cooling 
(FC) curves. MZFC shows a maximum at 33 K (Tmax) that can be ascribed to the 
superparamagnetic blocking temperature (Tb) of the MONPs (Fig. S.3). For a non-interacting 
NP system, Tmax can be considered as directly proportional to the average blocking 
temperature (<Tb>), with a proportionality constant of β =1 − 2, depending on the particle size 
distribution. 
[4, 5]
 Below 16 K, the MFC curve shows a decreased temperature dependence, 
suggesting the presence of some dipolar interactions between NPs. 
[6]
 This is supported by the 
field dependence of magnetization recorded at 5 and 80 K: At 80 K, a paramagnetic behavior 
is observed, as expected for temperatures above Tc. At 5K, magnetic hysteresis is observed, 
confirming the presence of magnetic NPs (quasi-static magnetic behavior). It is interesting to 
observe that despite a reversible behavior of magnetization above 3 tesla a non-saturating 
charterer is observed at high field. This suggests the presence of an antiferromagnetic 
contribution that can be ascribe to the presence of a small quantity of MnO. 
[6, 7]
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Fig. S3: a) ZFC (full symbols) and FC (empty symbols) recorded under and applied field of 
0.05T. b) M vs H curves recorded at 5 (full symbols) and 80 K (empty symbols).  
In order to get supporting evidences about chemical state and surface chemistry of MONPs 
prior and after surface modification, X-ray photoelectron spectroscopy (XPS) analysis was 
carried out. In high resolution spectra of Mn2p of MONPs, the doublet (2p3/2, 2p1/2) has been 
observed at the separation of 11.77 eV due to spin-orbit splitting (Fig. S4b). An Mn2p3/2 peak 
can be deconvoluted into three components. The components at ~641.2 and ~642 eV can be 
assigned to characteristics of Mn
2+
 and Mn
3+
. 
[8]
 A third component, which appears at ~645 
eV, is difficult to assign due to lack of reported literature. However, since this peak is close to 
Mn
4+
 cations, it may be related to a different coordination behavior of Mn
4+
. These results 
confirm the mixed oxide behavior of MONPs, which are in agreement with our HRTEM, 
XRD and magnetic measurement results.   
 Prior to surface functionalization, MONPs are capped with oleic acid which can be 
confirmed from a high resolution XPS spectra of C1s indicating peaks at ~285 and ~289 eV 
corresponding to C-C/C=C and O-C=O, respectively (Fig. S4c). 
[9]
 After functionalization of 
MONPs with L-DOPA, a wide scan XPS spectra shows the presence of an “N” peak which 
was absent before the functionalization (Fig. S5a, and Fig. S4a). We did not observe any 
significant difference of high resolution spectra of Mn2p after the surface functionalization 
which was collected immediately after the dispersion of MONPs in water phase (Fig. S5b). A 
high resolution C1s spectra reveals the presence of five components which can be assigned to 
C-C (~285 eV), C-N (~286 eV), C-O (~286.5 eV), O-C=O (~289 eV), and ππ* (~291.4 eV) 
respectively, suggesting the successful coating of L-DOPA on MONPs. 
[9]
 Moreover, the 
main component (~400 eV) in N1s spectra also indicates the presence of primary amine (-
NH2) on the MONPs surface. 
[9]
 From these results, it can be inferred that L-DOPA molecules 
anchor to MONPs via hydroxyl groups.  
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Fig. S4: a) A wide scan XPS spectra of oleic acid coated MONPs; b) high resolution XPS 
spectra of Mn2p and c) high resolution XPS spectra of C1s. 
 
Fig. S5: a) A wide scan XPS spectra of L-DOPA coated MONPs; b) high resolution XPS 
spectra of Mn2p; c) high resolution XPS spectra of C1s and d) high resolution XPS spectra 
N1s. 
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Fig. S6: a) A wide scan XPS spectra of L-DOPA coated MONPs; b) high resolution XPS 
spectra of Mn2p; c) high resolution XPS spectra of C1s and d) high resolution XPS spectra 
N1s. 
We have collected XPS spectra from two weeks old solution of L-DOPA coated MONPs, and 
no significant difference was noticed in a wide scan spectra and C1s (Fig. S6a,c). The 
presence of second component (~401.4 eV) at higher binding energy in N1s spectra indicate 
the protonation of amine group (Fig. S6d). Furthermore, the disappearance of 
Mn
3+
 components from Mn2p3/2 peaks suggests that Mn
3+ 
ions are unstable in deionized water 
(pH~6), and reduced into Mn
2+
.
[10]
 This further suggests the aqueous degradation of the 
MONPs. 
 
 
 
Ex vivo degradation of MONPs 
In order to monitor the T1 and T2 effects of MONPs as a function of time, pig eyes were 
injected with MONPs and scans were performed continuously for 34 hours. Fig. S.7 show 
scans of one pig eye which was injected with L-DOPA coated MONPs, and one non-injected 
control eye. An additional eye injected with PEG-coated iron oxide NPs (Fe3O4) was scanned 
in order to compare the T2* contrast.  
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b) c)
d) e) f)
a)
g)
 
Fig. S.7: Time-resolved T1 weighted and T2* weighted images of pig eyes injected with 
MONPs. The T1w (top) and T2w (bottom) images show how diffusion of Mn
2+
 ions cause T1 
contrast, and how the MONPs give T2* contrast. a) 1 hour, b) 3 hours, c) 4 hours d) 8 hours 
and e) 12 hours  after injection. Images f) and g) show the T1w image of the control eye, and 
of a pig eye injected with iron oxide NPs. 
 With time, the region in the injection site becomes less hypointense, with a concomitant 
hyperintensity observed in the T1w images (Fig. S.7a). The initial burst of T1 contrast is most 
likely due to Mn
2+
 ions already present in the suspension, and this high concentration of Mn
2+
 
ions may also give T2* contrast (Fig. S.7 b). The final T1 contrast is evenly distributed 
throughout the pig eye, and shows the same intensities both at the central part of the pig eye 
and the lateral side from injection. For both the T2* and T1 times, the changes in the lateral 
part of the eye are delayed compared with the central region, and this is explained by the time 
of diffusion of Mn
2+
 ions.  
 The T1 and T2 relaxation rate is the inverse of the T1 and T2 time, respectively. Fig. 
S.8 shows the inverse T1 and T2 times as a function of degradation time, ex vivo in pig eyes. 
The T1 and T2 relaxation rates increase with time ex vivo, and the highest rate is calculated 
for the 1/T2 at the  
central part of the pig eye. 
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Fig. S.8: Relaxation rates as a function of time, ex vivo. Beyond 6 hours, curve fitting was 
not achieved because the T1 andT2 times became too short.  
 
In vivo degradation of MONPs 
Fig. S.9 shows an example of determining the region of interest (ROI) for quantification of 
contrast in the optic nerve using ImageJ.  
 
 
Fig. S.9: Drawing ROI’s defining the optic nerve using image J 
The contrast in the retina and the vitreous body was determined using MatLab 2012a, and an 
example of an ROI is shown in Fig. S.10.  
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Fig. S.10: ROI for rats injected with manganese nanoparticles, T1-weighted image. The 
ROI for the vitreous body was chosen to be two thirds of the eye. The reason for this being 
that the outer part of the eye has some presence of artifacts, due to susceptibility at the eye/air 
interface. The ROI of the retina is chosen to lie outside of the vitreous body ROI in the same 
half circle.    
From these ROIs (Fig S.9 and S.10) the mean intensities and standard deviations were 
measured. 3 rats (n=3) injected with the same amount of MONPs suspension were used to 
determine the change in the contrast.   
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Fig. S.11: Intensity in retina and ON in rodent model Graph a) shows the intensity in the 
retina as a function of time (n=3), and graph b) shows the intensity ratio in the ON corrected 
with respect to the intensity in the contralateral control eye.  
 
Fig. S.12 shows the retina and ON 48 hours post injection of MONPs. No intensity 
differences were found when compared to the lateral control ON.  
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Fig. S.12: Visualization of the ON, 48 hours after intravitreal injection.  
Iron oxide NPs (Fe3O4) surface coated with PEG were used as control T2 contrast agents. 
Compared to the MONPs, the Fe3O4 NPs did not show the same movement towards the retina. 
This is probably a combination of the larger surface molecule, and that the Fe3O4 NPs do not 
dissolve in aqueous media.  Fig. S.13 show T2 weighted images of a rat brain after 
intravitreous injection of Fe3O4 NPs.   
 
Fig. S.13: Fe3O4 NPs as T2 contrast agents. Images a)-c) show T2*w images 24 hours after 
injection. Images d)-f) were acquired 48 hours after injection.  
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